
<html lang="en"     class="pb-page"  data-request-id="a3dda51a-4631-423f-850a-13439c6f096f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-10;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.7b00527;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier" /></meta><meta name="dc.Creator" content="Ilaria  Monaco" /></meta><meta name="dc.Creator" content="Simona  Camorani" /></meta><meta name="dc.Creator" content="David  Colecchia" /></meta><meta name="dc.Creator" content="Erica  Locatelli" /></meta><meta name="dc.Creator" content="Pierpaolo  Calandro" /></meta><meta name="dc.Creator" content="Anais  Oudin" /></meta><meta name="dc.Creator" content="Simone  Niclou" /></meta><meta name="dc.Creator" content="Claudio  Arra" /></meta><meta name="dc.Creator" content="Mario  Chiariello" /></meta><meta name="dc.Creator" content="Laura  Cerchia" /></meta><meta name="dc.Creator" content="Mauro  Comes Franchini" /></meta><meta name="dc.Description" content="Polymeric nanoparticles (PNPs) may efficiently deliver in vivo therapeutics to tumors when conjugated to specific targeting agents. Gint4.T aptamer specifically recognizes platelet-derived growth f..." /></meta><meta name="Description" content="Polymeric nanoparticles (PNPs) may efficiently deliver in vivo therapeutics to tumors when conjugated to specific targeting agents. Gint4.T aptamer specifically recognizes platelet-derived growth f..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 10, 2017" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00527" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00527" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00527" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00527" /></link>
        
    
    

<title>Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00527" /></meta><meta property="og:title" content="Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0005.jpeg" /></meta><meta property="og:description" content="Polymeric nanoparticles (PNPs) may efficiently deliver in vivo therapeutics to tumors when conjugated to specific targeting agents. Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor β and can cross the blood–brain barrier (BBB). We synthesized Gint4.T-conjugated PNPs able of high uptake into U87MG glioblastoma (GBM) cells and with astonishing EC50 value (38 pM) when loaded with a PI3K-mTOR inhibitor. We also demonstrated in vivo BBB passage and tumor accumulation in a GBM orthotopic model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00527"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00527">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00527&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00527&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00527&amp;href=/doi/10.1021/acs.jmedchem.7b00527" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4510-4516</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00422" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/jmv060i010_969955" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ilaria++Monaco">Ilaria Monaco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simona++Camorani">Simona Camorani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Colecchia">David Colecchia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erica++Locatelli">Erica Locatelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-0711-8082" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pierpaolo++Calandro">Pierpaolo Calandro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anais++Oudin">Anais Oudin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simone++Niclou">Simone Niclou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claudio++Arra">Claudio Arra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mario++Chiariello">Mario Chiariello</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Cerchia">Laura Cerchia</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mauro++Comes+Franchini">Mauro Comes Franchini</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-5765-7263" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Industrial Chemistry “Toso Montanari”, University of Bologna, Viale Risorgimento 4, 40136 Bologna, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">∥</span> <span class="aff-text">Istituto per l’Endocrinologia e l’Oncologia Sperimentale “G. Salvatore” (IEOS), Consiglio Nazionale delle Ricerche (CNR), Via S. Pansini 5, 80131 Naples, Italy</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Istituto Toscano Tumori (ITT), Core Research Laboratory and Consiglio Nazionale delle Ricerche (CNR), Istituto di Fisiologia Clinica, Via Fiorentina 1, 53100, Siena, Italy</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">‡</span> <span class="aff-text">NorLux Neuro-Oncology Laboratory, Department of Oncology, Luxembourg Institute of Health, 84 Val Fleuri, Luxembourg L-1586, Luxembourg</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">#</span> <span class="aff-text">Animal Facility Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori “Fondazione G. Pascale”, IRCCS, via M. Semmola, 80131 Naples, Italy</span></div><div class="corresp-info"><strong>*</strong>For M.C.F.: phone, +39-051-2093626; fax, +39-051-2092654; E-mail, <a href="/cdn-cgi/l/email-protection#e4898591968bca878b8981978296858a878c8d8a8da4918a8d868bca8d90"><span class="__cf_email__" data-cfemail="ec818d999e83c28f8381899f8a9e8d828f84858285ac9982858e83c28598">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For L.C.: E-mail: <a href="/cdn-cgi/l/email-protection#47242235242f2e260732292e2926692e33"><span class="__cf_email__" data-cfemail="f2919780919a9b93b2879c9b9c93dc9b86">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For M.C.: E-mail: <a href="/cdn-cgi/l/email-protection#224f43504b4d0c414a4b43504b474e4e4d62414c500c4b56"><span class="__cf_email__" data-cfemail="d7bab6a5beb8f9b4bfbeb6a5beb2bbbbb897b4b9a5f9bea3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00527&amp;href=/doi/10.1021%2Facs.jmedchem.7b00527" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4510–4516</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 4, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 April 2017</li><li><span class="item_label"><b>Published</b> online</span>10 May 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 May 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00527" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00527</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4510%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DIlaria%2BMonaco%252C%2BSimona%2BCamorani%252C%2BDavid%2BColecchia%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D10%26contentID%3Dacs.jmedchem.7b00527%26title%3DAptamer%2BFunctionalization%2Bof%2BNanosystems%2Bfor%2BGlioblastoma%2BTargeting%2Bthrough%2Bthe%2BBlood%25E2%2580%2593Brain%2BBarrier%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4516%26publicationDate%3DMay%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00527"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1972</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">58</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00527" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood–Brain Barrier&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ilaria&quot;,&quot;last_name&quot;:&quot;Monaco&quot;},{&quot;first_name&quot;:&quot;Simona&quot;,&quot;last_name&quot;:&quot;Camorani&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Colecchia&quot;},{&quot;first_name&quot;:&quot;Erica&quot;,&quot;last_name&quot;:&quot;Locatelli&quot;},{&quot;first_name&quot;:&quot;Pierpaolo&quot;,&quot;last_name&quot;:&quot;Calandro&quot;},{&quot;first_name&quot;:&quot;Anais&quot;,&quot;last_name&quot;:&quot;Oudin&quot;},{&quot;first_name&quot;:&quot;Simone&quot;,&quot;last_name&quot;:&quot;Niclou&quot;},{&quot;first_name&quot;:&quot;Claudio&quot;,&quot;last_name&quot;:&quot;Arra&quot;},{&quot;first_name&quot;:&quot;Mario&quot;,&quot;last_name&quot;:&quot;Chiariello&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Cerchia&quot;},{&quot;first_name&quot;:&quot;Mauro&quot;,&quot;last_name&quot;:&quot;Comes Franchini&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;4510-4516&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00527&quot;},&quot;abstract&quot;:&quot;Polymeric nanoparticles (PNPs) may efficiently deliver in vivo therapeutics to tumors when conjugated to specific targeting agents. Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor β and can cross the blood–brain barrier (BBB). We synthesized Gint4.T-conjugated PNPs able of high uptake into U87MG glioblastoma (GBM) cells and with astonishing EC50 value (38 pM) when loaded with a PI3K-mTOR inhibitor. We also demonstrated in vivo BBB passage and tumor accumulation in a GBM orthotopic model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00527&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00527" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00527&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00527" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00527&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00527" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00527&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00527&amp;href=/doi/10.1021/acs.jmedchem.7b00527" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00527" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00527" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00527%26sid%3Dliteratum%253Aachs%26pmid%3D28471660%26genre%3Darticle%26aulast%3DMonaco%26date%3D2017%26atitle%3DAptamer%2BFunctionalization%2Bof%2BNanosystems%2Bfor%2BGlioblastoma%2BTargeting%2Bthrough%2Bthe%2BBlood%25E2%2580%2593Brain%2BBarrier%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D10%26spage%3D4510%26epage%3D4516%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292544" title="Targeting">Targeting</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290920" title="Nanoparticles">Nanoparticles</a>,</li><li><a href="/action/doSearch?ConceptID=292221" title="Drug delivery">Drug delivery</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/jmcmar.2017.60.issue-10/20170525/jmcmar.2017.60.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Polymeric nanoparticles (PNPs) may efficiently deliver in vivo therapeutics to tumors when conjugated to specific targeting agents. Gint4.T aptamer specifically recognizes platelet-derived growth factor receptor β and can cross the blood–brain barrier (BBB). We synthesized Gint4.T-conjugated PNPs able of high uptake into U87MG glioblastoma (GBM) cells and with astonishing EC<sub>50</sub> value (38 pM) when loaded with a PI3K-mTOR inhibitor. We also demonstrated in vivo BBB passage and tumor accumulation in a GBM orthotopic model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Glioblastoma (GBM) is the most common and most aggressive type of primary brain tumor and the astrocytoma of the highest grade.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Surgery, radiotherapy, and chemotherapy are the current standard of care for its treatment, but the prognosis remains unforgiving, partly due to impediment of the blood–brain barrier (BBB).<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Thanks to targeted drug delivery nanovectors, nanotechnology represents an attractive strategy and is receiving increasing attention for its ability of transporting drugs within the cerebral tissue with minimal off-target toxicity.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> Because of its ability of creating biodegradable polymeric nanoparticles (PNPs) suitable for targeted drug delivery approaches, poly(lactic-<i>co</i>-glycolic)-<i>block</i>-poly ethylene glycol (PLGA-<i>b</i>-PEG) copolymer received great attention in the past decade as a main component for nanovectors.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> PNPs administered systemically may reach the cancerous site by passive targeting, due to the so-called “enhanced permeability and retention” (EPR) effect, which is the natural consequence of the defective vascularization and reduced lymphatic drainage in the tumor environment.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, the mere EPR effect cannot accomplish a significant improvement in intracellular uptake, thus it is not sufficient to ensure a high accumulation of PNPs in cancerous tissues. A more promising strategy is the introduction, onto the surface of PNPs, of targeting agents for tumor specific recognition and internalization, which lead to selective accumulation of the drug in cell compartments.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Potential agents for targeting tumor cells are small molecules, peptides, or monoclonal antibodies, but lately aptamers arose as the most promising ones. Aptamers, generated by the systematic evolution of ligands by exponential enrichment (SELEX) method, are short, artificial, single-stranded oligonucleotides that, similarly to antibodies, interact at high affinity with their targets by recognizing a specific three-dimensional structure. Thanks to their unique properties (small size, high stability, convenient synthesis, and modification with minimal interbatch variability, lack of immunogenicity), aptamers have been proved as a valid alternative to antibodies as targeted cancer therapeutic agents on their own or as carriers of chemotherapeutic agents, small interfering RNAs, or drug-loaded nanoparticles.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Specifically, proof-of-concept studies have suggested aptamers as efficacious escort agents to deliver PNPs to tumor in intracranial GBM-bearing mice.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> In choosing aptamers for targeting GBM cells, it is essential that they recognize receptors that are preferentially expressed on the surface of cancer cells. Several studies demonstrated the expression and activation of multiple growth factor receptors in GBM that dictate the tumor response to targeted therapies. Among them, platelet-derived growth factor receptors (PDGFRs), both α and β forms, are amplified and/or overexpressed in human glial tumors with PDGFRα strongly associated with the proneural subtype and PDGFRβ more commonly expressed in different GBM subtypes and preferentially expressed by self-renewing tumorigenic GBM stem cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Further, PDGFRβ upregulation has been recently shown as a cause of acquired resistance of GBMs to epidermal growth factor receptor inhibitors,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> highlighting the importance of specifically targeting this receptor for GBM treatment. Here, we investigated the possibility to associate the anti-PDGFRβ aptamer with PNPs acting as nanovectors for the delivery of a promising chemotherapeutic drug, <b>1</b> (Dactolisib, NVP-BEZ235),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> a potent dual PI3K-mTOR inhibitor that is currently under investigation for the treatment of solid tumors and has recently proved to be a radio- and chemosensitizer in preclinical mouse GBM models. When tested for functionality, the final targeted drug-loaded nanovectors were strongly effective to specifically induce cytotoxicity in U87MG GBM cells. Importantly, fluorescence imaging approaches demonstrated that, upon intravenous injection in nude mice bearing intracranial U87MG tumors, the aptamer-PNPs conjugates cross the BBB and accumulate at the tumor site. Accordingly, the assembled nanovectors were successful in delivering <b>1</b> to the tumors, as evidenced by their ability to inhibit mTOR activity in vivo, therefore encouraging their further investigation as active drug delivery systems in patient-specific orthotopic GBM xenograft models.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21676" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21676" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis and Characterization of <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="2c1d6c7c627c5f">[email protected]</a> Nanovectors</h3><div class="NLM_p">To demonstrate the improved efficiency of targeted nanovectors in delivering drugs into the brain tumor environment, we prepared PNPs based on poly(lactic-<i>co</i>-glycolic)-<i>block</i>-poly ethylene glycol (PLGA-<i>b</i>-PEG) copolymer and loaded them with a lipophilic dye, BODIPY505-515 (BODIPY), for visualization purposes, or with a PI3K-mTOR inhibitor, <b>1</b>, to evaluate their efficacy for cancer cell killing. Specifically, we loaded PNPs with <b>1</b> and conjugated them with an anti-PDGFRβ aptamer,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> named Gint4.T, onto the external surface for selective targeting against GBM cells. For this purpose, the copolymer PLGA-<i>b</i>-PEG-COOH was synthesized as the previously reported method shown in the <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>1</b> has the severe limitation of being poorly water-soluble, thus its bioavailability is reduced and huge administration doses are necessary for ascertaining a significant effect. In our case, by using the <i>water-in-oil-in-water</i> double-emulsion sonication method,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> we entrapped the drug in the lipophilic portion of PNPs, obtaining a final water dispersible formulation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> After purification of the obtained <b>1</b>@PNPs (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), conjugation of amino-terminated Gint4.T was performed by exploiting the superficial residual carboxylic groups onto the PNPs surface, derived from PEG chains. <b>1</b>@PNPs-Gint4.T was then purified and characterized by dynamic light scattering (DLS), which revealed particles with diameter equal to 52 ± 1 nm, a low polydispersity index (PDI = 0.169), and negative ζ-potential value of −13.1 mV due to unreacted carboxylic acid groups. <b>1</b> concentration was determined to be 25.2 μM by fluorimetric analysis.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Copolymer (PLGA-<i>b</i>-PEG-COOH)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DCC/NHS, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 12 h; (ii) NH<sub>2</sub>-PEG-COOH, DIPEA, room temperature, 12 h.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representation of the Water-in-Oil-in-Water Procedure for the Obtainment of the Final Nanovectors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The amount of aptamer conjugated to the PNPs was evaluated by RT-qPCR analysis on <b>1</b>@PNPs-Gint4.T. The concentration of Gint4.T was 1.4 nM, and the conjugation efficiency was 5.4%. The overall <b>1</b>@PNPs-Gint4.T concentration in solution was established by gravimetric analysis to be 18.4 mg/mL. To prove a direct correlation between results obtained and the presence of a specific aptamer onto the surface of the nanoparticles, <b>1</b>@PNPs were also conjugated with a 2′F-Py RNA with no affinity for PDGFRβ receptor, consisting in the scrambled sequence of a previously generated anti-EGFR aptamer and herein used as negative control (indicated as <b>1</b>@PNPs-SCR, see Supporting Information (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S1</a>).<a onclick="showRef(event, 'ref17 ref21'); return false;" href="javascript:void(0);" class="ref ref17 ref21">(17, 21)</a> Conversely, for fluorescence-based studies (internalization studies by confocal laser microscopy and in vivo tumor targeting), we substituted with a lipophilic dye, BODIPY505-515, allowing for visualization of the nanoparticles (see SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S2</a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> In Vitro Internalization Studies</h3><div class="NLM_p">Targeting efficiency of aptamer-decorated nanovectors is a crucial factor for optimal delivery of drugs to cancer cells. <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="fcbeb3b8b5aca5bcacb2ac8f">[email protected]</a>, conjugated with Gint4.T or scrambled (SCR) aptamers, were incubated with U87MG cells, a widely used GBM cell line, and nanovectors were visualized by confocal microscopy by taking advantage of a fluorophore incorporated in the oleic phase of PNPs, namely BODIPY. PNPs conjugated with Gint4.T aptamer resulted easily internalized in U87MG cells, becoming clearly visible 10 min after the beginning of the treatment; conversely, SCR decorated nanovectors were undetectable until 50 min (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a> and SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S3</a>).</div><figure id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. U87MG cells were incubated for different periods (from 30 to 60 min) with <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="eeaca1aaa7beb7aebea0be9dc3a987809adac0ba">[email protected]</a> or <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="8bc9c4cfc2dbd2cbdbc5dbf8a6d8c8d9">[email protected]</a> or left untreated. After washing and fixation, U87MG cells were labeled with WGA-647 to visualize cell membrane (red) and with DAPI to stain nuclei (blue). <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="33717c777a636a73637d6340">[email protected]</a> are displayed in green. White squares indicate the areas shown in insets. White bars correspond to 25 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These data indicated that the conjugation of PNPs with the anti-PDGFRβ aptamer strongly enhanced the internalization of the nanovectors in GBM cells. To additionally control that specificity of targeting depended on the recognition of the PDGFRβ by the Gint4.T aptamer, we next produced U87MG clonal cells depleted from this receptor by an shRNA approach. PDGFRβ-depleted cells were, therefore, evaluated by immunoblot analysis, revealing significantly reduced protein levels of this receptor compared with control cells silenced with scrambled shRNA and with parental cells (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S4A</a>). PNPs uptake was therefore monitored in PDGFRβ positive cells (parental and nonsilencing shRNA U87MG) compared to different PDGFRβ-depleted cell clones (PDGFRβ shRNA U87MG clones 3 and 6).</div><div class="NLM_p last">After a 40 min incubation, fluorescent <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="96d4d9d2dfc6cfd6c6d8c6e5bbd1fff8e2a2b8c2">[email protected]</a> were clearly internalized exclusively in PDGFRβ positive cells (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S4B,C</a>) while, as an additional control, untargeted, fluorescent <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="4a08050e031a130a1a041a3967190918">[email protected]</a> were not internalized in any of the cell clones. Altogether, these data clearly indicate that the Gint4.T aptamer specifically targets PNPs to GBM cells, strongly enhancing their intracellular uptake.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> In Vitro Cytotoxicity Studies</h3><div class="NLM_p">On the basis of our results demonstrating efficient and specific internalization of PDGFRβ-targeted PNPs in GBM cells, we next studied their ability to efficiently release drugs loaded into the nanovectors. For this purpose, we selected the lipophilic drug <b>1</b>, a novel dual kinase inhibitor directed against PI3K and MTOR, which is currently under investigation as a therapeutic tool against multiple solid tumors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Taking advantage of the lipophilic behavior of this compound, <b>1</b>, entrapment in PNPs was obtained by using the <i>water-in-oil-in-water</i> double-emulsion sonication method,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> ultimately allowing us to obtain a final water dispersible formulation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Pairwise, to check the potential toxicity of the nanoparticle carrier itself, unloaded PNPs targeted with either SCR or Gint4.T aptamer were tested for cell viability on U87MG GBM cell line. Unloaded carriers resulted in a very limited toxicity even at the maximal concentration (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S5</a>). Furthermore, <b>1</b> loaded PNPs were used in cytotoxicity studies at carrier concentrations lower than 0.020 mg/mL, at which unloaded carrier is extremely safe and completely atoxic. First, we confirmed the ability of <b>1</b> to inhibit the PI3K/MTOR pathway by evaluating in vitro phosphorylation of the 4EBP1 protein, a well-established substrate of MTOR.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Specifically, 4EBP1 phosphorylation was monitored after 40 min incubation of U87MG cells with <b>1</b>@PNPs-SCR and <b>1</b>@PNPs-Gint4.T or after 40 min incubation, followed by washing and a 6 h recovery period. In both conditions, <b>1</b>@PNPs-Gint4.T efficiently inhibited 4EBP1 phosphorylation at levels comparable to “free” <b>1</b> and, interestingly, more efficiently than <b>1</b>@PNPs-SCR (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S6A</a>). Interestingly, <b>1</b>@PNPs-Gint4.T were much less efficient in MTOR pathway down-regulation when compared to <b>1</b>@PNPs-SCR in shPDGFRβ U87MG cells in which the expression of Gint4.T aptamer target, PDGFRβ, was strongly decreased (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S6B,C</a>). Overall, these data therefore established the ability of the drug to be effective on its specific biochemical targets also when delivered inside our PNPs and suggested improved efficacy for U87MG targeting for Gint4.T-coupled PNPs. Therefore, the ability of drug-loaded nanovectors of killing U87MG target cells was next measured by cytotoxicity assays, evaluating EC<sub>50</sub> values for “free” <b>1</b>, <b>1</b>@PNPs-SCR, and <b>1</b>@PNPs-Gint4.T. After 72 h of continuous incubation with cells, free <b>1</b> showed an EC<sub>50</sub> of about 165 nM on the GBM cell line, while the same drug entrapped in PNPs resulted in being at least 1000-fold more cytotoxic, with PNPs-Gint4.T about 4-fold more effective than PNPs-SCR (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), demonstrating that our nanovectors strongly improved bioavailability of the drug and that PNP-coating aptamers additionally increased killing efficacy by enhancing nanovectors internalization. Moreover, Gint4.T aptamer specificity was confirmed also in this system, taking advantage of our shSCR and shPDGFRβ U87MG cells for evaluating EC<sub>50</sub> of “free” <b>1</b>, <b>1</b>@PNPs-Gint4.T, and <b>1</b>@PNPs-SCR upon 72 h of continuous incubation with cells (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> and SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S7</a>). In U87MG cells with downregulated PDGFRβ, the uptake advantage offered by Gint4.T aptamer was strongly reduced, as expected, as evidenced by highly similar EC<sub>50</sub> for SCR and Gint4.T decorated <b>1</b>@PNPs, which resulted in 441 ± 43 and 486 ± 38 nM, respectively. To further confirm quick PNPs internalization driven by Gint4.T aptamer, we next evaluated EC<sub>50</sub> of “free” <b>1</b>, <b>1</b>@PNPs-Gint4.T, and <b>1</b>@PNPs-SCR upon a short 40 min incubation time followed by washing and a 72 h recovery period. In these settings, EC<sub>50</sub> of <b>1</b>@PNPs-Gint4.T was 6500-fold better than free drug and 65-fold better than <b>1</b>@PNPs-SCR (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), demonstrating faster upload and more efficient GBM cell killing of targeted as compared to untargeted nanovectors. Overall, our data therefore suggest that our PDGFRβ targeted, drug-loaded nanovectors already represent more efficient alternatives to water-insoluble “free” drugs such as <b>1</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. EC<sub>50</sub> Values on GBM Cell Line<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub> (72 h) (pM)</th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub> (40 min + WO + 72 h) (pM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">165693 ± 1822</td><td class="colsep0 rowsep0" align="char" char="±">1017585 ± 8774</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>@PNPs-SCR</td><td class="colsep0 rowsep0" align="char" char="±">156 ± 18</td><td class="colsep0 rowsep0" align="char" char="±">10443 ± 632</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>@PNPs-Gint4.T</td><td class="colsep0 rowsep0" align="char" char="±">38 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">160 ± 11</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">EC<sub>50</sub>s ± SD for free <b>1</b>, <b>1</b>@PNPs-SCR, and <b>1</b>@PNPs-Gint4.T were evaluated after continuous incubation (EC<sub>50</sub> at 72 h) and after 40 min incubation followed by washes (WO = washout) and 72 h recovery. EC<sub>50</sub>s were assessed by automatic cell counting and estimated on the basis of three different experiments (<i>n</i> = 3).</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. EC<sub>50</sub> Values on shSCR and shPDGFRβ U87MG Cells<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> on U87 shSCR (pM)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> on U87 shPDGFRβ (pM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">143237 ± 1542</td><td class="colsep0 rowsep0" align="center">134527 ± 1288</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>@PNPs-SCR</td><td class="colsep0 rowsep0" align="center">448 ± 51</td><td class="colsep0 rowsep0" align="center">441 ± 43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>@PNPs-Gint4.T</td><td class="colsep0 rowsep0" align="center">141 ± 36</td><td class="colsep0 rowsep0" align="center">486 ± 38</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">EC<sub>50</sub>s ± SD for free <b>1</b>, <b>1</b>@PNPs-SCR, and <b>1</b>@PNPs-Gint4.T were evaluated after continuous incubation (EC<sub>50</sub> at 72 h). EC<sub>50</sub> were assessed by Cell Titer Glo and estimated on the basis of three different experiments (<i>n</i> = 3).</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Specific Tumor Targeting of Aptamer-Based Nanovectors</h3><div class="NLM_p">The existence of the BBB is a major impediment for the delivery of drugs to brain tumors through the blood. It is, therefore, of uppermost importance also for any novel systemic drug delivery system to prove its ability to pass this barrier to specifically accumulate into targeted tumors. The intracranial U87MG (PTEN null) tumor model was used to test, in vivo, the <b>1</b>-loaded nanovectors because these tumors share, with a large proportion of GBM, the deregulation of the PI3K pathway. Further, even though U87MG tumor xenografts are not representative of the infiltrative behavior of human GBM, their fast growth with delineated boundaries (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S8A</a>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> allows easy identification and dissection, thus representing the most frequently used glioma model. First, to evaluate passage through the BBB and specific brain tumor accumulation, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="672528232e373e27372937144a200e0913534933">[email protected]</a> or <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3f7d707b766f667f6f716f4c126c7c6d">[email protected]</a> nanovectors were systemically administered to nude mice bearing intracranial U87MG tumor xenografts.</div><div class="NLM_p">High-resolution fluorescence imaging of whole brains, explanted from mice sacrificed 2 h after injection, showed a clear signal, distinct from noises of autofluorescence background, in tumor from <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="cc8e8388859c958c9c829cbfe18ba5a2b8f8e298e1b8bea9adb8a9a8">[email protected]</a> animals, while no specific signal was observed in tumors from mice treated with the negative control nanovectors (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). To further corroborate these findings, indicating the accumulation into the tumor of the nanoparticles conjugated with Gint4.T, but not with the scrambled aptamer, sagittal sections of the brains were analyzed by confocal microscopy (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S8B</a>) or H&E stained to confirm the location and the boundary of the tumor (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S8A</a>).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Ex vivo fluorescence imaging of entire brains explanted from mice bearing U87MG orthotopic xenografts 2 h after injection of PBS, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="e4a6aba0adb4bda4b4aab497c9a38d8a90d0cab0">[email protected]</a>, or <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="98dad7dcd1c8c1d8c8d6c8ebb5cbdbcab6">[email protected]</a> Magnified views of the tumor areas (white square) are indicated in the insets. White arrows indicate fluorescent signals from Gint4.T-PNPs. (B) Aptamer-PNPs fluorescence in the tumor, at 2 and 4 h post injection, was quantified on six separate slices for each experimental group and expressed as mean fluorescence intensity (MFI) ± SD of 10 microscopy fields randomly taken from each slice. (C) Western blot of p4EBP1 and total 4EBP1 in intracranial U87MG xenografts after completion of the 5-day treatment with saline, <b>1</b>@PNPs-SCR, or <b>1</b>@PNPs-Gint4.T. (left) Four representative tumors per group are shown. α-tubulin was used as internal control. (right) Quantitation of p4EBP1/4EBP1. Each data point represents the sample from an individual mouse (<i>n</i> = 8). One-way ANOVA followed by Tukey’s multiple comparison test (C) or student’s <i>t</i>-test (B). **<i>P</i> < 0.01; *<i>P</i> < 0.05; ns, no significance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consistently with the entire brain imaging results, the fluorescence intensity, distributed in the tumor, from the Gint4.T-conjugated PNPs was significantly higher than from the SCR-conjugated PNPs. Importantly, the fluorescence from the control nanoparticles was almost undetectable also at 4 h after injection while the fluorescence from the Gint4.T-nanovectors was significantly higher at 4 h than at the 2 h time point (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S8B</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). In this context, it is worth to noticing that, although the BBB is partially damaged at the tumor core of the intracranial U87MG model, it is conversely fully intact in the brain areas that are distant from the central tumor mass, such as the tumor rim and the contralateral normal hemisphere, where it prevents drug penetration.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a> Importantly, such distribution mirrors what occurs in large part of human GBMs where it is essential to potentially treat not only the “core” of the tumor but also invasive peripheral areas and, even more so, sparsely invaded regions distant from the tumor bulk and protected by an intact BBB.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24-26)</a></div><div class="NLM_p last">Therefore, to confirm that our delivery system was indeed able to cross an intact BBB, we analyzed the amount of fluorescence in the areas of normal brain distant from the tumor, i.e., the contralateral hemisphere, detecting a greater fluorescence in the brain from mice that received Gint4.T-PNPs injection compared to those treated with the scrambled nanovectors, again supporting that conjugation with the anti-PDGFRβ aptamer allows the nanoparticles to cross the BBB (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">Figure S9</a>). Next, to confirm the tumor-specific targeting of nanovectors, we assessed the effectiveness of the Gint4.T-PNPs in delivering the drug to mouse brain tumors. To this aim, <b>1</b>@PNPs-SCR and <b>1</b>@PNPs-Gint4.T were systemically administered daily over 5 consecutive days to tumor-bearing mice. At the end of the treatment, the tumors isolated from the brains were processed for inhibition of phospho-4EBP1. Following such a short and acute treatment, phospho-4EBP1 levels were significantly lower in Gint4.T-PNPs treated tumors than in the control tumors (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). Overall, these results prove the efficacy of our specifically assembled nanosystem to overcome the BBB and accumulate in the tumor and suggest that both these processes are mediated by Gint4.T aptamer-dependent recognition of the PDGFRβ expressed on these cells. Regarding NP accumulation into GBM cells, we clearly prove that it is mediated by interaction of NP with the PDGFRβ expressed on tumor cells,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> being abrogated by receptor downregulation obtained with an shRNA approach. Moreover, the high affinity and specificity of Gint4.T vs the receptor target allows a very low amount of aptamer to efficaciously drive GBM cells internalization of the nanoparticles and their tumor uptake upon in vivo administration. Regarding passage through the BBB, we also clearly demonstrate, in vivo, the requirement of the Gint4.T aptamer on the NP’s surface as scrambled aptamers cannot induce such passage. In this regard, it should be pointed out that PDGFRβ is highly expressed on endothelial cells of vessels, which vascularize the tumor,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> while it has been recently shown<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> that an in vitro reconstituted BBB model, consisting of endothelial cells, astrocytes, and pericytes grown on a three-dimensional scaffold resulted in being permeable to the Gint4.T aptamer, suggesting that the aptamer could cross the BBB model by transcytosis mediated by its target. Thus, the anti-PDGFRβ Gint4.T aptamer could plausibly allow both receptor-mediated transcytosis through the BBB and GBM targeting, revealing a precious strategy to mediate highly specific and effective drug delivery to gliomas. Notably, despite an increasing number of cell-type specific aptamers that have been integrated with nanocarriers for both imaging and therapeutic applications in different tumors, only a few studies employed aptamers as targeting agent for glioma through the BBB.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Moreover, while Gao et al. needed to functionalize NP with both an antinucleolin AS1411 aptamer for tumor uptake and with the 12-amino acid TGN peptide to cross the BBB in a C6 orthotopic glioma model,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> the same group more recently demonstrated, in the U87MG orthototopic model, a better tumor accumulation of NPs functionalized with an aptamer, selected by glioma cell-SELEX, whose molecular target was not identified, limiting the possibility of deeper investigation of involved mechanisms.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Overall, our study indicates the Gint4.T-based nanosystems as a promising tool to efficiently deliver innovative drugs or conventional chemotherapeutics through the BBB for GBM treatment. Importantly, unconjugated Gint4.T aptamer has been shown to directly inhibit PDGFRβ function both in vitro and in vivo.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Thus, it will potentially act not only as a targeting moiety but also as PDGFRβ antagonist, thus further improving the therapeutic efficacy of the aptamer/drug-PNPs conjugates. Further, apart from therapeutic utility, the assembled nanovectors could be usefully applied for diagnostic purposes allowing the site-targeted controlled delivery of imaging agents to the brain tumor. Notably, given that the list of oligonucleotide aptamers interacting with biomarkers expressed on tumor cell surfaces is growing rapidly, the proposed approach could be generally applicable to different surface-decorating aptamers and/or entrapped drugs (or imaging agents) in order to test new therapeutic (or diagnostic) options for GBMs and other human cancers.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we have prepared a novel multifunctional nanosystem having specific PDGFRβ aptamer conjugated on the outer shell of the PNPs. This nanovector has been validated in vitro and proved to be extremely efficient for “active” targeting and internalization in GBM cellular models. Importantly, entrapment of a very promising but low water-soluble drug, <b>1</b>, for GBM treatment strongly increased its bioavailability with a 1000-fold augmented cytotoxicity as compared to the free drug. Ultimately, we have also demonstrated for the first time the in vivo specific GBM tumor uptake on orthotopic cancer-bearing mice after intravenously administration, thus demonstrating these nanovectors as very promising “carriers” for any drug through the BBB and to specifically target GBM tumors. Taken together, we show that the increased presence and activity of PDGFRβ aptamer can be used to specifically, effectively, and safely to deliver a multifunctional nanosystem to an orthotopic brain tumor. Through this approach, important breakthroughs can be envisaged in biomedical sciences, offering interesting potentialities for basic science and translational applications.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General</h3><div class="NLM_p last">All reagents were purchased from Sigma-Aldrich and used as received, unless stated otherwise. <b>1</b> was purchased from Selleck Chemicals (Munich, Germany) with purity of 99.02%, as determined by HPLC. Gint4.T and its scrambled sequence were purchased from TriLink Biotechnologies (Tebu-bio, San Diego, USA) with purity above 95% (PAGE analysis, short wave).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis of Polymeric Nanovectors</h3><div class="NLM_p last">First, 100 mg of PLGA-<i>b</i>-PEG-COOH prepared as already reported by us,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and 6 mg (0.013 mmol) of 1 or 0.5 mg (0.02 mmol) of BODIPY505-515 were dissolved in 10 mL of dichloromethane and admixed to 1 mL of water. Then the two-phase mixture was emulsified, in an ice bath, with a tip-probe sonicator (600 W input, 50% ampl) for 45 s. Then 40 mL of 1.25% sodium cholate solution in water was slowly added to the obtained emulsion: the resulted two-phase mixture was further emulsified for 3 min, in an ice bath, at the above-reported amplitude. The solvent was evaporated under reduced pressure and the resulting particles washed and concentrated by using centrifugal filter devices (Amicon Ultra, Ultracell membrane with 100,000 NMWL, Millipore) to a final volume of 2 mL and finally filtered by using a syringe filters Phenex-PES of polyether sulfone (26 mm, 0.20 μm, Phenomenex, Italy). <b>1</b>@PNPs were diluted in PBS (5 mL, 0.01 M) and a solution of <i>N</i>-hydroxysulfosuccinimide 2.3 mM (4.3 mL), and a solution of 1-ethyl-3-(3-(dimethylamino)propyl) carbodiimide 0.28 M (1.8 mL) was added. The reaction was carried out at room temperature for 15 min, then 102 pmol of 2′F-Py RNA Gint4.T aptamer or the scrambled sequence of the anti-EGFR aptamers,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> dissolved in 1 mL of water, was added and left to react for 24 h.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00527">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00527" class="ext-link">10.1021/acs.jmedchem.7b00527</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedure, quantitative analysis, in vitro and in vivo additional experiments (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf">jm7b00527_si_001.pdf (1.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_002.csv">jm7b00527_si_002.csv (0.26 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00527" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mario Chiariello</span> - <span class="hlFld-Affiliation affiliation">Istituto Toscano Tumori (ITT), Core Research Laboratory
and Consiglio Nazionale delle Ricerche (CNR), Istituto di Fisiologia Clinica, Via Fiorentina 1, 53100, Siena, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2e434f5c4741004d46474f5c474b4242416e4d405c00475a"><span class="__cf_email__" data-cfemail="b8d5d9cad1d796dbd0d1d9cad1ddd4d4d7f8dbd6ca96d1cc">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Cerchia</span> - <span class="hlFld-Affiliation affiliation">Istituto per l’Endocrinologia
e l’Oncologia Sperimentale “G. Salvatore” (IEOS), Consiglio Nazionale delle Ricerche (CNR), Via S. Pansini 5, 80131 Naples, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#395a5c4b5a515058794c5750575817504d"><span class="__cf_email__" data-cfemail="c2a1a7b0a1aaaba382b7acabaca3ecabb6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mauro Comes Franchini</span> - <span class="hlFld-Affiliation affiliation">Department of Industrial
Chemistry “Toso Montanari”, University of Bologna, Viale Risorgimento 4, 40136 Bologna, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5765-7263" title="Orcid link">http://orcid.org/0000-0001-5765-7263</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1a777b6f6875347975777f697c687b7479727374735a6f7473787534736e"><span class="__cf_email__" data-cfemail="b0ddd1c5c2df9ed3dfddd5c3d6c2d1ded3d8d9ded9f0c5ded9d2df9ed9c4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ilaria Monaco</span> - <span class="hlFld-Affiliation affiliation">Department of Industrial
Chemistry “Toso Montanari”, University of Bologna, Viale Risorgimento 4, 40136 Bologna, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simona Camorani</span> - <span class="hlFld-Affiliation affiliation">Istituto per l’Endocrinologia
e l’Oncologia Sperimentale “G. Salvatore” (IEOS), Consiglio Nazionale delle Ricerche (CNR), Via S. Pansini 5, 80131 Naples, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Colecchia</span> - <span class="hlFld-Affiliation affiliation">Istituto Toscano Tumori (ITT), Core Research Laboratory
and Consiglio Nazionale delle Ricerche (CNR), Istituto di Fisiologia Clinica, Via Fiorentina 1, 53100, Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erica Locatelli</span> - <span class="hlFld-Affiliation affiliation">Department of Industrial
Chemistry “Toso Montanari”, University of Bologna, Viale Risorgimento 4, 40136 Bologna, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0711-8082" title="Orcid link">http://orcid.org/0000-0002-0711-8082</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierpaolo Calandro</span> - <span class="hlFld-Affiliation affiliation">Istituto Toscano Tumori (ITT), Core Research Laboratory
and Consiglio Nazionale delle Ricerche (CNR), Istituto di Fisiologia Clinica, Via Fiorentina 1, 53100, Siena, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anais Oudin</span> - <span class="hlFld-Affiliation affiliation">NorLux Neuro-Oncology
Laboratory, Department of Oncology, Luxembourg
Institute of Health, 84 Val Fleuri, Luxembourg L-1586, Luxembourg</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simone Niclou</span> - <span class="hlFld-Affiliation affiliation">NorLux Neuro-Oncology
Laboratory, Department of Oncology, Luxembourg
Institute of Health, 84 Val Fleuri, Luxembourg L-1586, Luxembourg</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudio Arra</span> - <span class="hlFld-Affiliation affiliation">Animal Facility Unit, Department
of Experimental Oncology, Istituto Nazionale
per lo Studio e la Cura dei Tumori “Fondazione G. Pascale”,
IRCCS, via M. Semmola, 80131 Naples, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. I.M, S.C., and D.C. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d149e1012-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73516" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73516" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">University of Bologna and Istituto Toscano Tumori are acknowledged for funding this project. The work was supported in part by IG AIRC (n. 18753 to L.C.). S.C. was supported by a Fondazione Umberto Veronesi Fellowship.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i18" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i18"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i19" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i19"> Abbreviations Used</h2><tr><td class="NLM_term">GBM</td><td class="NLM_def"><p class="first last">glioblastoma multiforme</p></td></tr><tr><td class="NLM_term">PNPs</td><td class="NLM_def"><p class="first last">polymeric nanoparticles</p></td></tr><tr><td class="NLM_term">SCR</td><td class="NLM_def"><p class="first last">scrambled</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">PDGFRs</td><td class="NLM_def"><p class="first last">platelet-derived growth factor receptors</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Louis, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reifenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Deimling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figarella-Branger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavenee, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohgaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiestler, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleihues, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellison, D. W.</span><span> </span><span class="NLM_article-title">The 2016 World Health Organization classification of tumors of the central nervous system: a summary</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span><span class="refDoi"> DOI: 10.1007/s00401-016-1545-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1007%2Fs00401-016-1545-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=27157931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A280%3ADC%252BC28bnsVektA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2016&pages=803-820&issue=6&author=D.+N.+Louisauthor=A.+Perryauthor=G.+Reifenbergerauthor=A.+Von+Deimlingauthor=D.+Figarella-Brangerauthor=W.+K.+Caveneeauthor=H.+Ohgakiauthor=O.+D.+Wiestlerauthor=P.+Kleihuesauthor=D.+W.+Ellison&title=The+2016+World+Health+Organization+classification+of+tumors+of+the+central+nervous+system%3A+a+summary&doi=10.1007%2Fs00401-016-1545-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary</span></div><div class="casAuthors">Louis David N; Perry Arie; Reifenberger Guido; Reifenberger Guido; von Deimling Andreas; von Deimling Andreas; Figarella-Branger Dominique; Cavenee Webster K; Ohgaki Hiroko; Wiestler Otmar D; Kleihues Paul; Ellison David W</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor.  For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era.  As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and other embryonal tumors, and incorporates new entities that are defined by both histology and molecular features, including glioblastoma, IDH-wildtype and glioblastoma, IDH-mutant; diffuse midline glioma, H3 K27M-mutant; RELA fusion-positive ependymoma; medulloblastoma, WNT-activated and medulloblastoma, SHH-activated; and embryonal tumour with multilayered rosettes, C19MC-altered.  The 2016 edition has added newly recognized neoplasms, and has deleted some entities, variants and patterns that no longer have diagnostic and/or biological relevance.  Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma-a departure from the manner by which other CNS tumors are graded.  Overall, it is hoped that the 2016 CNS WHO will facilitate clinical, experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7YzqOXqWReQqdek-gHSrIfW6udTcc2eZMeq5pJmtWXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bnsVektA%253D%253D&md5=f9ac51999bf1b171477b20ea0085c9e8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00401-016-1545-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-016-1545-1%26sid%3Dliteratum%253Aachs%26aulast%3DLouis%26aufirst%3DD.%2BN.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3DVon%2BDeimling%26aufirst%3DA.%26aulast%3DFigarella-Branger%26aufirst%3DD.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DOhgaki%26aufirst%3DH.%26aulast%3DWiestler%26aufirst%3DO.%2BD.%26aulast%3DKleihues%26aufirst%3DP.%26aulast%3DEllison%26aufirst%3DD.%2BW.%26atitle%3DThe%25202016%2520World%2520Health%2520Organization%2520classification%2520of%2520tumors%2520of%2520the%2520central%2520nervous%2520system%253A%2520a%2520summary%26jtitle%3DActa%2520Neuropathol.%26date%3D2016%26volume%3D131%26issue%3D6%26spage%3D803%26epage%3D820%26doi%3D10.1007%2Fs00401-016-1545-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naishadham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer statistic</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.3322/caac.20138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.3322%2Fcaac.20138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=22237781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A280%3ADC%252BC387jvVaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=10-29&author=R.+Siegelauthor=D.+Naishadhamauthor=A.+Jemal&title=Cancer+statistic&doi=10.3322%2Fcaac.20138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2012</span></div><div class="casAuthors">Siegel Rebecca; Naishadham Deepa; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics.  A total of 1,638,910 new cancer cases and 577,190 deaths from cancer are projected to occur in the United States in 2012.  During the most recent 5 years for which there are data (2004-2008), overall cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.6% per year in women.  Over the past 10 years of available data (1999-2008), cancer death rates have declined by more than 1% per year in men and women of every racial/ethnic group with the exception of American Indians/Alaska Natives, among whom rates have remained stable.  The most rapid declines in death rates occurred among African American and Hispanic men (2.4% and 2.3% per year, respectively).  Death rates continue to decline for all 4 major cancer sites (lung, colorectum, breast, and prostate), with lung cancer accounting for almost 40% of the total decline in men and breast cancer accounting for 34% of the total decline in women.  The reduction in overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of about 1,024,400 deaths from cancer.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzMtZQZY6EXFMGsG_HTXYFfW6udTcc2eZMeq5pJmtWXLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387jvVaitg%253D%253D&md5=4d68e55759bf217f9a46c22be1af7f86</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20138%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DNaishadham%26aufirst%3DD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistic%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2012%26volume%3D62%26spage%3D10%26epage%3D29%26doi%3D10.3322%2Fcaac.20138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Deeken, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löscher, W.</span><span> </span><span class="NLM_article-title">The blood-brain barrier and cancer: transporters, treatment, and trojan horses</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-2854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F1078-0432.CCR-06-2854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=17363519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1663&author=J.+F.+Deekenauthor=W.+L%C3%B6scher&title=The+blood-brain+barrier+and+cancer%3A+transporters%2C+treatment%2C+and+trojan+horses&doi=10.1158%2F1078-0432.CCR-06-2854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses</span></div><div class="casAuthors">Deeken, John F.; Loescher, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1663-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite scientific advances in understanding the causes and treatment of human malignancy, a persistent challenge facing basic and clin. investigators is how to adequately treat primary and metastatic brain tumors.  The blood-brain barrier is a physiol. obstruction to the delivery of systemic chemotherapy to the brain parenchyma and central nervous system (CNS).  A no. of physiol. properties make the endothelium in the CNS distinct from the vasculature found in the periphery.  Recent evidence has shown that a crit. aspect of this barrier is composed of xenobiotic transporters which extrude substrates from the brain into the cerebrospinal fluid and systemic circulation.  These transporters also extrude drugs and toxins if they gain entry into the cytoplasm of brain endothelial cells before they enter the brain.  This review highlights the properties of the blood-brain barrier, including the location, function, and relative importance of the drug transporters that maintain this barrier.  Primary and metastatic brain malignancy can compromise this barrier, allowing some access of chemotherapy treatment to reach the tumor.  The responsiveness of brain tumors to systemic treatment found in past clin. research is discussed, as are possible explanations as to why CNS tumors are nonetheless able to evade therapy.  Finally, strategies to overcome this barrier and better deliver chemotherapy into CNS tumors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxa44seefNF7Vg90H21EOLACvtfcHk0ljWqjEYcOGBMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D&md5=dc7ea92d49779b99871f98a5e2b59858</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2854%26sid%3Dliteratum%253Aachs%26aulast%3DDeeken%26aufirst%3DJ.%2BF.%26aulast%3DL%25C3%25B6scher%26aufirst%3DW.%26atitle%3DThe%2520blood-brain%2520barrier%2520and%2520cancer%253A%2520transporters%252C%2520treatment%252C%2520and%2520trojan%2520horses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1663%26doi%3D10.1158%2F1078-0432.CCR-06-2854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wang, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farokhzad, O. C.</span><span> </span><span class="NLM_article-title">Nanoparticle delivery of cancer drugs</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1146/annurev-med-040210-162544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1146%2Fannurev-med-040210-162544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=21888516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC38Xisleksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2012&pages=185-198&author=A.+Z.+Wangauthor=R.+Langerauthor=O.+C.+Farokhzad&title=Nanoparticle+delivery+of+cancer+drugs&doi=10.1146%2Fannurev-med-040210-162544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle delivery of cancer drugs</span></div><div class="casAuthors">Wang, Andrew Z.; Langer, Robert; Farokhzad, Omid C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185-198</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Nanomedicine, the application of nanotechnol. to medicine, enabled the development of nanoparticle therapeutic carriers.  These drug carriers are passively targeted to tumors through the enhanced permeability and retention effect, so they are ideally suited for the delivery of chemotherapeutics in cancer treatment.  Indeed, advances in nanomedicine have rapidly translated into clin. practice.  To date, there are 5 clin. approved nanoparticle chemotherapeutics for cancer and many more under clin. investigation.  In this review, the authors discuss the various nanoparticle drug delivery platforms and the important concepts involved in nanoparticle drug delivery.  The authors also review the clin. data on the approved nanoparticle therapeutics as well as the nanotherapeutics under clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_JZzo8Pq47Vg90H21EOLACvtfcHk0liNxRtfIBouIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xisleksb4%253D&md5=e85e3486cc45faea405d2f5437570bfe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-040210-162544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-040210-162544%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DA.%2BZ.%26aulast%3DLanger%26aufirst%3DR.%26aulast%3DFarokhzad%26aufirst%3DO.%2BC.%26atitle%3DNanoparticle%2520delivery%2520of%2520cancer%2520drugs%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2012%26volume%3D63%26spage%3D185%26epage%3D198%26doi%3D10.1146%2Fannurev-med-040210-162544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sanna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marceddu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathania, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span> </span><span class="NLM_article-title">Targeted nanoparticles for the delivery of novel bioactive molecules to pancreatic cancer cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">5209</span><span class="NLM_x">–</span> <span class="NLM_lpage">5220</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01571</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01571" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5209-5220&issue=11&author=V.+Sannaauthor=S.+Nurraauthor=N.+Palaauthor=S.+Marcedduauthor=D.+Pathaniaauthor=N.+Neamatiauthor=M.+Sechi&title=Targeted+nanoparticles+for+the+delivery+of+novel+bioactive+molecules+to+pancreatic+cancer+cells&doi=10.1021%2Facs.jmedchem.5b01571"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01571%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DV.%26aulast%3DNurra%26aufirst%3DS.%26aulast%3DPala%26aufirst%3DN.%26aulast%3DMarceddu%26aufirst%3DS.%26aulast%3DPathania%26aufirst%3DD.%26aulast%3DNeamati%26aufirst%3DN.%26aulast%3DSechi%26aufirst%3DM.%26atitle%3DTargeted%2520nanoparticles%2520for%2520the%2520delivery%2520of%2520novel%2520bioactive%2520molecules%2520to%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D11%26spage%3D5209%26epage%3D5220%26doi%3D10.1021%2Facs.jmedchem.5b01571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Locatelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes Franchini, M.</span><span> </span><span class="NLM_article-title">Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system</span> <span class="citation_source-journal">J. Nanopart. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span><span class="refDoi"> DOI: 10.1007/s11051-012-1316-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1007%2Fs11051-012-1316-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=1316-1333&author=E.+Locatelliauthor=M.+Comes+Franchini&title=Biodegradable+PLGA-b-PEG+polymeric+nanoparticles%3A+synthesis%2C+properties%2C+and+nanomedical+applications+as+drug+delivery+system&doi=10.1007%2Fs11051-012-1316-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties and nanomedical applications as drug delivery system</span></div><div class="casAuthors">Locatelli, Erica; Franchini, Mauro Comes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nanoparticle Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1316/1-1316/17, 17 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNARFA</span>;
        ISSN:<span class="NLM_cas:issn">1388-0764</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  During the past decades many synthetic polymers have been studied for nanomedicine applications and in particular as drug delivery systems.  For this purpose, polymers must be non-toxic, biodegradable and biocompatible.  Polylactic-co-glycolic acid (PLGA) is one of the most studied polymers due to its complete biodegradability and ability to self-assemble into nano-metric micelles that are able to entrap small mols. like drugs and to release them into body in a time-dependent manner.  Despite fine qualities, using PLGA polymeric nanoparticles for in vivo applications still remains an open challenge due to many factors such as poor stability in water, big diam. (150-200 nm) and the removal of these nanocarriers from the blood stream by the liver and spleen thus reducing the concn. of drugs drastically in tumor tissue.  Polyethylene glycol (PEG) is the most used polymers for drug delivery applications and the first PEGylated product is already on the market for over 20 years.  This is due to its stealth behavior that inhibits the fast recognition by the immune system (opsonization) and generally leads to a reduced blood clearance of nanocarriers increasing blood circulation time.  Furthermore, PEG is hydrophilic and able to stabilize nanoparticles by steric and not ionic effects esp. in water.  PLGA-PEG block copolymer is an emergent system because it can be easily synthesized and it possesses all good qualities of PLGA and also PEG capability so in the last decade it arose as one of the most promising systems for nanoparticles formation, drug loading and in vivo drug delivery applications.  This review will discuss briefly on PLGA-b-PEG synthesis and physicochem. properties, together with its improved qualities with respect to the single PLGA and PEG polymers.  Moreover, we will focus on but in particular will treat nanoparticles formation and uses as new drug delivery system for nanomedical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23tZMBQIXLLVg90H21EOLACvtfcHk0liNxRtfIBouIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFygs7g%253D&md5=f73bba881d632cdfecff111981f2470d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs11051-012-1316-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11051-012-1316-4%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DE.%26aulast%3DComes%2BFranchini%26aufirst%3DM.%26atitle%3DBiodegradable%2520PLGA-b-PEG%2520polymeric%2520nanoparticles%253A%2520synthesis%252C%2520properties%252C%2520and%2520nanomedical%2520applications%2520as%2520drug%2520delivery%2520system%26jtitle%3DJ.%2520Nanopart.%2520Res.%26date%3D2012%26volume%3D14%26spage%3D1316%26epage%3D1333%26doi%3D10.1007%2Fs11051-012-1316-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Locatelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naddaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Vallejo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lellouche, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes Franchini, M.</span><span> </span><span class="NLM_article-title">Biocompatible nanocomposite for PET/MRI hybrid imaging</span> <span class="citation_source-journal">Int. J. Nanomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">6021</span><span class="NLM_x">–</span> <span class="NLM_lpage">6033</span><span class="refDoi"> DOI: 10.2147/IJN.S38107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.2147%2FIJN.S38107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=23271907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslerurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=6021-6033&author=E.+Locatelliauthor=L.+Gilauthor=L.+Israelauthor=L.+Passoniauthor=M.+Naddakaauthor=A.+Pucciauthor=T.+Reeseauthor=V.+Gomez-Vallejoauthor=P.+Milaniauthor=M.+Matteoliauthor=J.+Llopauthor=J.+P.+Lelloucheauthor=M.+Comes+Franchini&title=Biocompatible+nanocomposite+for+PET%2FMRI+hybrid+imaging&doi=10.2147%2FIJN.S38107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Biocompatible nanocomposite for PET/MRI hybrid imaging</span></div><div class="casAuthors">Locatelli, Erica; Gil, Larraitz; Israel, Liron Limor; Passoni, Lorena; Naddaka, Maria; Pucci, Andrea; Reese, Torsten; Gomez-Vallejo, Vanessa; Milani, Paolo; Matteoli, Michela; Llop, Jordi; Lellouche, Jean Paul; Franchini, Mauro Comes</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6021-6033</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A novel nanocarrier system was designed and developed with key components uniquely structured at the nanoscale for early cancer diagnosis and treatment.  In order to perform magnetic resonance imaging, hydrophilic superparamagnetic maghemite nanoparticles (NPs) were synthesized and coated with a lipophilic org. ligand.  Next, they were entrapped into polymeric NPs made of biodegradable poly(lactic-co-glycolic acid) linked to polyethylene glycol.  In addn., resulting NPs have been conjugated on their surface with a 2,2'-(7-(4-((2-aminoethyl)amino)-1-carboxy-4-oxobutyl)-1,4,7-triazonane-1,4-diyl)diacetic acid ligand for subsequent 68Ga incorporation.  A cell-based cytotoxicity assay has been employed to verify the in vitro cell viability of human pancreatic cancer cells exposed to this nanosystem.  Finally, in vivo positron emission tomog.-computerized tomog. biodistribution studies in healthy animals were performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprWfhA_gP3nbVg90H21EOLACvtfcHk0lixTINHRm8nAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslerurk%253D&md5=84a31df1c8091c008977e88ab9505b22</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2147%2FIJN.S38107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S38107%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DE.%26aulast%3DGil%26aufirst%3DL.%26aulast%3DIsrael%26aufirst%3DL.%26aulast%3DPassoni%26aufirst%3DL.%26aulast%3DNaddaka%26aufirst%3DM.%26aulast%3DPucci%26aufirst%3DA.%26aulast%3DReese%26aufirst%3DT.%26aulast%3DGomez-Vallejo%26aufirst%3DV.%26aulast%3DMilani%26aufirst%3DP.%26aulast%3DMatteoli%26aufirst%3DM.%26aulast%3DLlop%26aufirst%3DJ.%26aulast%3DLellouche%26aufirst%3DJ.%2BP.%26aulast%3DComes%2BFranchini%26aufirst%3DM.%26atitle%3DBiocompatible%2520nanocomposite%2520for%2520PET%252FMRI%2520hybrid%2520imaging%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2012%26volume%3D7%26spage%3D6021%26epage%3D6033%26doi%3D10.2147%2FIJN.S38107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Maeda, H.</span><span> </span><span class="NLM_article-title">Tumor-selective delivery of macromolecular drugs via the epr effect: background and future prospects</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span><span class="refDoi"> DOI: 10.1021/bc100070g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc100070g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVKrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=797-802&author=H.+Maeda&title=Tumor-selective+delivery+of+macromolecular+drugs+via+the+epr+effect%3A+background+and+future+prospects&doi=10.1021%2Fbc100070g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects</span></div><div class="casAuthors">Maeda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">797-802</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper briefly documents the history of the discovery of the EPR (enhanced permeability and retention) effect and elucidates an analogy between bacterial infection involving proteases that trigger kinin generation and cancer.  The EPR effect of macromols. in cancer tissues is defined, and the distinction between the EPR effect (with ref. to clearance of macromols. from the interstitial space of tumor tissues) and the simple passive targeting of drugs to tumors is described.  Addnl. points of discussion include the uniqueness of tumor vessels, the influence of kinin and other vascular mediators such as nitric oxide (NO) and prostaglandins, and the heterogeneity of the EPR effect.  Two different strategies to augment the EPR effect that were discovered are elevating blood pressure artificially via slow infusion of angiotensin II and applying nitroglycerin or other NO donors.  Use of the nitro-agent increased not only the blood flow of the tumor, but also the delivery of drug to the tumor and the drug's therapeutic effect.  This finding shows an intriguing analogy to hypoxic cardiac infarct tissue, in that both are improved by NO.  These two methods were applied to treatment of rodents and human cancers, in combination with other anticancer agents, with successful results achieved in rodents as well as humans.  These data suggest very appealing prospects for utilization of the EPR effect in future development of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1C6eqnxCV3LVg90H21EOLACvtfcHk0lixTINHRm8nAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVKrtLw%253D&md5=04609cee8cb26620b364c252d93c5335</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbc100070g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc100070g%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DTumor-selective%2520delivery%2520of%2520macromolecular%2520drugs%2520via%2520the%2520epr%2520effect%253A%2520background%2520and%2520future%2520prospects%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D797%26epage%3D802%26doi%3D10.1021%2Fbc100070g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kreuter, J.</span><span> </span><span class="NLM_article-title">Nanoparticles as drug delivery systems</span> <span class="citation_source-journal">ENN</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=161-180&author=J.+Kreuter&title=Nanoparticles+as+drug+delivery+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKreuter%26aufirst%3DJ.%26atitle%3DNanoparticles%2520as%2520drug%2520delivery%2520systems%26jtitle%3DENN%26date%3D2004%26volume%3D7%26spage%3D161%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phua, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, K. W.</span><span> </span><span class="NLM_article-title">Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation</span> <span class="citation_source-journal">ACS Nano</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">2235</span><span class="NLM_x">–</span> <span class="NLM_lpage">2254</span><span class="refDoi"> DOI: 10.1021/nn507494p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/nn507494p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=2235-2254&issue=3&author=Y.+H.+Laoauthor=K.+K.+Phuaauthor=K.+W.+Leong&title=Aptamer+nanomedicine+for+cancer+therapeutics%3A+barriers+and+potential+for+translation&doi=10.1021%2Fnn507494p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation</span></div><div class="casAuthors">Lao, Yeh-Hsing; Phua, Kyle K. L.; Leong, Kam W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2235-2254</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aptamer nanomedicine, including therapeutic aptamers and aptamer nanocomplexes, is beginning to fulfill its potential in both clin. trials and preclin. studies.  Esp. in oncol., aptamer nanomedicine may perform better than conventional or antibody-based chemotherapeutics due to specificity compared to the former and stability compared to the latter.  Many proof-of-concept studies on applying aptamers to drug delivery, gene therapy, and cancer imaging have shown promising efficacy and impressive safety in vivo toward translation.  Yet, there remains ample room for improvement and crit. barriers to be addressed.  In this review, we will first introduce the recent progress in clin. trials of aptamer nanomedicine, followed by a discussion of the barriers at the design and in vivo application stages.  We will then highlight recent advances and engineering strategies proposed to tackle these barriers.  Aptamer cancer nanomedicine has the potential to address one of the most important healthcare issues of the society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqze6LjH1t1uLVg90H21EOLACvtfcHk0lixTINHRm8nAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtL0%253D&md5=b3c82fc91d325a559bf13b81fd0d5691</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fnn507494p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnn507494p%26sid%3Dliteratum%253Aachs%26aulast%3DLao%26aufirst%3DY.%2BH.%26aulast%3DPhua%26aufirst%3DK.%2BK.%26aulast%3DLeong%26aufirst%3DK.%2BW.%26atitle%3DAptamer%2520nanomedicine%2520for%2520cancer%2520therapeutics%253A%2520barriers%2520and%2520potential%2520for%2520translation%26jtitle%3DACS%2520Nano%26date%3D2015%26volume%3D9%26issue%3D3%26spage%3D2235%26epage%3D2254%26doi%3D10.1021%2Fnn507494p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Camorani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchia, L.</span><span> </span><span class="NLM_article-title">Oligonucleotide aptamers for glioma targeting: an update</span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.2174/1871524915666150430122525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.2174%2F1871524915666150430122525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=25924917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVWgsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=126-137&issue=2&author=S.+Camoraniauthor=L.+Cerchia&title=Oligonucleotide+aptamers+for+glioma+targeting%3A+an+update&doi=10.2174%2F1871524915666150430122525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oligonucleotide Aptamers for Glioma Targeting: An Update</span></div><div class="casAuthors">Camorani, Simona; Cerchia, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-137</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Malignant glioma is the most prevalent and lethal primary brain tumor.  Due to mol. heterogeneity and organ-specific clin. manifestations, it is essential to improve glioma treatment by shifting from conventional cytotoxic chemotherapy to more targeted therapies.  Hence, innovative approaches based on ligands able to specifically detect and measure mutated proteins assocd. to a specific tumor phenotype are needed in order to refine diagnosis and therapy of glioma.  To date, antibody- based approaches have been developed for in vivo applications but, in most cases, they show toxicity, do not reach adequate sensitivity and have a low permeability across the blood-brain-barrier.  Single-stranded nucleic acid aptamers, generated by the SELEX (Systematic Evolution of Ligands by EXponential enrichment) process, have been shown as a valuable alternative to protein antibodies because may couple the advantages of their chem. nature to the high specific binding of antibodies to their proper targets.  The simplicity of aptamers selection and derivatization with other mols. (nanocarriers, tracers for imaging, drugs) combined to low immunogenicity and toxicity, render them a versatile tool for identification of new biomarkers, in vitro diagnosis, in vivo imaging and targeted therapy.  Aim of this review article is to discuss contemporary applications of aptamers as innovative tools for glioma diagnosis and therapy.  We will describe promising new approaches for the identification of aptamers targeting proteins with a crucial role in glioma, including SELEX protocols against living glioma cells and brain tumor-initiating cells.  Addnl., we will review recently proposed aptamer-based strategies for site-targeted controlled delivery of therapeutics and imaging agents to the brain.  Summarizing, we hope that this article will provide an updated overview of perspectives and challenges for aptamer-based glioma treatment in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsADJeGS27p7Vg90H21EOLACvtfcHk0lhGB1WNVdRslw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVWgsL8%253D&md5=73963ce4ef91812f646dd921093c1b1f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1871524915666150430122525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524915666150430122525%26sid%3Dliteratum%253Aachs%26aulast%3DCamorani%26aufirst%3DS.%26aulast%3DCerchia%26aufirst%3DL.%26atitle%3DOligonucleotide%2520aptamers%2520for%2520glioma%2520targeting%253A%2520an%2520update%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26issue%3D2%26spage%3D126%26epage%3D137%26doi%3D10.2174%2F1871524915666150430122525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">5115</span><span class="NLM_x">–</span> <span class="NLM_lpage">5123</span><span class="refDoi"> DOI: 10.1016/j.biomaterials.2012.03.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1016%2Fj.biomaterials.2012.03.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=22484043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1ajtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=5115-5123&issue=20&author=H.+Gaoauthor=J.+Qianauthor=S.+Caoauthor=Z.+Yangauthor=Z.+Pangauthor=S.+Panauthor=L.+Fanauthor=Z.+Xiauthor=X.+Jiangauthor=Q.+Zhang&title=Precise+glioma+targeting+of+and+penetration+by+aptamer+and+peptide+dual-functioned+nanoparticles&doi=10.1016%2Fj.biomaterials.2012.03.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles</span></div><div class="casAuthors">Gao, Huile; Qian, Jun; Cao, Shijie; Yang, Zhi; Pang, Zhiqing; Pan, Shuaiqi; Fan, Li; Xi, Zhangjie; Jiang, Xinguo; Zhang, Qizhi</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5115-5123</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The treatment of a brain glioma is still one of the most difficult challenges in oncol.  To effectively treat brain glioma and reduce the side effects, drugs must be transported across the blood brain barrier (BBB) and then targeted to the brain cancer cells because most anti-tumor drugs are highly toxic to the normal brain tissue.  A cascade delivery strategy was developed to perform these two aims and to achieve enhanced and precisely targeted delivery.  Herein, we utilize a phage-displayed TGN peptide and an AS1411 aptamer, which are specific targeting ligands of the BBB and cancer cells, resp. and we conjugate them with nanoparticles to establish the brain glioma cascade delivery system (AsTNP).  In vitro cell uptake and three-dimensional tumor spheroid penetration studies demonstrated that the system could not only target endothelial and tumor cells but also penetrate the endothelial monolayers and tumor cells to reach the core of the tumor spheroids, which was extremely important but mostly ignored in glioma therapy.  In vivo imaging further demonstrated that the AsTNP provided the highest tumor distribution and tumor/normal brain ratio.  The distribution was also reconfirmed by fluorescent images of the brain slides.  As a result, the docetaxel-loaded AsTNP presents the best anti-glioma effect with improved glioma bearing survival.  In conclusion, the AsTNP could precisely target to the brain glioma, which was a valuable target for glioma imaging and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdM4ckZPwFebVg90H21EOLACvtfcHk0lhGB1WNVdRslw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1ajtLg%253D&md5=1e3a4d9b178e45637ca0ca2943d01f1e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2012.03.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2012.03.058%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DPang%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DXi%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DPrecise%2520glioma%2520targeting%2520of%2520and%2520penetration%2520by%2520aptamer%2520and%2520peptide%2520dual-functioned%2520nanoparticles%26jtitle%3DBiomaterials%26date%3D2012%26volume%3D33%26issue%3D20%26spage%3D5115%26epage%3D5123%26doi%3D10.1016%2Fj.biomaterials.2012.03.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Whole-cell SELEX aptamer-functionalised poly (ethyleneglycol)-poly (ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span><span class="refDoi"> DOI: 10.1016/j.biomaterials.2012.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1016%2Fj.biomaterials.2012.05.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=6264-6272&issue=26&author=H.+Gaoauthor=J.+Qianauthor=Z.+Yangauthor=Z.+Pangauthor=Z.+Xiauthor=S.+Caoauthor=Y.+Wangauthor=S.+Panauthor=S.+Zhangauthor=W.+Wangauthor=X.+Jiangauthor=X.+Jiangauthor=Q.+Zhang&title=Whole-cell+SELEX+aptamer-functionalised+poly+%28ethyleneglycol%29-poly+%28%CE%B5-caprolactone%29+nanoparticles+for+enhanced+targeted+glioblastoma+therapy&doi=10.1016%2Fj.biomaterials.2012.05.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2012.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2012.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DPang%26aufirst%3DZ.%26aulast%3DXi%26aufirst%3DZ.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DWhole-cell%2520SELEX%2520aptamer-functionalised%2520poly%2520%2528ethyleneglycol%2529-poly%2520%2528%25CE%25B5-caprolactone%2529%2520nanoparticles%2520for%2520enhanced%2520targeted%2520glioblastoma%2520therapy%26jtitle%3DBiomaterials%26date%3D2012%26volume%3D33%26issue%3D26%26spage%3D6264%26epage%3D6272%26doi%3D10.1016%2Fj.biomaterials.2012.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guryanova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitomi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lathia, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serwanski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weil, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjelmeland, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span> </span><span class="NLM_article-title">Platelet-derived growth factor receptors differentially form intertumoral and intratumoral heterogeneity</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1247</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span><span class="refDoi"> DOI: 10.1101/gad.193565.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1101%2Fgad.193565.112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1247-1262&issue=11&author=Y.+Kimauthor=E.+Kimauthor=Q.+Wuauthor=O.+Guryanovaauthor=M.+Hitomiauthor=J.+D.+Lathiaauthor=D.+Serwanskiauthor=A.+E.+Sloanauthor=R.+J.+Weilauthor=J.+Leeauthor=A.+Nishiyamaauthor=S.+Baoauthor=A.+B.+Hjelmelandauthor=J.+N.+Rich&title=Platelet-derived+growth+factor+receptors+differentially+form+intertumoral+and+intratumoral+heterogeneity&doi=10.1101%2Fgad.193565.112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1101%2Fgad.193565.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.193565.112%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DGuryanova%26aufirst%3DO.%26aulast%3DHitomi%26aufirst%3DM.%26aulast%3DLathia%26aufirst%3DJ.%2BD.%26aulast%3DSerwanski%26aufirst%3DD.%26aulast%3DSloan%26aufirst%3DA.%2BE.%26aulast%3DWeil%26aufirst%3DR.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DBao%26aufirst%3DS.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520receptors%2520differentially%2520form%2520intertumoral%2520and%2520intratumoral%2520heterogeneity%26jtitle%3DGenes%2520Dev.%26date%3D2012%26volume%3D26%26issue%3D11%26spage%3D1247%26epage%3D1262%26doi%3D10.1101%2Fgad.193565.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Akhavan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourzia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourian, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamanoi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblum, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavenee, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensinger, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F2159-8290.CD-12-0502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=534-547&author=D.+Akhavanauthor=A.+L.+Pourziaauthor=A.+A.+Nourianauthor=K.+J.+Williamsauthor=D.+Nathansonauthor=I.+Babicauthor=G.+R.+Villaauthor=K.+Tanakaauthor=A.+Naelauthor=H.+Yangauthor=J.+Dangauthor=H.+V.+Vintersauthor=W.+H.+Yongauthor=M.+Flaggauthor=F.+Tamanoiauthor=T.+Sasayamaauthor=C.+D.+Jamesauthor=H.+I.+Kornblumauthor=T.+F.+Cloughesyauthor=W.+K.+Caveneeauthor=S.+J.+Bensingerauthor=P.+S.+Mischel&title=De-repression+of+PDGFR%CE%B2+transcription+promotes+acquired+resistance+to+EGFR+tyrosine+kinase+inhibitors+in+glioblastoma+patients&doi=10.1158%2F2159-8290.CD-12-0502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0502%26sid%3Dliteratum%253Aachs%26aulast%3DAkhavan%26aufirst%3DD.%26aulast%3DPourzia%26aufirst%3DA.%2BL.%26aulast%3DNourian%26aufirst%3DA.%2BA.%26aulast%3DWilliams%26aufirst%3DK.%2BJ.%26aulast%3DNathanson%26aufirst%3DD.%26aulast%3DBabic%26aufirst%3DI.%26aulast%3DVilla%26aufirst%3DG.%2BR.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DNael%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDang%26aufirst%3DJ.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DYong%26aufirst%3DW.%2BH.%26aulast%3DFlagg%26aufirst%3DM.%26aulast%3DTamanoi%26aufirst%3DF.%26aulast%3DSasayama%26aufirst%3DT.%26aulast%3DJames%26aufirst%3DC.%2BD.%26aulast%3DKornblum%26aufirst%3DH.%2BI.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DBensinger%26aufirst%3DS.%2BJ.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DDe-repression%2520of%2520PDGFR%25CE%25B2%2520transcription%2520promotes%2520acquired%2520resistance%2520to%2520EGFR%2520tyrosine%2520kinase%2520inhibitors%2520in%2520glioblastoma%2520patients%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D534%26epage%3D547%26doi%3D10.1158%2F2159-8290.CD-12-0502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gil del Alcazar, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardebeck, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomimatsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachoo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burma, S.</span><span> </span><span class="NLM_article-title">Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1248</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-1607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F1078-0432.CCR-13-1607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=24366691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXks1Ohurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1235-1248&issue=5&author=C.+R.+Gil+del+Alcazarauthor=M.+C.+Hardebeckauthor=B.+Mukherjeeauthor=N.+Tomimatsuauthor=X.+Gaoauthor=J.+Yanauthor=X.+J.+Xieauthor=R.+Bachooauthor=L.+Liauthor=A.+A.+Habibauthor=S.+Burma&title=Inhibition+of+DNA+double-strand+break+repair+by+the+dual+PI3K%2FmTOR+inhibitor+NVP-BEZ235+as+a+strategy+for+radiosensitization+of+glioblastoma&doi=10.1158%2F1078-0432.CCR-13-1607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma</span></div><div class="casAuthors">Gil del Alcazar, Carlos Rodrigo; Hardebeck, Molly Catherine; Mukherjee, Bipasha; Tomimatsu, Nozomi; Gao, Xiaohuan; Yan, Jingsheng; Xie, Xian-Jin; Bachoo, Robert; Li, Li; Habib, Amyn A.; Burma, Sandeep</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1235-1248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Inhibitors of the DNA damage response (DDR) have great potential for radiosensitization of numerous cancers, including glioblastomas, which are extremely radio- and chemoresistant brain tumors.  Currently, there are no DNA double-strand break (DSB) repair inhibitors that have been successful in treating glioblastoma.  Our lab. previously demonstrated that the dual phosphoinositide 3-kinase/mTOR inhibitor NVP-BEZ235 can potently inhibit the two central DDR kinases, DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and ataxia-telangiectasia mutated (ATM), in vitro.  Here, we tested whether NVP-BEZ235 could also inhibit ATM and DNA-PKcs in tumors in vivo and assessed its potential as a radio- and chemosensitizer in preclin. mouse glioblastoma models.  Exptl. Design: The radiosensitizing effect of NVP-BEZ235 was tested by following tumor growth in s.c. and orthotopic glioblastoma models.  Tumors were generated using the radioresistant U87-vIII glioma cell line and GBM9 neurospheres in nude mice.  These tumors were then treated with ionizing radiation and/or NVP-BEZ235 and analyzed for DNA-PKcs and ATM activation, DSB repair inhibition, and attenuation of growth.  Results: NVP-BEZ235 potently inhibited both DNA-PKcs and ATM kinases and attenuated the repair of ionizing radiation-induced DNA damage in tumors.  This resulted in striking tumor radiosensitization, which extended the survival of brain tumor-bearing mice.  Notably, tumors displayed a higher DSB-load when compared with normal brain tissue.  NVP-BEZ235 also sensitized a subset of s.c. tumors to temozolomide, a drug routinely used concurrently with ionizing radiation for the treatment of glioblastoma.  Conclusions: These results demonstrate that it may be possible to significantly improve glioblastoma therapy by combining ionizing radiation with potent and bioavailable DNA repair inhibitors such as NVP-BEZ235.  Clin Cancer Res; 20(5); 1235-48. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU7klfy2L_M7Vg90H21EOLACvtfcHk0lj1JeM6ZN3a5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXks1Ohurg%253D&md5=22c4c555e6d11d3ea1b426ce7bb261c7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1607%26sid%3Dliteratum%253Aachs%26aulast%3DGil%2Bdel%2BAlcazar%26aufirst%3DC.%2BR.%26aulast%3DHardebeck%26aufirst%3DM.%2BC.%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DTomimatsu%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DBachoo%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DBurma%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520DNA%2520double-strand%2520break%2520repair%2520by%2520the%2520dual%2520PI3K%252FmTOR%2520inhibitor%2520NVP-BEZ235%2520as%2520a%2520strategy%2520for%2520radiosensitization%2520of%2520glioblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26issue%3D5%26spage%3D1235%26epage%3D1248%26doi%3D10.1158%2F1078-0432.CCR-13-1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Camorani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rienzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catuogno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iaboni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condorelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Franciscis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchia, L.</span><span> </span><span class="NLM_article-title">Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ Aptamer</span> <span class="citation_source-journal">Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span><span class="refDoi"> DOI: 10.1038/mt.2013.300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1038%2Fmt.2013.300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=24566984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12ht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=828-841&author=S.+Camoraniauthor=C.+Espositoauthor=A.+Rienzoauthor=S.+Catuognoauthor=M.+Iaboniauthor=G.+Condorelliauthor=V.+De+Franciscisauthor=L.+Cerchia&title=Inhibition+of+receptor+signaling+and+of+glioblastoma-derived+tumor+growth+by+a+novel+PDGFR%CE%B2+Aptamer&doi=10.1038%2Fmt.2013.300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer</span></div><div class="casAuthors">Camorani, Simona; Esposito, Carla L.; Rienzo, Anna; Catuogno, Silvia; Iaboni, Margherita; Condorelli, Gerolama; de Franciscis, Vittorio; Cerchia, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">828-841</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelet-derived growth factor receptor β (PDGFRβ) is a cell-surface tyrosine kinase receptor implicated in several cellular processes including proliferation, migration, and angiogenesis.  It represents a compelling therapeutic target in many human tumors, including glioma.  A no. of tyrosine kinase inhibitors under development as antitumor agents have been found to inhibit PDGFRβ.  However, they are not selective as they present multiple tyrosine kinase targets.  Here, we report a novel PDGFRβ-specific antagonist represented by a nuclease-resistant RNA-aptamer, named Gint4.  T.  This aptamer is able to specifically bind to the human PDGFRβ ectodomain (Kd: 9.6 nmol/l) causing a strong inhibition of ligand-dependent receptor activation and of downstream signaling in cell lines and primary cultures of human glioblastoma cells.  Moreover, Gint4.  T aptamer drastically inhibits cell migration and proliferation, induces differentiation, and blocks tumor growth in vivo.  In addn., Gint4.  T aptamer prevents PDGFRβ heterodimerization with and resultant transactivation of epidermal growth factor receptor.  As a result, the combination of Gint4.  T and an epidermal growth factor receptor-targeted aptamer is better at slowing tumor growth than either single aptamer alone.  These findings reveal Gint4.  T as a PDGFRβ-drug candidate with translational potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos-a6AeMu6cbVg90H21EOLACvtfcHk0lg_VEPaAxw2kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12ht74%253D&md5=81b64a3fbb3079a1b56f27b522936dd1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fmt.2013.300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2013.300%26sid%3Dliteratum%253Aachs%26aulast%3DCamorani%26aufirst%3DS.%26aulast%3DEsposito%26aufirst%3DC.%26aulast%3DRienzo%26aufirst%3DA.%26aulast%3DCatuogno%26aufirst%3DS.%26aulast%3DIaboni%26aufirst%3DM.%26aulast%3DCondorelli%26aufirst%3DG.%26aulast%3DDe%2BFranciscis%26aufirst%3DV.%26aulast%3DCerchia%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520receptor%2520signaling%2520and%2520of%2520glioblastoma-derived%2520tumor%2520growth%2520by%2520a%2520novel%2520PDGFR%25CE%25B2%2520Aptamer%26jtitle%3DMol.%2520Ther.%26date%3D2014%26volume%3D22%26spage%3D828%26epage%3D841%26doi%3D10.1038%2Fmt.2013.300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gentili, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes Franchini, M.</span><span> </span><span class="NLM_article-title">Double phase transfer of gold nanorods for surface functionalization and entrapment into PEG-Based nanocarriers</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5874</span><span class="NLM_x">–</span> <span class="NLM_lpage">5876</span><span class="refDoi"> DOI: 10.1039/b911582j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1039%2Fb911582j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=5874-5876&author=D.+Gentiliauthor=G.+Oriauthor=M.+Comes+Franchini&title=Double+phase+transfer+of+gold+nanorods+for+surface+functionalization+and+entrapment+into+PEG-Based+nanocarriers&doi=10.1039%2Fb911582j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2Fb911582j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb911582j%26sid%3Dliteratum%253Aachs%26aulast%3DGentili%26aufirst%3DD.%26aulast%3DOri%26aufirst%3DG.%26aulast%3DComes%2BFranchini%26aufirst%3DM.%26atitle%3DDouble%2520phase%2520transfer%2520of%2520gold%2520nanorods%2520for%2520surface%2520functionalization%2520and%2520entrapment%2520into%2520PEG-Based%2520nanocarriers%26jtitle%3DChem.%2520Commun.%26date%3D2009%26volume%3D39%26spage%3D5874%26epage%3D5876%26doi%3D10.1039%2Fb911582j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Schuch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deiters, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Köhler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuchmann, H. P.</span><span> </span><span class="NLM_article-title">Production of W/O/W (water-in-oil-in-water) multiple emulsions: droplet breakup and release of water</span> <span class="citation_source-journal">J. Colloid Interface Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span><span class="refDoi"> DOI: 10.1016/j.jcis.2013.03.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1016%2Fj.jcis.2013.03.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=23643254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVaksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2013&pages=157-164&author=A.+Schuchauthor=P.+Deitersauthor=J.+Henneauthor=K.+K%C3%B6hlerauthor=H.+P.+Schuchmann&title=Production+of+W%2FO%2FW+%28water-in-oil-in-water%29+multiple+emulsions%3A+droplet+breakup+and+release+of+water&doi=10.1016%2Fj.jcis.2013.03.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Production of W/O/W (water-in-oil-in-water) multiple emulsions. Droplet breakup and release of water</span></div><div class="casAuthors">Schuch, Anna; Deiters, Philipp; Henne, Julius; Kohler, Karsten; Schuchmann, Heike P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Colloid and Interface Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-164</span>CODEN:
                <span class="NLM_cas:coden">JCISA5</span>;
        ISSN:<span class="NLM_cas:issn">0021-9797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigate breakup of W/O/W double emulsion droplets at high viscosity ratios and coalescence of inner water droplets dependent on the dispersed phase content (DPC) of the inner emulsion.The rheol. analyses of the inner emulsions confirm the behavior expected from literature - increasing viscosity with increasing DPC and elastic behavior for high DPC.  The resulting droplet sizes seem to be influenced only by the viscosity ratio calcd. using the viscosity of the inner emulsion.  An influence of the elastic properties of the inner emulsions could not be obsd.  Moreover, breakup of double emulsion droplets seems to follow the same rules as breakup of Newtonian droplets.  In the second part of the paper we focus on the release of water from double emulsions by coalescence.  A direct correlation between resulting double emulsion droplet sizes and encapsulation efficiency was found for each system.  The initial inner dispersed phase content has a big influence on the release rate.  This can partly be explained by the influence of the dispersed phase content on collision rate.  For high internal phase concns. inner droplets coalesce with each other.  The so formed bigger inner droplets seem to increase the overall release rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWxMDw8Knqj7Vg90H21EOLACvtfcHk0lg_VEPaAxw2kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVaksLc%253D&md5=dd21d9746fb5b23446d9c5a07c57c136</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jcis.2013.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcis.2013.03.066%26sid%3Dliteratum%253Aachs%26aulast%3DSchuch%26aufirst%3DA.%26aulast%3DDeiters%26aufirst%3DP.%26aulast%3DHenne%26aufirst%3DJ.%26aulast%3DK%25C3%25B6hler%26aufirst%3DK.%26aulast%3DSchuchmann%26aufirst%3DH.%2BP.%26atitle%3DProduction%2520of%2520W%252FO%252FW%2520%2528water-in-oil-in-water%2529%2520multiple%2520emulsions%253A%2520droplet%2520breakup%2520and%2520release%2520of%2520water%26jtitle%3DJ.%2520Colloid%2520Interface%2520Sci.%26date%3D2013%26volume%3D402%26spage%3D157%26epage%3D164%26doi%3D10.1016%2Fj.jcis.2013.03.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Makadia, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span> </span><span class="NLM_article-title">Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier</span> <span class="citation_source-journal">Polymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1397</span><span class="refDoi"> DOI: 10.3390/polym3031377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.3390%2Fpolym3031377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=22577513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOis7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1377-1397&issue=3&author=H.+K.+Makadiaauthor=S.+J.+Siegel&title=Poly+lactic-co-glycolic+acid+%28PLGA%29+as+biodegradable+controlled+drug+delivery+carrier&doi=10.3390%2Fpolym3031377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier</span></div><div class="casAuthors">Makadia, Hirenkumar K.; Siegel, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Polymers (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1377-1397</span>CODEN:
                <span class="NLM_cas:coden">POLYCK</span>;
        ISSN:<span class="NLM_cas:issn">2073-4360</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  In past two decades poly lactic-co-glycolic acid (PLGA) has been among the most attractive polymeric candidates used to fabricate devices for drug delivery and tissue engineering applications.  PLGA is biocompatible and biodegradable, exhibits a wide range of erosion times, has tunable mech. properties and most importantly, is a FDA approved polymer.  In particular, PLGA has been extensively studied for the development of devices for controlled delivery of small mol. drugs, proteins and other macromols. in com. use and in research.  This manuscript describes the various fabrication techniques for these devices and the factors affecting their degrdn. and drug release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqKSnjbA3YlrVg90H21EOLACvtfcHk0lgHDzsN96BM9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOis7jJ&md5=dcc6e49beb083af56e0cc3213bb99f72</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3390%2Fpolym3031377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpolym3031377%26sid%3Dliteratum%253Aachs%26aulast%3DMakadia%26aufirst%3DH.%2BK.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26atitle%3DPoly%2520lactic-co-glycolic%2520acid%2520%2528PLGA%2529%2520as%2520biodegradable%2520controlled%2520drug%2520delivery%2520carrier%26jtitle%3DPolymers%26date%3D2011%26volume%3D3%26issue%3D3%26spage%3D1377%26epage%3D1397%26doi%3D10.3390%2Fpolym3031377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Camorani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colecchia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpentieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amoresano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiariello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchia, L.</span><span> </span><span class="NLM_article-title">Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37570</span><span class="NLM_x">–</span> <span class="NLM_lpage">37587</span><span class="refDoi"> DOI: 10.18632/oncotarget.6066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.18632%2Foncotarget.6066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=26461476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A280%3ADC%252BC28zhs1SjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=37570-37587&author=S.+Camoraniauthor=E.+Crescenziauthor=D.+Colecchiaauthor=A.+Carpentieriauthor=A.+Amoresanoauthor=M.+Fedeleauthor=M.+Chiarielloauthor=L.+Cerchia&title=Aptamer+targeting+EGFRvIII+mutant+hampers+its+constitutive+autophosphorylation+and+affects+migration%2C+invasion+and+proliferation+of+glioblastoma+cells&doi=10.18632%2Foncotarget.6066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells</span></div><div class="casAuthors">Camorani Simona; Crescenzi Elvira; Fedele Monica; Cerchia Laura; Colecchia David; Chiariello Mario; Carpentieri Andrea; Amoresano Angela</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">37570-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma Multiforme (GBM) is the most common and aggressive human brain tumor, associated with very poor survival despite surgery, radiotherapy and chemotherapy.The epidermal growth factor receptor (EGFR) and the platelet-derived growth factor receptor β (PDGFRβ) are hallmarks in GBM with driving roles in tumor progression.  In approximately half of the tumors with amplified EGFR, the EGFRvIII truncated extracellular mutant is detected.  EGFRvIII does not bind ligands, is highly oncogenic and its expression confers resistance to EGFR tyrosine kinase inhibitors (TKIs).  It has been demonstrated that EGFRvIII-dependent cancers may escape targeted therapy by developing dependence on PDGFRβ signaling, thus providing a strong rationale for combination therapy aimed at blocking both EGFRvIII and PDGFRβsignaling.We have recently generated two nuclease resistant RNA aptamers, CL4 and Gint4.T, as high affinity ligands and inhibitors of the human wild-type EGFR (EGFRwt) and PDGFRβ, respectively.Herein, by different approaches, we demonstrate that CL4 aptamer binds to the EGFRvIII mutant even though it lacks most of the extracellular domain.  As a consequence of binding, the aptamer inhibits EGFRvIII autophosphorylation and downstream signaling pathways, thus affecting migration, invasion and proliferation of EGFRvIII-expressing GBM cell lines.Further, we show that targeting EGFRvIII by CL4, as well as by EGFR-TKIs, erlotinib and gefitinib, causes upregulation of PDGFRβ.  Importantly, CL4 and gefitinib cooperate with the anti-PDGFRβ Gint4.T aptamer in inhibiting cell proliferation.The proposed aptamer-based strategy could have impact on targeted molecular cancer therapies and may result in progresses against GBMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzbSs0VCb97WZyxfu64m4ffW6udTcc2ebipRjYqHCVt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zhs1SjtQ%253D%253D&md5=570c85775ada7655e509c0ef0b8c2d8e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6066%26sid%3Dliteratum%253Aachs%26aulast%3DCamorani%26aufirst%3DS.%26aulast%3DCrescenzi%26aufirst%3DE.%26aulast%3DColecchia%26aufirst%3DD.%26aulast%3DCarpentieri%26aufirst%3DA.%26aulast%3DAmoresano%26aufirst%3DA.%26aulast%3DFedele%26aufirst%3DM.%26aulast%3DChiariello%26aufirst%3DM.%26aulast%3DCerchia%26aufirst%3DL.%26atitle%3DAptamer%2520targeting%2520EGFRvIII%2520mutant%2520hampers%2520its%2520constitutive%2520autophosphorylation%2520and%2520affects%2520migration%252C%2520invasion%2520and%2520proliferation%2520of%2520glioblastoma%2520cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D37570%26epage%3D37587%26doi%3D10.18632%2Foncotarget.6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Advances in development of phosphatidylinositol 3-kinase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">2839</span><span class="NLM_x">–</span> <span class="NLM_lpage">2854</span><span class="refDoi"> DOI: 10.2174/092986709788803222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.2174%2F092986709788803222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=19689267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVynt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2839-2854&issue=22&author=D.+Kongauthor=T.+Yamori&title=Advances+in+development+of+phosphatidylinositol+3-kinase+inhibitors&doi=10.2174%2F092986709788803222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in development of phosphatidylinositol 3-kinase inhibitors</span></div><div class="casAuthors">Kong, Dexin; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2839-2854</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (P13Ks) are a class of lipid kinases that phosphorylate phosphatidylinositol 4,5-bisphosphate (PIP2) at the 3-OH of the inositol ring to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3), which in turn activates Akt and the downstream effectors like mTOR, and therefore play important roles in cell growth, survival, etc.  The phosphatase and tensin homolog deleted in chromosome ten (PTEN), acts as the catalytic antagonist of PI3K by dephosphorylating PIP3 to PIP2.  PI3K has become an important drug target for cancer therapy, since gain-of-function mutations of PIK3CA encoding PI3Kα, as well as loss-of-function mutations of PTEN, have been frequently found in human cancers.  The pharmaceutical development of PI3K inhibitors has made a great leap forward during the last 3 years.  While PI3Kβ, δ and γ isoform-specific PI3K inhibitors (TGX-221, IC87114 and AS-605240) have been developed for therapy of coronary heart disease, asthma, and glomerulonephritis, resp., a promising PI3Kα specific inhibitor is not yet available.  Correspondingly, almost all of the promising PI3K inhibitors under development for cancer therapy, such as NVP-BEZ235, GDC-0941 and ZSTK474, are pan-PI3K isoform inhibitors.  Each of these pan-PI3K inhibitors seems to induce a common G1 phase arrest.  All have shown favorable in vivo anticancer efficacies and low toxicities, and therefore most have entered evaluation in clin. trials.  P-Akt and p-S6 have been reported to be feasible pharmacodynamic biomarkers for monitoring the efficacy of these agents.  In the process of discovery of these and other PI3K inhibitors, detailed structure-activity relation studies were carried out.  This review summarizes key advances in the development of PI3K inhibitors, which is preceded by an introduction of PI3K family and their functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34auL80q6urVg90H21EOLACvtfcHk0lgHDzsN96BM9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVynt7c%253D&md5=7bcedc62a6b1a0b570143d49ba861fee</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F092986709788803222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788803222%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAdvances%2520in%2520development%2520of%2520phosphatidylinositol%25203-kinase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26issue%3D22%26spage%3D2839%26epage%3D2854%26doi%3D10.2174%2F092986709788803222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Gingras, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raught, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakiewicz, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenberg, N.</span><span> </span><span class="NLM_article-title">Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1422</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.1101/gad.13.11.1422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1101%2Fgad.13.11.1422" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1422-1437&issue=11&author=A.+C.+Gingrasauthor=S.+P.+Gygiauthor=B.+Raughtauthor=R.+D.+Polakiewiczauthor=R.+T.+Abrahamauthor=M.+F.+Hoekstraauthor=R.+Aebersoldauthor=N.+Sonenberg&title=Regulation+of+4E-BP1+phosphorylation%3A+a+novel+two-step+mechanism&doi=10.1101%2Fgad.13.11.1422"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.11.1422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.11.1422%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DA.%2BC.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DPolakiewicz%26aufirst%3DR.%2BD.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DHoekstra%26aufirst%3DM.%2BF.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DRegulation%2520of%25204E-BP1%2520phosphorylation%253A%2520a%2520novel%2520two-step%2520mechanism%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26issue%3D11%26spage%3D1422%26epage%3D1437%26doi%3D10.1101%2Fgad.13.11.1422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Carcaboso, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmeliegy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4499</span><span class="NLM_x">–</span> <span class="NLM_lpage">4508</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-4264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F0008-5472.CAN-09-4264" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=4499-4508&issue=11&author=A.+M.+Carcabosoauthor=M.+A.+Elmeliegyauthor=J.+Shenauthor=S.+J.+Juelauthor=Z.+M.+Zhangauthor=C.+Calabreseauthor=L.+Traceyauthor=C.+M.+Watersauthor=C.+F.+Stewart&title=Tyrosine+kinase+inhibitor+gefitinib+enhances+topotecan+penetration+of+gliomas&doi=10.1158%2F0008-5472.CAN-09-4264"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-4264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-4264%26sid%3Dliteratum%253Aachs%26aulast%3DCarcaboso%26aufirst%3DA.%2BM.%26aulast%3DElmeliegy%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DJuel%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BM.%26aulast%3DCalabrese%26aufirst%3DC.%26aulast%3DTracey%26aufirst%3DL.%26aulast%3DWaters%26aufirst%3DC.%2BM.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26atitle%3DTyrosine%2520kinase%2520inhibitor%2520gefitinib%2520enhances%2520topotecan%2520penetration%2520of%2520gliomas%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D11%26spage%3D4499%26epage%3D4508%26doi%3D10.1158%2F0008-5472.CAN-09-4264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchanda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelbaum, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlfest, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, W. F.</span><span> </span><span class="NLM_article-title">Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1124/dmd.112.048322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1124%2Fdmd.112.048322" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=33-39&author=S.+Agarwalauthor=P.+Manchandaauthor=M.+A.+Vogelbaumauthor=J.+R.+Ohlfestauthor=W.+F.+Elmquist&title=Function+of+the+blood-brain+barrier+and+restriction+of+drug+delivery+to+invasive+glioma+cells%3A+findings+in+an+orthotopic+rat+xenograft+model+of+glioma&doi=10.1124%2Fdmd.112.048322"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.048322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.048322%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DManchanda%26aufirst%3DP.%26aulast%3DVogelbaum%26aufirst%3DM.%2BA.%26aulast%3DOhlfest%26aufirst%3DJ.%2BR.%26aulast%3DElmquist%26aufirst%3DW.%2BF.%26atitle%3DFunction%2520of%2520the%2520blood-brain%2520barrier%2520and%2520restriction%2520of%2520drug%2520delivery%2520to%2520invasive%2520glioma%2520cells%253A%2520findings%2520in%2520an%2520orthotopic%2520rat%2520xenograft%2520model%2520of%2520glioma%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D33%26epage%3D39%26doi%3D10.1124%2Fdmd.112.048322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alicke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carano, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharbanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeppen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokorny, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reslan, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkaria, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, H. S.</span><span> </span><span class="NLM_article-title">Targeting the PI3K pathway in the brain-efficacy of a PI3K inhibitor optimized to cross, the blood-brain barrier</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6239</span><span class="NLM_x">–</span> <span class="NLM_lpage">6248</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-0720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F1078-0432.CCR-12-0720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=22992516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12jur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=6239-6248&author=L.+Salphatiauthor=T.+P.+Heffronauthor=B.+Alickeauthor=M.+Nishimuraauthor=K.+Barckauthor=R.+A.+Caranoauthor=J.+Cheongauthor=K.+A.+Edgarauthor=J.+Greveauthor=S.+Kharbandaauthor=H.+Koeppenauthor=S.+Lauauthor=L.+B.+Leeauthor=J.+Pangauthor=E.+G.+Pliseauthor=J.+L.+Pokornyauthor=H.+B.+Reslanauthor=J.+N.+Sarkariaauthor=J.+J.+Wallinauthor=X.+Zhangauthor=S.+E.+Gouldauthor=A.+G.+Oliveroauthor=H.+S.+Phillips&title=Targeting+the+PI3K+pathway+in+the+brain-efficacy+of+a+PI3K+inhibitor+optimized+to+cross%2C+the+blood-brain+barrier&doi=10.1158%2F1078-0432.CCR-12-0720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K Pathway in the Brain-Efficacy of a PI3K Inhibitor Optimized to Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Salphati, Laurent; Heffron, Timothy P.; Alicke, Bruno; Nishimura, Merry; Barck, Kai; Carano, Richard A.; Cheong, Jonathan; Edgar, Kyle A.; Greve, Joan; Kharbanda, Samir; Koeppen, Hartmut; Lau, Shari; Lee, Leslie B.; Pang, Jodie; Plise, Emile G.; Pokorny, Jenny L.; Reslan, Hani Bou; Sarkaria, Jann N.; Wallin, Jeffrey J.; Zhang, Xiaolin; Gould, Stephen E.; Olivero, Alan G.; Phillips, Heidi S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6239-6248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Glioblastoma (GBM), the most common primary brain tumor in adults, presents a high frequency of alteration in the PI3K pathway.  Our objectives were to identify a dual PI3K/mTOR inhibitor optimized to cross the blood-brain barrier (BBB) and characterize its brain penetration, pathway modulation in the brain and efficacy in orthotopic xenograft models of GBM.  Exptl. Design: Physicochem. properties of PI3K inhibitors were optimized using in silico tools, leading to the identification of GNE-317.  This compd. was tested in cells overexpressing P-glycoprotein (P-gp) or breast cancer resistance protein (BCRP).  Following administration to mice, GNE-317 plasma and brain concns. were detd., and phosphorylated biomarkers (pAkt, p4EBP1, and pS6) were measured to assess PI3K pathway suppression in the brain.  GNE-317 efficacy was evaluated in the U87, GS2, and GBM10 orthotopic models of GBM.  Results: GNE-317 was identified as having physicochem. properties predictive of low efflux by P-gp and BCRP.  Studies in transfected MDCK cells showed that GNE-317 was not a substrate of either transporter.  GNE-317 markedly inhibited the PI3K pathway in mouse brain, causing 40% to 90% suppression of the pAkt and pS6 signals up to 6-h postdose.  GNE-317 was efficacious in the U87, GS2, and GBM10 orthotopic models, achieving tumor growth inhibition of 90% and 50%, and survival benefit, resp.  Conclusions: These results indicated that specific optimization of PI3K inhibitors to cross the BBB led to potent suppression of the PI3K pathway in healthy brain.  The efficacy of GNE-317 in 3 intracranial models of GBM suggested that this compd. could be effective in the treatment of GBM.  Clin Cancer Res; 18(22); 6239-48. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw61JdQWneebVg90H21EOLACvtfcHk0lh6M7g8yN1GRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12jur3J&md5=04450de4d9e3106d7f4d8fb831f9e9ac</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-0720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-0720%26sid%3Dliteratum%253Aachs%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DNishimura%26aufirst%3DM.%26aulast%3DBarck%26aufirst%3DK.%26aulast%3DCarano%26aufirst%3DR.%2BA.%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DEdgar%26aufirst%3DK.%2BA.%26aulast%3DGreve%26aufirst%3DJ.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DKoeppen%26aufirst%3DH.%26aulast%3DLau%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPlise%26aufirst%3DE.%2BG.%26aulast%3DPokorny%26aufirst%3DJ.%2BL.%26aulast%3DReslan%26aufirst%3DH.%2BB.%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DWallin%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPhillips%26aufirst%3DH.%2BS.%26atitle%3DTargeting%2520the%2520PI3K%2520pathway%2520in%2520the%2520brain-efficacy%2520of%2520a%2520PI3K%2520inhibitor%2520optimized%2520to%2520cross%252C%2520the%2520blood-brain%2520barrier%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D6239%26epage%3D6248%26doi%3D10.1158%2F1078-0432.CCR-12-0720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Plate, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risau, W.</span><span> </span><span class="NLM_article-title">Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1992&pages=529-534&issue=4&author=K.+H.+Plateauthor=G.+Breierauthor=C.+L.+Farrellauthor=W.+Risau&title=Platelet-derived+growth+factor+receptor-beta+is+induced+during+tumor+development+and+upregulated+during+tumor+progression+in+endothelial+cells+in+human+gliomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlate%26aufirst%3DK.%2BH.%26aulast%3DBreier%26aufirst%3DG.%26aulast%3DFarrell%26aufirst%3DC.%2BL.%26aulast%3DRisau%26aufirst%3DW.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520receptor-beta%2520is%2520induced%2520during%2520tumor%2520development%2520and%2520upregulated%2520during%2520tumor%2520progression%2520in%2520endothelial%2520cells%2520in%2520human%2520gliomas%26jtitle%3DLab.%2520Invest.%26date%3D1992%26volume%3D67%26issue%3D4%26spage%3D529%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Esposito, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuzzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rienzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alder, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci-Vitiani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catuogno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Franciscis, V.</span><span> </span><span class="NLM_article-title">A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">238</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2016.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1016%2Fj.jconrel.2016.07.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=27448441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ersLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=238&publication_year=2016&pages=43-57&author=C.+L.+Espositoauthor=S.+Nuzzoauthor=S.+A.+Kumarauthor=A.+Rienzoauthor=C.+L.+Lawrenceauthor=R.+Palliniauthor=L.+Shawauthor=J.+E.+Alderauthor=L.+Ricci-Vitianiauthor=S.+Catuognoauthor=V.+de+Franciscis&title=A+combined+microRNA-based+targeted+therapeutic+approach+to+eradicate+glioblastoma+stem-like+cells&doi=10.1016%2Fj.jconrel.2016.07.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells</span></div><div class="casAuthors">Esposito, Carla L.; Nuzzo, Silvia; Kumar, Swati A.; Rienzo, Anna; Lawrence, Clare L.; Pallini, Roberto; Shaw, Lisa; Alder, Jane E.; Ricci-Vitiani, Lucia; Catuogno, Silvia; de Franciscis, Vittorio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">238</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-57</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A minor population of glioblastoma stem-like cells (GSCs) has been implicated in the relapse and resistance of glioblastoma to therapeutic treatments.  Based on knowledge of the involvement of multiple microRNAs in GSC propagation, we designed a combinational approach to target the GSC population with multiple miRNA-based therapeutics.  As carriers for the targeted delivery we took advantage of two aptamers that bind to, and inhibit, the receptor tyrosine kinases, Axl and PDGFRβ.  We showed that the aptamer conjugates are transported through an in vitro blood-brain barrier (BBB) model.  Furthermore, combining miR-137 and antimiR-10b synergizes with the receptor inhibitory function of aptamer carriers and prevents GSC expansion.  Results highlighted the potential of combining multifunctional RNA-based therapeutics for selective targeting of GSCs and offer a proof of principle strategy to potentially fulfill the still unmet need for effective and safe treatment of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoplPwWarxGb7Vg90H21EOLACvtfcHk0li_KOYCr8unCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ersLbP&md5=6dedad082afe6256c959391029644947</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2016.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2016.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DC.%2BL.%26aulast%3DNuzzo%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DS.%2BA.%26aulast%3DRienzo%26aufirst%3DA.%26aulast%3DLawrence%26aufirst%3DC.%2BL.%26aulast%3DPallini%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DL.%26aulast%3DAlder%26aufirst%3DJ.%2BE.%26aulast%3DRicci-Vitiani%26aufirst%3DL.%26aulast%3DCatuogno%26aufirst%3DS.%26aulast%3Dde%2BFranciscis%26aufirst%3DV.%26atitle%3DA%2520combined%2520microRNA-based%2520targeted%2520therapeutic%2520approach%2520to%2520eradicate%2520glioblastoma%2520stem-like%2520cells%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2016%26volume%3D238%26spage%3D43%26epage%3D57%26doi%3D10.1016%2Fj.jconrel.2016.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Martin, R. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locatelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes Franchini, M.</span><span> </span><span class="NLM_article-title">Gold nanorods and curcumin-loaded nanomicelles for efficient <i>in vivo</i> photothermal therapy of Barrett’s esophagus</span> <span class="citation_source-journal">Nanomedicine (London, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1723</span><span class="NLM_x">–</span> <span class="NLM_lpage">1733</span><span class="refDoi"> DOI: 10.2217/nnm.15.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.2217%2Fnnm.15.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=25706349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1723-1733&author=R.+C.+G.+Martinauthor=E.+Locatelliauthor=Y.+Liauthor=W.+Zhangauthor=S.+Liauthor=I.+Monacoauthor=M.+Comes+Franchini&title=Gold+nanorods+and+curcumin-loaded+nanomicelles+for+efficient+in+vivo+photothermal+therapy+of+Barrett%E2%80%99s+esophagus&doi=10.2217%2Fnnm.15.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Gold nanorods and curcumin-loaded nanomicelles for efficient in vivo photothermal therapy of Barrett's esophagus</span></div><div class="casAuthors">Martin, Robert C. G.; Locatelli, Erica; Li, Yan; Zhang, Weizhong; Li, Suping; Monaco, Ilaria; Franchini, Mauro Comes</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1723-1733</span>CODEN:
                <span class="NLM_cas:coden">NLUKAC</span>;
        ISSN:<span class="NLM_cas:issn">1743-5889</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Aim: Provide an enhanced local drug delivery, nanoparticle(s) to minimize systemic effects and achieve enhanced permeability and drug retention into abnormal cells and stroma.  Materials & methods: Here a simultaneous loading of lipophilic gold nanorods (GNRs) and curcumin into polymeric nanomicelles made of biocompatible PLGA-b-PEG copolymer through a double re-emulsification process has been developed.  Results: Initial results in vitro on Barrett's esophagus and esophageal adenocarcinoma cell lines demonstrated a significant redn. in cell viability with curcumin and GNRs exposure (p < 0.05).  In vivo Barrett's-assocd. animal model confirmed these results with successful in vivo demonstrated eradication of all high-grade dysplastic premalignant cancer cells.  Conclusion: The synthesis of this novel nanosystem contg. GNRs and curcumin is safe and effective in treating and eradicating premalignant esophageal adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE94vSxHlsPbVg90H21EOLACvtfcHk0li_KOYCr8unCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSru7fE&md5=9740aef90c83f8ed712b6e4f5fe4ed28</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2217%2Fnnm.15.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fnnm.15.25%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DR.%2BC.%2BG.%26aulast%3DLocatelli%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMonaco%26aufirst%3DI.%26aulast%3DComes%2BFranchini%26aufirst%3DM.%26atitle%3DGold%2520nanorods%2520and%2520curcumin-loaded%2520nanomicelles%2520for%2520efficient%2520in%2520vivo%2520photothermal%2520therapy%2520of%2520Barrett%25E2%2580%2599s%2520esophagus%26jtitle%3DNanomedicine%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2015%26volume%3D10%26spage%3D1723%26epage%3D1733%26doi%3D10.2217%2Fnnm.15.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 58 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gayathri Ravichandran, <span class="NLM_string-name hlFld-ContribAuthor">Aravind Kumar Rengan</span>. </span><span class="cited-content_cbyCitation_article-title">Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Nano Materials</span><span> <strong>2020,</strong> <em>3 </em>
                                    (10)
                                     , 9542-9559. <a href="https://doi.org/10.1021/acsanm.0c01785" title="DOI URL">https://doi.org/10.1021/acsanm.0c01785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsanm.0c01785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsanm.0c01785%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Nano%2520Materials%26atitle%3DAptamer-Mediated%252BNanotheranostics%252Bfor%252BCancer%252BTreatment%25253A%252BA%252BReview%26aulast%3DRavichandran%26aufirst%3DGayathri%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29062020%26date%3D29092020%26date%3D14102020%26date%3D29092020%26volume%3D3%26issue%3D10%26spage%3D9542%26epage%3D9559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qian Lu, Xiaoli Cai, Xian Zhang, Suiqiong Li, Yang Song, Dan Du, Prashanta Dutta, <span class="NLM_string-name hlFld-ContribAuthor">Yuehe Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Polymer Nanoparticles Functionalized with Different Ligands for Receptor-Mediated Transcytosis across the Blood–Brain Barrier. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2018,</strong> <em>1 </em>
                                    (5)
                                     , 1687-1694. <a href="https://doi.org/10.1021/acsabm.8b00502" title="DOI URL">https://doi.org/10.1021/acsabm.8b00502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.8b00502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.8b00502%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DSynthetic%252BPolymer%252BNanoparticles%252BFunctionalized%252Bwith%252BDifferent%252BLigands%252Bfor%252BReceptor-Mediated%252BTranscytosis%252Bacross%252Bthe%252BBlood%2525E2%252580%252593Brain%252BBarrier%26aulast%3DLu%26aufirst%3DQian%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D05092018%26date%3D08102018%26date%3D23102018%26date%3D09102018%26volume%3D1%26issue%3D5%26spage%3D1687%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rakesh Kumar, Sandeep Chaudhary, Rohit Kumar, Pooja Upadhyay, Dinkar Sahal, <span class="NLM_string-name hlFld-ContribAuthor">Upendra Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst and Additive-Free Diastereoselective 1,3-Dipolar Cycloaddition of Quinolinium Imides with Olefins, Maleimides, and Benzynes: Direct Access to Fused N,N′-Heterocycles with Promising Activity against a Drug-Resistant Malaria Parasite. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (19)
                                     , 11552-11570. <a href="https://doi.org/10.1021/acs.joc.8b01520" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01520%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DCatalyst%252Band%252BAdditive-Free%252BDiastereoselective%252B1%25252C3-Dipolar%252BCycloaddition%252Bof%252BQuinolinium%252BImides%252Bwith%252BOlefins%25252C%252BMaleimides%25252C%252Band%252BBenzynes%25253A%252BDirect%252BAccess%252Bto%252BFused%252BN%25252CN%2525E2%252580%2525B2-Heterocycles%252Bwith%252BPromising%252BActivity%252Bagainst%252Ba%252BDrug-Resistant%252BMalaria%252BParasite%26aulast%3DKumar%26aufirst%3DRakesh%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D17062018%26date%3D11092018%26date%3D30082018%26volume%3D83%26issue%3D19%26spage%3D11552%26epage%3D11570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aaron Y.  Mochizuki</span>, <span class="hlFld-ContribAuthor ">Isaura M.  Frost</span>, <span class="hlFld-ContribAuthor ">Melina B.  Mastrodimos</span>, <span class="hlFld-ContribAuthor ">Ashley S.  Plant</span>, <span class="hlFld-ContribAuthor ">Anthony C.  Wang</span>, <span class="hlFld-ContribAuthor ">Theodore B.  Moore</span>, <span class="hlFld-ContribAuthor ">Robert M.  Prins</span>, <span class="hlFld-ContribAuthor ">Paul S.  Weiss</span>, and <span class="hlFld-ContribAuthor ">Steven J.  Jonas</span>  . </span><span class="cited-content_cbyCitation_article-title">Precision Medicine in Pediatric Neurooncology: A Review. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     , 11-28. <a href="https://doi.org/10.1021/acschemneuro.7b00388" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00388%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DPrecision%252BMedicine%252Bin%252BPediatric%252BNeurooncology%25253A%252BA%252BReview%26aulast%3DMochizuki%26aufirst%3DAaron%2BY.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09102017%26date%3D04122017%26date%3D27122017%26date%3D17012018%26date%3D04122017%26volume%3D9%26issue%3D1%26spage%3D11%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa  Agnello</span>, <span class="hlFld-ContribAuthor ">Silvia  Tortorella</span>, <span class="hlFld-ContribAuthor ">Annachiara  d’Argenio</span>, <span class="hlFld-ContribAuthor ">Clarissa  Carbone</span>, <span class="hlFld-ContribAuthor ">Simona  Camorani</span>, <span class="hlFld-ContribAuthor ">Erica  Locatelli</span>, <span class="hlFld-ContribAuthor ">Luigi  Auletta</span>, <span class="hlFld-ContribAuthor ">Domenico  Sorrentino</span>, <span class="hlFld-ContribAuthor ">Monica  Fedele</span>, <span class="hlFld-ContribAuthor ">Antonella  Zannetti</span>, <span class="hlFld-ContribAuthor ">Mauro Comes  Franchini</span>, <span class="hlFld-ContribAuthor ">Laura  Cerchia</span>. </span><span class="cited-content_cbyCitation_article-title">Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2021,</strong> <em>40 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-021-02039-w" title="DOI URL">https://doi.org/10.1186/s13046-021-02039-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-021-02039-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-021-02039-w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DOptimizing%252Bcisplatin%252Bdelivery%252Bto%252Btriple-negative%252Bbreast%252Bcancer%252Bthrough%252Bnovel%252BEGFR%252Baptamer-conjugated%252Bpolymeric%252Bnanovectors%26aulast%3DAgnello%26aufirst%3DLisa%26date%3D2021%26date%3D2021%26volume%3D40%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Li</span>, <span class="hlFld-ContribAuthor ">Caixia  Wang</span>, <span class="hlFld-ContribAuthor ">Meng  Zhang</span>, <span class="hlFld-ContribAuthor ">Songjiao  Li</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Mao</span>, <span class="hlFld-ContribAuthor ">Zhihong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Activatable luminescent probes for imaging brain diseases. </span><span class="cited-content_cbyCitation_journal-name">Nano Today</span><span> <strong>2021,</strong> <em>39 </em>, 101239. <a href="https://doi.org/10.1016/j.nantod.2021.101239" title="DOI URL">https://doi.org/10.1016/j.nantod.2021.101239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nantod.2021.101239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nantod.2021.101239%26sid%3Dliteratum%253Aachs%26jtitle%3DNano%2520Today%26atitle%3DActivatable%252Bluminescent%252Bprobes%252Bfor%252Bimaging%252Bbrain%252Bdiseases%26aulast%3DLi%26aufirst%3DZhen%26date%3D2021%26volume%3D39%26spage%3D101239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcela Tavares  Luiz</span>, <span class="hlFld-ContribAuthor ">Leonardo  Delello Di Filippo</span>, <span class="hlFld-ContribAuthor ">Larissa Bueno  Tofani</span>, <span class="hlFld-ContribAuthor ">Jennifer Thayanne Cavalcante  de Araújo</span>, <span class="hlFld-ContribAuthor ">Jessyca Aparecida Paes  Dutra</span>, <span class="hlFld-ContribAuthor ">Juliana Maldonado  Marchetti</span>, <span class="hlFld-ContribAuthor ">Marlus  Chorilli</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in targeted nanoparticles as a delivery strategy for glioma treatment. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmaceutics</span><span> <strong>2021,</strong> <em>604 </em>, 120758. <a href="https://doi.org/10.1016/j.ijpharm.2021.120758" title="DOI URL">https://doi.org/10.1016/j.ijpharm.2021.120758</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpharm.2021.120758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpharm.2021.120758%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmaceutics%26atitle%3DHighlights%252Bin%252Btargeted%252Bnanoparticles%252Bas%252Ba%252Bdelivery%252Bstrategy%252Bfor%252Bglioma%252Btreatment%26aulast%3DLuiz%26aufirst%3DMarcela%2BTavares%26date%3D2021%26volume%3D604%26spage%3D120758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yamir  Islam</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>, <span class="hlFld-ContribAuthor ">Jayden  Smith</span>, <span class="hlFld-ContribAuthor ">Stefano  Pluchino</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Coxon</span>, <span class="hlFld-ContribAuthor ">Muttuswamy  Sivakumaran</span>, <span class="hlFld-ContribAuthor ">James  Downing</span>, <span class="hlFld-ContribAuthor ">Amos A.  Fatokun</span>, <span class="hlFld-ContribAuthor ">Meritxell  Teixidò</span>, <span class="hlFld-ContribAuthor ">Touraj  Ehtezazi</span>. </span><span class="cited-content_cbyCitation_article-title">Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Science</span><span> <strong>2021,</strong> <em>8 </em>
                                    (11)
                                     , 2002085. <a href="https://doi.org/10.1002/advs.202002085" title="DOI URL">https://doi.org/10.1002/advs.202002085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/advs.202002085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadvs.202002085%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Science%26atitle%3DPhysiological%252Band%252BPathological%252BFactors%252BAffecting%252BDrug%252BDelivery%252Bto%252Bthe%252BBrain%252Bby%252BNanoparticles%26aulast%3DIslam%26aufirst%3DYamir%26date%3D2021%26date%3D2021%26volume%3D8%26issue%3D11%26spage%3D2002085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shi'qi  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Zeng</span>, <span class="hlFld-ContribAuthor ">Li  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">Detection of Body Blood Glucose Index Based on Nano-material-Coupled Aptamer Sensor. </span><span class="cited-content_cbyCitation_journal-name">Integrated Ferroelectrics</span><span> <strong>2021,</strong> <em>215 </em>
                                    (1)
                                     , 219-232. <a href="https://doi.org/10.1080/10584587.2021.1911240" title="DOI URL">https://doi.org/10.1080/10584587.2021.1911240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10584587.2021.1911240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10584587.2021.1911240%26sid%3Dliteratum%253Aachs%26jtitle%3DIntegrated%2520Ferroelectrics%26atitle%3DDetection%252Bof%252BBody%252BBlood%252BGlucose%252BIndex%252BBased%252Bon%252BNano-material-Coupled%252BAptamer%252BSensor%26aulast%3DLiu%26aufirst%3DShi%2527qi%26date%3D2021%26date%3D2021%26volume%3D215%26issue%3D1%26spage%3D219%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yadollah  Omidi</span>, <span class="hlFld-ContribAuthor ">Nazanin  Kianinejad</span>, <span class="hlFld-ContribAuthor ">Young  Kwon</span>, <span class="hlFld-ContribAuthor ">Hossein  Omidian</span>. </span><span class="cited-content_cbyCitation_article-title">Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Clinical Pharmacology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (3)
                                     , 357-381. <a href="https://doi.org/10.1080/17512433.2021.1887729" title="DOI URL">https://doi.org/10.1080/17512433.2021.1887729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17512433.2021.1887729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17512433.2021.1887729%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Clinical%2520Pharmacology%26atitle%3DDrug%252Bdelivery%252Band%252Btargeting%252Bto%252Bbrain%252Btumors%25253A%252Bconsiderations%252Bfor%252Bcrossing%252Bthe%252Bblood-brain%252Bbarrier%26aulast%3DOmidi%26aufirst%3DYadollah%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D3%26spage%3D357%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheina  Emrani</span>, <span class="hlFld-ContribAuthor ">Melissa  Lamar</span>, <span class="hlFld-ContribAuthor ">Catherine C.  Price</span>, <span class="hlFld-ContribAuthor ">Satya  Baliga</span>, <span class="hlFld-ContribAuthor ">Victor  Wasserman</span>, <span class="hlFld-ContribAuthor ">Emily  Matusz</span>, <span class="hlFld-ContribAuthor ">Rod  Swenson</span>, <span class="hlFld-ContribAuthor ">Ganesh  Baliga</span>, <span class="hlFld-ContribAuthor ">David J.  Libon</span>. </span><span class="cited-content_cbyCitation_article-title">Assessing the capacity for mental manipulation in patients with statically-determined mild cognitive impairment using digital technology. </span><span class="cited-content_cbyCitation_journal-name">Exploration of Medicine</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.37349/emed.2021.00034" title="DOI URL">https://doi.org/10.37349/emed.2021.00034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.37349/emed.2021.00034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.37349%2Femed.2021.00034%26sid%3Dliteratum%253Aachs%26jtitle%3DExploration%2520of%2520Medicine%26atitle%3DAssessing%252Bthe%252Bcapacity%252Bfor%252Bmental%252Bmanipulation%252Bin%252Bpatients%252Bwith%252Bstatically-determined%252Bmild%252Bcognitive%252Bimpairment%252Busing%252Bdigital%252Btechnology%26aulast%3DEmrani%26aufirst%3DSheina%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa  Agnello</span>, <span class="hlFld-ContribAuthor ">Simona  Camorani</span>, <span class="hlFld-ContribAuthor ">Monica  Fedele</span>, <span class="hlFld-ContribAuthor ">Laura  Cerchia</span>. </span><span class="cited-content_cbyCitation_article-title">Aptamers and antibodies: rivals or allies in cancer targeted therapy?. </span><span class="cited-content_cbyCitation_journal-name">Exploration of Targeted Anti-tumor Therapy</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.37349/etat.2021.00035" title="DOI URL">https://doi.org/10.37349/etat.2021.00035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.37349/etat.2021.00035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.37349%2Fetat.2021.00035%26sid%3Dliteratum%253Aachs%26jtitle%3DExploration%2520of%2520Targeted%2520Anti-tumor%2520Therapy%26atitle%3DAptamers%252Band%252Bantibodies%25253A%252Brivals%252Bor%252Ballies%252Bin%252Bcancer%252Btargeted%252Btherapy%25253F%26aulast%3DAgnello%26aufirst%3DLisa%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronika  Subjakova</span>, <span class="hlFld-ContribAuthor ">Veronika  Oravczova</span>, <span class="hlFld-ContribAuthor ">Tibor  Hianik</span>. </span><span class="cited-content_cbyCitation_article-title">Polymer Nanoparticles and Nanomotors Modified by DNA/RNA Aptamers and Antibodies in Targeted Therapy of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Polymers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (3)
                                     , 341. <a href="https://doi.org/10.3390/polym13030341" title="DOI URL">https://doi.org/10.3390/polym13030341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/polym13030341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpolym13030341%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymers%26atitle%3DPolymer%252BNanoparticles%252Band%252BNanomotors%252BModified%252Bby%252BDNA%25252FRNA%252BAptamers%252Band%252BAntibodies%252Bin%252BTargeted%252BTherapy%252Bof%252BCancer%26aulast%3DSubjakova%26aufirst%3DVeronika%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D3%26spage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yadan  Zhang</span>, <span class="hlFld-ContribAuthor ">Junlin  He</span>, <span class="hlFld-ContribAuthor ">Liao  Shen</span>, <span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Yao  Li</span>, <span class="hlFld-ContribAuthor ">Yongan  Wang</span>, <span class="hlFld-ContribAuthor ">Dongqin  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Controlled Release</span><span> <strong>2021,</strong> <em>329 </em>, 1117-1128. <a href="https://doi.org/10.1016/j.jconrel.2020.10.039" title="DOI URL">https://doi.org/10.1016/j.jconrel.2020.10.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jconrel.2020.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jconrel.2020.10.039%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Controlled%2520Release%26atitle%3DBrain-targeted%252Bdelivery%252Bof%252Bobidoxime%25252C%252Busing%252Baptamer-modified%252Bliposomes%25252C%252Bfor%252Bdetoxification%252Bof%252Borganophosphorus%252Bcompounds%26aulast%3DZhang%26aufirst%3DYadan%26date%3D2021%26volume%3D329%26spage%3D1117%26epage%3D1128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Battista</span>, <span class="hlFld-ContribAuthor ">Laura  Cerchia</span>, <span class="hlFld-ContribAuthor ">Monica  Fedele</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular and cellular mechanisms in recurrent glioblastoma chemoresistance. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 365-400. <a href="https://doi.org/10.1016/B978-0-12-821567-8.00011-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-821567-8.00011-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821567-8.00011-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821567-8.00011-7%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252Band%252Bcellular%252Bmechanisms%252Bin%252Brecurrent%252Bglioblastoma%252Bchemoresistance%26aulast%3DBattista%26aufirst%3DSabrina%26date%3D2021%26spage%3D365%26epage%3D400%26pub%3DElsevier%26atitle%3DGlioblastoma%252BResistance%252Bto%252BChemotherapy%25253A%252BMolecular%252BMechanisms%252Band%252BInnovative%252BReversal%252BStrategies%26date%3D2021%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simona  Camorani</span>, <span class="hlFld-ContribAuthor ">Margherita  Passariello</span>, <span class="hlFld-ContribAuthor ">Lisa  Agnello</span>, <span class="hlFld-ContribAuthor ">Silvia  Esposito</span>, <span class="hlFld-ContribAuthor ">Francesca  Collina</span>, <span class="hlFld-ContribAuthor ">Monica  Cantile</span>, <span class="hlFld-ContribAuthor ">Maurizio  Di Bonito</span>, <span class="hlFld-ContribAuthor ">Ilya V.  Ulasov</span>, <span class="hlFld-ContribAuthor ">Monica  Fedele</span>, <span class="hlFld-ContribAuthor ">Antonella  Zannetti</span>, <span class="hlFld-ContribAuthor ">Claudia  De Lorenzo</span>, <span class="hlFld-ContribAuthor ">Laura  Cerchia</span>. </span><span class="cited-content_cbyCitation_article-title">Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2020,</strong> <em>39 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-020-01694-9" title="DOI URL">https://doi.org/10.1186/s13046-020-01694-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-020-01694-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-020-01694-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DAptamer%252Btargeted%252Btherapy%252Bpotentiates%252Bimmune%252Bcheckpoint%252Bblockade%252Bin%252Btriple-negative%252Bbreast%252Bcancer%26aulast%3DCamorani%26aufirst%3DSimona%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaoying  Fu</span>, <span class="hlFld-ContribAuthor ">Jim  Xiang</span>. </span><span class="cited-content_cbyCitation_article-title">Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (23)
                                     , 9123. <a href="https://doi.org/10.3390/ijms21239123" title="DOI URL">https://doi.org/10.3390/ijms21239123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21239123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21239123%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DAptamer-Functionalized%252BNanoparticles%252Bin%252BTargeted%252BDelivery%252Band%252BCancer%252BTherapy%26aulast%3DFu%26aufirst%3DZhaoying%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D23%26spage%3D9123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Yanghao  Zhou</span>, <span class="hlFld-ContribAuthor ">Si  Cheng</span>, <span class="hlFld-ContribAuthor ">Jinhe  Lou</span>, <span class="hlFld-ContribAuthor ">Xiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Qiuguang  He</span>, <span class="hlFld-ContribAuthor ">Ning  Huang</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Gint4.T-Modified DNA Tetrahedrons Loaded with Doxorubicin Inhibits Glioma Cell Proliferation by Targeting PDGFRβ. </span><span class="cited-content_cbyCitation_journal-name">Nanoscale Research Letters</span><span> <strong>2020,</strong> <em>15 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s11671-020-03377-y" title="DOI URL">https://doi.org/10.1186/s11671-020-03377-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s11671-020-03377-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs11671-020-03377-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNanoscale%2520Research%2520Letters%26atitle%3DGint4.T-Modified%252BDNA%252BTetrahedrons%252BLoaded%252Bwith%252BDoxorubicin%252BInhibits%252BGlioma%252BCell%252BProliferation%252Bby%252BTargeting%252BPDGFR%2525CE%2525B2%26aulast%3DWang%26aufirst%3DFeng%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Gallego</span>, <span class="hlFld-ContribAuthor ">V.  Ceña</span>. </span><span class="cited-content_cbyCitation_article-title">Nanoparticle-mediated therapeutic compounds delivery to glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Delivery</span><span> <strong>2020,</strong> <em>17 </em>
                                    (11)
                                     , 1541-1554. <a href="https://doi.org/10.1080/17425247.2020.1810015" title="DOI URL">https://doi.org/10.1080/17425247.2020.1810015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425247.2020.1810015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425247.2020.1810015%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Delivery%26atitle%3DNanoparticle-mediated%252Btherapeutic%252Bcompounds%252Bdelivery%252Bto%252Bglioblastoma%26aulast%3DGallego%26aufirst%3DL.%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D11%26spage%3D1541%26epage%3D1554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Babaei</span>, <span class="hlFld-ContribAuthor ">Javid  Davoodi</span>, <span class="hlFld-ContribAuthor ">Reza  Dehghan</span>, <span class="hlFld-ContribAuthor ">Mahsa  Zahiri</span>, <span class="hlFld-ContribAuthor ">Khalil  Abnous</span>, <span class="hlFld-ContribAuthor ">Seyed Mohammad  Taghdisi</span>, <span class="hlFld-ContribAuthor ">Mohammad  Ramezani</span>, <span class="hlFld-ContribAuthor ">Mona  Alibolandi</span>. </span><span class="cited-content_cbyCitation_article-title">Thermosensitive composite hydrogel incorporated with curcumin-loaded nanopolymersomes for prolonged and localized treatment of glioma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Drug Delivery Science and Technology</span><span> <strong>2020,</strong> <em>59 </em>, 101885. <a href="https://doi.org/10.1016/j.jddst.2020.101885" title="DOI URL">https://doi.org/10.1016/j.jddst.2020.101885</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jddst.2020.101885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jddst.2020.101885%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Drug%2520Delivery%2520Science%2520and%2520Technology%26atitle%3DThermosensitive%252Bcomposite%252Bhydrogel%252Bincorporated%252Bwith%252Bcurcumin-loaded%252Bnanopolymersomes%252Bfor%252Bprolonged%252Band%252Blocalized%252Btreatment%252Bof%252Bglioma%26aulast%3DBabaei%26aufirst%3DMaryam%26date%3D2020%26volume%3D59%26spage%3D101885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Amero</span>, <span class="hlFld-ContribAuthor ">Soumen  Khatua</span>, <span class="hlFld-ContribAuthor ">Cristian  Rodriguez-Aguayo</span>, <span class="hlFld-ContribAuthor ">Gabriel  Lopez-Berestein</span>. </span><span class="cited-content_cbyCitation_article-title">Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 2889. <a href="https://doi.org/10.3390/cancers12102889" title="DOI URL">https://doi.org/10.3390/cancers12102889</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12102889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12102889%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DAptamers%25253A%252BNovel%252BTherapeutics%252Band%252BPotential%252BRole%252Bin%252BNeuro-Oncology%26aulast%3DAmero%26aufirst%3DPaola%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D2889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Nuzzo</span>, <span class="hlFld-ContribAuthor ">Valentina  Brancato</span>, <span class="hlFld-ContribAuthor ">Alessandra  Affinito</span>, <span class="hlFld-ContribAuthor ">Marco  Salvatore</span>, <span class="hlFld-ContribAuthor ">Carlo  Cavaliere</span>, <span class="hlFld-ContribAuthor ">Gerolama  Condorelli</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of RNA and DNA Aptamers in Glioblastoma Diagnosis and Therapy: A Systematic Review of the Literature. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (8)
                                     , 2173. <a href="https://doi.org/10.3390/cancers12082173" title="DOI URL">https://doi.org/10.3390/cancers12082173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12082173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12082173%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BRole%252Bof%252BRNA%252Band%252BDNA%252BAptamers%252Bin%252BGlioblastoma%252BDiagnosis%252Band%252BTherapy%25253A%252BA%252BSystematic%252BReview%252Bof%252Bthe%252BLiterature%26aulast%3DNuzzo%26aufirst%3DSilvia%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D8%26spage%3D2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shichao  Ding</span>, <span class="hlFld-ContribAuthor ">Aminul Islam  Khan</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Cai</span>, <span class="hlFld-ContribAuthor ">Yang  Song</span>, <span class="hlFld-ContribAuthor ">Zhaoyuan  Lyu</span>, <span class="hlFld-ContribAuthor ">Dan  Du</span>, <span class="hlFld-ContribAuthor ">Prashanta  Dutta</span>, <span class="hlFld-ContribAuthor ">Yuehe  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies. </span><span class="cited-content_cbyCitation_journal-name">Materials Today</span><span> <strong>2020,</strong> <em>37 </em>, 112-125. <a href="https://doi.org/10.1016/j.mattod.2020.02.001" title="DOI URL">https://doi.org/10.1016/j.mattod.2020.02.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mattod.2020.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mattod.2020.02.001%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Today%26atitle%3DOvercoming%252Bblood%2525E2%252580%252593brain%252Bbarrier%252Btransport%25253A%252BAdvances%252Bin%252Bnanoparticle-based%252Bdrug%252Bdelivery%252Bstrategies%26aulast%3DDing%26aufirst%3DShichao%26date%3D2020%26volume%3D37%26spage%3D112%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan  Xiao</span>, <span class="hlFld-ContribAuthor ">Lin  Lin</span>, <span class="hlFld-ContribAuthor ">Zhicong  Chao</span>, <span class="hlFld-ContribAuthor ">Chen  Shao</span>, <span class="hlFld-ContribAuthor ">Zhe  Chen</span>, <span class="hlFld-ContribAuthor ">Zixiang  Wei</span>, <span class="hlFld-ContribAuthor ">Jingxiong  Lu</span>, <span class="hlFld-ContribAuthor ">Yishun  Huang</span>, <span class="hlFld-ContribAuthor ">Lanqing  Li</span>, <span class="hlFld-ContribAuthor ">Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Yongye  Liang</span>, <span class="hlFld-ContribAuthor ">Leilei  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Organic Spherical Nucleic Acids for the Transport of a NIR‐II‐Emitting Dye Across the Blood–Brain Barrier. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (24)
                                     , 9789-9797. <a href="https://doi.org/10.1002/ange.202002312" title="DOI URL">https://doi.org/10.1002/ange.202002312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202002312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202002312%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DOrganic%252BSpherical%252BNucleic%252BAcids%252Bfor%252Bthe%252BTransport%252Bof%252Ba%252BNIR%2525E2%252580%252590II%2525E2%252580%252590Emitting%252BDye%252BAcross%252Bthe%252BBlood%2525E2%252580%252593Brain%252BBarrier%26aulast%3DXiao%26aufirst%3DFan%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D24%26spage%3D9789%26epage%3D9797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan  Xiao</span>, <span class="hlFld-ContribAuthor ">Lin  Lin</span>, <span class="hlFld-ContribAuthor ">Zhicong  Chao</span>, <span class="hlFld-ContribAuthor ">Chen  Shao</span>, <span class="hlFld-ContribAuthor ">Zhe  Chen</span>, <span class="hlFld-ContribAuthor ">Zixiang  Wei</span>, <span class="hlFld-ContribAuthor ">Jingxiong  Lu</span>, <span class="hlFld-ContribAuthor ">Yishun  Huang</span>, <span class="hlFld-ContribAuthor ">Lanqing  Li</span>, <span class="hlFld-ContribAuthor ">Quan  Liu</span>, <span class="hlFld-ContribAuthor ">Yongye  Liang</span>, <span class="hlFld-ContribAuthor ">Leilei  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Organic Spherical Nucleic Acids for the Transport of a NIR‐II‐Emitting Dye Across the Blood–Brain Barrier. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (24)
                                     , 9702-9710. <a href="https://doi.org/10.1002/anie.202002312" title="DOI URL">https://doi.org/10.1002/anie.202002312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202002312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202002312%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DOrganic%252BSpherical%252BNucleic%252BAcids%252Bfor%252Bthe%252BTransport%252Bof%252Ba%252BNIR%2525E2%252580%252590II%2525E2%252580%252590Emitting%252BDye%252BAcross%252Bthe%252BBlood%2525E2%252580%252593Brain%252BBarrier%26aulast%3DXiao%26aufirst%3DFan%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D24%26spage%3D9702%26epage%3D9710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carla Lucia  Esposito</span>, <span class="hlFld-ContribAuthor ">Silvia  Nuzzo</span>, <span class="hlFld-ContribAuthor ">Maria Luigia  Ibba</span>, <span class="hlFld-ContribAuthor ">Lucia  Ricci-Vitiani</span>, <span class="hlFld-ContribAuthor ">Roberto  Pallini</span>, <span class="hlFld-ContribAuthor ">Gerolama  Condorelli</span>, <span class="hlFld-ContribAuthor ">Silvia  Catuogno</span>, <span class="hlFld-ContribAuthor ">Vittorio  de Franciscis</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1434. <a href="https://doi.org/10.3390/cancers12061434" title="DOI URL">https://doi.org/10.3390/cancers12061434</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12061434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12061434%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCombined%252BTargeting%252Bof%252BGlioblastoma%252BStem-Like%252BCells%252Bby%252BNeutralizing%252BRNA-Bio-Drugs%252Bfor%252BSTAT3%26aulast%3DEsposito%26aufirst%3DCarla%2BLucia%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bakhtiar  Bukari</span>, <span class="hlFld-ContribAuthor ">Rasika M.  Samarasinghe</span>, <span class="hlFld-ContribAuthor ">Jinjutha  Noibanchong</span>, <span class="hlFld-ContribAuthor ">Sarah L.  Shigdar</span>. </span><span class="cited-content_cbyCitation_article-title">Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2020,</strong> <em>8 </em>
                                    (5)
                                     , 120. <a href="https://doi.org/10.3390/biomedicines8050120" title="DOI URL">https://doi.org/10.3390/biomedicines8050120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines8050120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines8050120%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DNon-Invasive%252BDelivery%252Bof%252BTherapeutics%252Binto%252Bthe%252BBrain%25253A%252BThe%252BPotential%252Bof%252BAptamers%252Bfor%252BTargeted%252BDelivery%26aulast%3DBukari%26aufirst%3DBakhtiar%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D5%26spage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xun  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Jin-Liang  Sheng</span>, <span class="hlFld-ContribAuthor ">Min-Xuan  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Advances and Application of DNA-functionalized Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>26 </em>
                                    (40)
                                     , 7147-7165. <a href="https://doi.org/10.2174/0929867325666180501103620" title="DOI URL">https://doi.org/10.2174/0929867325666180501103620</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180501103620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180501103620%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Band%252BApplication%252Bof%252BDNA-functionalized%252BNanoparticles%26aulast%3DZhang%26aufirst%3DXun%26date%3D2020%26volume%3D26%26issue%3D40%26spage%3D7147%26epage%3D7165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rupa  Juthani</span>, <span class="hlFld-ContribAuthor ">Brian  Madajewski</span>, <span class="hlFld-ContribAuthor ">Barney  Yoo</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Pei-Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Feng  Chen</span>, <span class="hlFld-ContribAuthor ">Melik Z.  Turker</span>, <span class="hlFld-ContribAuthor ">Kai  Ma</span>, <span class="hlFld-ContribAuthor ">Michael  Overholtzer</span>, <span class="hlFld-ContribAuthor ">Valerie A.  Longo</span>, <span class="hlFld-ContribAuthor ">Sean  Carlin</span>, <span class="hlFld-ContribAuthor ">Virginia  Aragon-Sanabria</span>, <span class="hlFld-ContribAuthor ">Jason  Huse</span>, <span class="hlFld-ContribAuthor ">Mithat  Gonen</span>, <span class="hlFld-ContribAuthor ">Pat  Zanzonico</span>, <span class="hlFld-ContribAuthor ">Charles M.  Rudin</span>, <span class="hlFld-ContribAuthor ">Ulrich  Wiesner</span>, <span class="hlFld-ContribAuthor ">Michelle S.  Bradbury</span>, <span class="hlFld-ContribAuthor ">Cameron W.  Brennan</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2020,</strong> <em>26 </em>
                                    (1)
                                     , 147-158. <a href="https://doi.org/10.1158/1078-0432.CCR-19-1834" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-19-1834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-19-1834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-19-1834%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DUltrasmall%252BCore-Shell%252BSilica%252BNanoparticles%252Bfor%252BPrecision%252BDrug%252BDelivery%252Bin%252Ba%252BHigh-Grade%252BMalignant%252BBrain%252BTumor%252BModel%26aulast%3DJuthani%26aufirst%3DRupa%26date%3D2020%26date%3D2019%26volume%3D26%26issue%3D1%26spage%3D147%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John JE  Mulvihill</span>, <span class="hlFld-ContribAuthor ">Eoghan M  Cunnane</span>, <span class="hlFld-ContribAuthor ">Aisling M  Ross</span>, <span class="hlFld-ContribAuthor ">Jason T  Duskey</span>, <span class="hlFld-ContribAuthor ">Giovanni  Tosi</span>, <span class="hlFld-ContribAuthor ">Andreas M  Grabrucker</span>. </span><span class="cited-content_cbyCitation_article-title">Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine</span><span> <strong>2020,</strong> <em>15 </em>
                                    (2)
                                     , 205-214. <a href="https://doi.org/10.2217/nnm-2019-0367" title="DOI URL">https://doi.org/10.2217/nnm-2019-0367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/nnm-2019-0367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fnnm-2019-0367%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%26atitle%3DDrug%252Bdelivery%252Bacross%252Bthe%252Bblood%2525E2%252580%252593brain%252Bbarrier%25253A%252Brecent%252Badvances%252Bin%252Bthe%252Buse%252Bof%252Bnanocarriers%26aulast%3DMulvihill%26aufirst%3DJohn%2BJE%26date%3D2020%26volume%3D15%26issue%3D2%26spage%3D205%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fadwa  Odeh</span>, <span class="hlFld-ContribAuthor ">Hamdi  Nsairat</span>, <span class="hlFld-ContribAuthor ">Walhan  Alshaer</span>, <span class="hlFld-ContribAuthor ">Mohammad A.  Ismail</span>, <span class="hlFld-ContribAuthor ">Ezaldeen  Esawi</span>, <span class="hlFld-ContribAuthor ">Baraa  Qaqish</span>, <span class="hlFld-ContribAuthor ">Abeer Al  Bawab</span>, <span class="hlFld-ContribAuthor ">Said I.  Ismail</span>. </span><span class="cited-content_cbyCitation_article-title">Aptamers Chemistry: Chemical Modifications and Conjugation Strategies. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 3. <a href="https://doi.org/10.3390/molecules25010003" title="DOI URL">https://doi.org/10.3390/molecules25010003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25010003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25010003%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAptamers%252BChemistry%25253A%252BChemical%252BModifications%252Band%252BConjugation%252BStrategies%26aulast%3DOdeh%26aufirst%3DFadwa%26date%3D2020%26date%3D2019%26volume%3D25%26issue%3D1%26spage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.D.  Cayero-Otero</span>, <span class="hlFld-ContribAuthor ">Maria João  Gomes</span>, <span class="hlFld-ContribAuthor ">Cláudia  Martins</span>, <span class="hlFld-ContribAuthor ">J.  Álvarez-Fuentes</span>, <span class="hlFld-ContribAuthor ">M.  Fernández-Arévalo</span>, <span class="hlFld-ContribAuthor ">B.  Sarmento</span>, <span class="hlFld-ContribAuthor ">L.  Martín-Banderas</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo
              biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Delivery</span><span> <strong>2019,</strong> <em>16 </em>
                                    (12)
                                     , 1413-1427. <a href="https://doi.org/10.1080/17425247.2019.1690452" title="DOI URL">https://doi.org/10.1080/17425247.2019.1690452</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17425247.2019.1690452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17425247.2019.1690452%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Delivery%26atitle%3DIn%252Bvivo%252Bbiodistribution%252Bof%252Bvenlafaxine-PLGA%252Bnanoparticles%252Bfor%252Bbrain%252Bdelivery%25253A%252Bplain%252Bvs.%252Bfunctionalized%252Bnanoparticles%26aulast%3DCayero-Otero%26aufirst%3DM.D.%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D12%26spage%3D1413%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin J  Umlauf</span>, <span class="hlFld-ContribAuthor ">Eric V  Shusta</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting BBB disruption for the delivery of nanocarriers to the diseased CNS. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Biotechnology</span><span> <strong>2019,</strong> <em>60 </em>, 146-152. <a href="https://doi.org/10.1016/j.copbio.2019.01.013" title="DOI URL">https://doi.org/10.1016/j.copbio.2019.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.copbio.2019.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.copbio.2019.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Biotechnology%26atitle%3DExploiting%252BBBB%252Bdisruption%252Bfor%252Bthe%252Bdelivery%252Bof%252Bnanocarriers%252Bto%252Bthe%252Bdiseased%252BCNS%26aulast%3DUmlauf%26aufirst%3DBenjamin%2BJ%26date%3D2019%26volume%3D60%26spage%3D146%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra  Affinito</span>, <span class="hlFld-ContribAuthor ">Cristina  Quintavalle</span>, <span class="hlFld-ContribAuthor ">Carla Lucia  Esposito</span>, <span class="hlFld-ContribAuthor ">Giuseppina  Roscigno</span>, <span class="hlFld-ContribAuthor ">Claudia  Vilardo</span>, <span class="hlFld-ContribAuthor ">Silvia  Nuzzo</span>, <span class="hlFld-ContribAuthor ">Lucia  Ricci-Vitiani</span>, <span class="hlFld-ContribAuthor ">Gabriele  De Luca</span>, <span class="hlFld-ContribAuthor ">Roberto  Pallini</span>, <span class="hlFld-ContribAuthor ">Anna S.  Kichkailo</span>, <span class="hlFld-ContribAuthor ">Ivan N.  Lapin</span>, <span class="hlFld-ContribAuthor ">Vittorio  de Franciscis</span>, <span class="hlFld-ContribAuthor ">Gerolama  Condorelli</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Therapy - Nucleic Acids</span><span> <strong>2019,</strong> <em>18 </em>, 99-109. <a href="https://doi.org/10.1016/j.omtn.2019.08.015" title="DOI URL">https://doi.org/10.1016/j.omtn.2019.08.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.omtn.2019.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.omtn.2019.08.015%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Therapy%2520-%2520Nucleic%2520Acids%26atitle%3DThe%252BDiscovery%252Bof%252BRNA%252BAptamers%252Bthat%252BSelectively%252BBind%252BGlioblastoma%252BStem%252BCells%26aulast%3DAffinito%26aufirst%3DAlessandra%26date%3D2019%26volume%3D18%26spage%3D99%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Caleb  Acquah</span>, <span class="hlFld-ContribAuthor ">Yi Wei  Chan</span>, <span class="hlFld-ContribAuthor ">Sharadwata  Pan</span>, <span class="hlFld-ContribAuthor ">Lau Sie  Yon</span>, <span class="hlFld-ContribAuthor ">Clarence M.  Ongkudon</span>, <span class="hlFld-ContribAuthor ">Haobo  Guo</span>, <span class="hlFld-ContribAuthor ">Michael K.  Danquah</span>. </span><span class="cited-content_cbyCitation_article-title">Characterisation of aptamer-anchored poly(EDMA-co-GMA) monolith for high throughput affinity binding. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-50862-1" title="DOI URL">https://doi.org/10.1038/s41598-019-50862-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-50862-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-50862-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCharacterisation%252Bof%252Baptamer-anchored%252Bpoly%252528EDMA-co-GMA%252529%252Bmonolith%252Bfor%252Bhigh%252Bthroughput%252Baffinity%252Bbinding%26aulast%3DAcquah%26aufirst%3DCaleb%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdalena  Bamburowicz-Klimkowska</span>, <span class="hlFld-ContribAuthor ">Magdalena  Poplawska</span>, <span class="hlFld-ContribAuthor ">Ireneusz P.  Grudzinski</span>. </span><span class="cited-content_cbyCitation_article-title">Nanocomposites as biomolecules delivery agents in nanomedicine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nanobiotechnology</span><span> <strong>2019,</strong> <em>17 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12951-019-0479-x" title="DOI URL">https://doi.org/10.1186/s12951-019-0479-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12951-019-0479-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12951-019-0479-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nanobiotechnology%26atitle%3DNanocomposites%252Bas%252Bbiomolecules%252Bdelivery%252Bagents%252Bin%252Bnanomedicine%26aulast%3DBamburowicz-Klimkowska%26aufirst%3DMagdalena%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sirong  Shi</span>, <span class="hlFld-ContribAuthor ">Wei  Fu</span>, <span class="hlFld-ContribAuthor ">Shiyu  Lin</span>, <span class="hlFld-ContribAuthor ">Taoran  Tian</span>, <span class="hlFld-ContribAuthor ">Songhang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoru  Shao</span>, <span class="hlFld-ContribAuthor ">Yuxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zisheng  Tang</span>, <span class="hlFld-ContribAuthor ">Yi  Zhou</span>, <span class="hlFld-ContribAuthor ">Yunfeng  Lin</span>, <span class="hlFld-ContribAuthor ">Xiaoxiao  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted and effective glioblastoma therapy via aptamer-modified tetrahedral framework nucleic acid-paclitaxel nanoconjugates that can pass the blood brain barrier. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine: Nanotechnology, Biology and Medicine</span><span> <strong>2019,</strong> <em>21 </em>, 102061. <a href="https://doi.org/10.1016/j.nano.2019.102061" title="DOI URL">https://doi.org/10.1016/j.nano.2019.102061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nano.2019.102061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nano.2019.102061%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%253A%2520Nanotechnology%252C%2520Biology%2520and%2520Medicine%26atitle%3DTargeted%252Band%252Beffective%252Bglioblastoma%252Btherapy%252Bvia%252Baptamer-modified%252Btetrahedral%252Bframework%252Bnucleic%252Bacid-paclitaxel%252Bnanoconjugates%252Bthat%252Bcan%252Bpass%252Bthe%252Bblood%252Bbrain%252Bbarrier%26aulast%3DShi%26aufirst%3DSirong%26date%3D2019%26volume%3D21%26spage%3D102061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raul  Ortiz</span>, <span class="hlFld-ContribAuthor ">Laura  Cabeza</span>, <span class="hlFld-ContribAuthor ">Gloria  Perazzoli</span>, <span class="hlFld-ContribAuthor ">Julia  Jimenez-Lopez</span>, <span class="hlFld-ContribAuthor ">Beatriz  García-Pinel</span>, <span class="hlFld-ContribAuthor ">Consolación  Melguizo</span>, <span class="hlFld-ContribAuthor ">Jose  Prados</span>. </span><span class="cited-content_cbyCitation_article-title">Nanoformulations for glioblastoma multiforme: a new hope for treatment. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (18)
                                     , 2459-2480. <a href="https://doi.org/10.4155/fmc-2018-0521" title="DOI URL">https://doi.org/10.4155/fmc-2018-0521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0521%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNanoformulations%252Bfor%252Bglioblastoma%252Bmultiforme%25253A%252Ba%252Bnew%252Bhope%252Bfor%252Btreatment%26aulast%3DOrtiz%26aufirst%3DRaul%26date%3D2019%26volume%3D11%26issue%3D18%26spage%3D2459%26epage%3D2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoli  Wu</span>, <span class="hlFld-ContribAuthor ">Han  Yang</span>, <span class="hlFld-ContribAuthor ">Weitao  Yang</span>, <span class="hlFld-ContribAuthor ">Xingmeng  Chen</span>, <span class="hlFld-ContribAuthor ">Junxiao  Gao</span>, <span class="hlFld-ContribAuthor ">Xiaoqun  Gong</span>, <span class="hlFld-ContribAuthor ">Hanjie  Wang</span>, <span class="hlFld-ContribAuthor ">Yue  Duan</span>, <span class="hlFld-ContribAuthor ">Daohe  Wei</span>, <span class="hlFld-ContribAuthor ">Jin  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Nanoparticle-based diagnostic and therapeutic systems for brain tumors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Materials Chemistry B</span><span> <strong>2019,</strong> <em>7 </em>
                                    (31)
                                     , 4734-4750. <a href="https://doi.org/10.1039/C9TB00860H" title="DOI URL">https://doi.org/10.1039/C9TB00860H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9TB00860H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9TB00860H%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Materials%2520Chemistry%2520B%26atitle%3DNanoparticle-based%252Bdiagnostic%252Band%252Btherapeutic%252Bsystems%252Bfor%252Bbrain%252Btumors%26aulast%3DWu%26aufirst%3DXiaoli%26date%3D2019%26date%3D2019%26volume%3D7%26issue%3D31%26spage%3D4734%26epage%3D4750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipeng  Dong</span>, <span class="hlFld-ContribAuthor ">Qiyan  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Huo</span>, <span class="hlFld-ContribAuthor ">Nanxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Bingxia  Li</span>, <span class="hlFld-ContribAuthor ">Hongmei  Li</span>, <span class="hlFld-ContribAuthor ">Yisong  Xu</span>, <span class="hlFld-ContribAuthor ">Meng  Chen</span>, <span class="hlFld-ContribAuthor ">Hao  Hong</span>, <span class="hlFld-ContribAuthor ">Yue  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Mannose‐Modified Multi‐Walled Carbon Nanotubes as a Delivery Nanovector Optimizing the Antigen Presentation of Dendritic Cells. </span><span class="cited-content_cbyCitation_journal-name">ChemistryOpen</span><span> <strong>2019,</strong> <em>8 </em>
                                    (7)
                                     , 915-921. <a href="https://doi.org/10.1002/open.201900126" title="DOI URL">https://doi.org/10.1002/open.201900126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/open.201900126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fopen.201900126%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistryOpen%26atitle%3DMannose%2525E2%252580%252590Modified%252BMulti%2525E2%252580%252590Walled%252BCarbon%252BNanotubes%252Bas%252Ba%252BDelivery%252BNanovector%252BOptimizing%252Bthe%252BAntigen%252BPresentation%252Bof%252BDendritic%252BCells%26aulast%3DDong%26aufirst%3DZhipeng%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D7%26spage%3D915%26epage%3D921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monica  Fedele</span>, <span class="hlFld-ContribAuthor ">Laura  Cerchia</span>, <span class="hlFld-ContribAuthor ">Silvia  Pegoraro</span>, <span class="hlFld-ContribAuthor ">Riccardo  Sgarra</span>, <span class="hlFld-ContribAuthor ">Guidalberto  Manfioletti</span>. </span><span class="cited-content_cbyCitation_article-title">Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (11)
                                     , 2746. <a href="https://doi.org/10.3390/ijms20112746" title="DOI URL">https://doi.org/10.3390/ijms20112746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20112746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20112746%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DProneural-Mesenchymal%252BTransition%25253A%252BPhenotypic%252BPlasticity%252Bto%252BAcquire%252BMultitherapy%252BResistance%252Bin%252BGlioblastoma%26aulast%3DFedele%26aufirst%3DMonica%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D11%26spage%3D2746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Ma</span>, <span class="hlFld-ContribAuthor ">Agnivo  Gosai</span>, <span class="hlFld-ContribAuthor ">Ganesh  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Pranav  Shrotriya</span>. </span><span class="cited-content_cbyCitation_article-title">Force spectroscopy of the thrombin-aptamer interaction: Comparison between AFM experiments and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Applied Surface Science</span><span> <strong>2019,</strong> <em>475 </em>, 462-472. <a href="https://doi.org/10.1016/j.apsusc.2019.01.004" title="DOI URL">https://doi.org/10.1016/j.apsusc.2019.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsusc.2019.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsusc.2019.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Surface%2520Science%26atitle%3DForce%252Bspectroscopy%252Bof%252Bthe%252Bthrombin-aptamer%252Binteraction%25253A%252BComparison%252Bbetween%252BAFM%252Bexperiments%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DMa%26aufirst%3DXiao%26date%3D2019%26volume%3D475%26spage%3D462%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna M.  Krichevsky</span>, <span class="hlFld-ContribAuthor ">Erik J.  Uhlmann</span>. </span><span class="cited-content_cbyCitation_article-title">Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Neurotherapeutics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (2)
                                     , 319-347. <a href="https://doi.org/10.1007/s13311-018-00702-3" title="DOI URL">https://doi.org/10.1007/s13311-018-00702-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13311-018-00702-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13311-018-00702-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurotherapeutics%26atitle%3DOligonucleotide%252BTherapeutics%252Bas%252Ba%252BNew%252BClass%252Bof%252BDrugs%252Bfor%252BMalignant%252BBrain%252BTumors%25253A%252BTargeting%252BmRNAs%25252C%252BRegulatory%252BRNAs%25252C%252BMutations%25252C%252BCombinations%25252C%252Band%252BBeyond%26aulast%3DKrichevsky%26aufirst%3DAnna%2BM.%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D2%26spage%3D319%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandeep  Kumar</span>, <span class="hlFld-ContribAuthor ">Shikha  Jain</span>, <span class="hlFld-ContribAuthor ">Neeraj  Dilbaghi</span>, <span class="hlFld-ContribAuthor ">Amrik Singh  Ahluwalia</span>, <span class="hlFld-ContribAuthor ">Ashraf Aly  Hassan</span>, <span class="hlFld-ContribAuthor ">Ki-Hyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Advanced Selection Methodologies for DNAzymes in Sensing and Healthcare Applications. </span><span class="cited-content_cbyCitation_journal-name">Trends in Biochemical Sciences</span><span> <strong>2019,</strong> <em>44 </em>
                                    (3)
                                     , 190-213. <a href="https://doi.org/10.1016/j.tibs.2018.11.001" title="DOI URL">https://doi.org/10.1016/j.tibs.2018.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tibs.2018.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tibs.2018.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Biochemical%2520Sciences%26atitle%3DAdvanced%252BSelection%252BMethodologies%252Bfor%252BDNAzymes%252Bin%252BSensing%252Band%252BHealthcare%252BApplications%26aulast%3DKumar%26aufirst%3DSandeep%26date%3D2019%26volume%3D44%26issue%3D3%26spage%3D190%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonia  Salha</span>, <span class="hlFld-ContribAuthor ">Sebastian  Gehmert</span>, <span class="hlFld-ContribAuthor ">Vanessa  Brébant</span>, <span class="hlFld-ContribAuthor ">Alexandra  Anker</span>, <span class="hlFld-ContribAuthor ">Markus  Loibl</span>, <span class="hlFld-ContribAuthor ">Lukas  Prantl</span>, <span class="hlFld-ContribAuthor ">Sanga  Gehmert</span>, , , . </span><span class="cited-content_cbyCitation_article-title">PDGF regulated migration of mesenchymal stem cells towards malignancy acts via the PI3K signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Clinical Hemorheology and Microcirculation</span><span> <strong>2019,</strong> <em>70 </em>
                                    (4)
                                     , 543-551. <a href="https://doi.org/10.3233/CH-189319" title="DOI URL">https://doi.org/10.3233/CH-189319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/CH-189319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FCH-189319%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Hemorheology%2520and%2520Microcirculation%26atitle%3DPDGF%252Bregulated%252Bmigration%252Bof%252Bmesenchymal%252Bstem%252Bcells%252Btowards%252Bmalignancy%252Bacts%252Bvia%252Bthe%252BPI3K%252Bsignaling%252Bpathway%26aulast%3DSalha%26aufirst%3DSonia%26date%3D2019%26volume%3D70%26issue%3D4%26spage%3D543%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simona  Camorani</span>, <span class="hlFld-ContribAuthor ">Monica  Fedele</span>, <span class="hlFld-ContribAuthor ">Antonella  Zannetti</span>, <span class="hlFld-ContribAuthor ">Laura  Cerchia</span>. </span><span class="cited-content_cbyCitation_article-title">TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2018,</strong> <em>11 </em>
                                    (4)
                                     , 123. <a href="https://doi.org/10.3390/ph11040123" title="DOI URL">https://doi.org/10.3390/ph11040123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph11040123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph11040123%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DTNBC%252BChallenge%25253A%252BOligonucleotide%252BAptamers%252Bfor%252BNew%252BImaging%252Band%252BTherapy%252BModalities%26aulast%3DCamorani%26aufirst%3DSimona%26date%3D2018%26date%3D2018%26volume%3D11%26issue%3D4%26spage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samar M.  Etman</span>, <span class="hlFld-ContribAuthor ">Yosra S. R.  Elnaggar</span>, <span class="hlFld-ContribAuthor ">Doaa A.  Abdelmonsif</span>, <span class="hlFld-ContribAuthor ">Ossama Y.  Abdallah</span>. </span><span class="cited-content_cbyCitation_article-title">Oral Brain-Targeted Microemulsion for Enhanced Piperine Delivery in Alzheimer’s Disease Therapy: In Vitro Appraisal, In Vivo Activity, and Nanotoxicity. </span><span class="cited-content_cbyCitation_journal-name">AAPS PharmSciTech</span><span> <strong>2018,</strong> <em>19 </em>
                                    (8)
                                     , 3698-3711. <a href="https://doi.org/10.1208/s12249-018-1180-3" title="DOI URL">https://doi.org/10.1208/s12249-018-1180-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12249-018-1180-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12249-018-1180-3%26sid%3Dliteratum%253Aachs%26jtitle%3DAAPS%2520PharmSciTech%26atitle%3DOral%252BBrain-Targeted%252BMicroemulsion%252Bfor%252BEnhanced%252BPiperine%252BDelivery%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252BTherapy%25253A%252BIn%252BVitro%252BAppraisal%25252C%252BIn%252BVivo%252BActivity%25252C%252Band%252BNanotoxicity%26aulast%3DEtman%26aufirst%3DSamar%2BM.%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D8%26spage%3D3698%26epage%3D3711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulio  Bertuzzi</span>, <span class="hlFld-ContribAuthor ">Simone  Crotti</span>, <span class="hlFld-ContribAuthor ">Pierpaolo  Calandro</span>, <span class="hlFld-ContribAuthor ">Bianca Flavia  Bonini</span>, <span class="hlFld-ContribAuthor ">Ilaria  Monaco</span>, <span class="hlFld-ContribAuthor ">Erica  Locatelli</span>, <span class="hlFld-ContribAuthor ">Mariafrancesca  Fochi</span>, <span class="hlFld-ContribAuthor ">Paolo  Zani</span>, <span class="hlFld-ContribAuthor ">Elena  Strocchi</span>, <span class="hlFld-ContribAuthor ">Andrea  Mazzanti</span>, <span class="hlFld-ContribAuthor ">Mario  Chiariello</span>, <span class="hlFld-ContribAuthor ">Mauro Comes  Franchini</span>. </span><span class="cited-content_cbyCitation_article-title">Quinone-Fused Pyrazoles through 1,3-Dipolar Cycloadditions: Synthesis of Tricyclic Scaffolds and in vitro Cytotoxic Activity Evaluation on Glioblastoma Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (17)
                                     , 1744-1750. <a href="https://doi.org/10.1002/cmdc.201800251" title="DOI URL">https://doi.org/10.1002/cmdc.201800251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800251%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DQuinone-Fused%252BPyrazoles%252Bthrough%252B1%25252C3-Dipolar%252BCycloadditions%25253A%252BSynthesis%252Bof%252BTricyclic%252BScaffolds%252Band%252Bin%252Bvitro%252BCytotoxic%252BActivity%252BEvaluation%252Bon%252BGlioblastoma%252BCancer%252BCells%26aulast%3DBertuzzi%26aufirst%3DGiulio%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D17%26spage%3D1744%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Walhan  Alshaer</span>, <span class="hlFld-ContribAuthor ">Hervé  Hillaireau</span>, <span class="hlFld-ContribAuthor ">Elias  Fattal</span>. </span><span class="cited-content_cbyCitation_article-title">Aptamer-guided nanomedicines for anticancer drug delivery. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2018,</strong> <em>134 </em>, 122-137. <a href="https://doi.org/10.1016/j.addr.2018.09.011" title="DOI URL">https://doi.org/10.1016/j.addr.2018.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2018.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2018.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DAptamer-guided%252Bnanomedicines%252Bfor%252Banticancer%252Bdrug%252Bdelivery%26aulast%3DAlshaer%26aufirst%3DWalhan%26date%3D2018%26volume%3D134%26spage%3D122%26epage%3D137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simona  Camorani</span>, <span class="hlFld-ContribAuthor ">Elvira  Crescenzi</span>, <span class="hlFld-ContribAuthor ">Monica  Fedele</span>, <span class="hlFld-ContribAuthor ">Laura  Cerchia</span>. </span><span class="cited-content_cbyCitation_article-title">Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2018,</strong> <em>1869 </em>
                                    (2)
                                     , 263-277. <a href="https://doi.org/10.1016/j.bbcan.2018.03.003" title="DOI URL">https://doi.org/10.1016/j.bbcan.2018.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2018.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2018.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DOligonucleotide%252Baptamers%252Bagainst%252Btyrosine%252Bkinase%252Breceptors%25253A%252BProspect%252Bfor%252Banticancer%252Bapplications%26aulast%3DCamorani%26aufirst%3DSimona%26date%3D2018%26volume%3D1869%26issue%3D2%26spage%3D263%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdullah Tahir  Bayraç</span>, <span class="hlFld-ContribAuthor ">Oya Ercan  Akça</span>, <span class="hlFld-ContribAuthor ">Füsun İnci  Eyidoğan</span>, <span class="hlFld-ContribAuthor ">Hüseyin Avni  Öktem</span>. </span><span class="cited-content_cbyCitation_article-title">Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biosciences</span><span> <strong>2018,</strong> <em>43 </em>
                                    (1)
                                     , 97-104. <a href="https://doi.org/10.1007/s12038-018-9733-x" title="DOI URL">https://doi.org/10.1007/s12038-018-9733-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12038-018-9733-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12038-018-9733-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biosciences%26atitle%3DTarget-specific%252Bdelivery%252Bof%252Bdoxorubicin%252Bto%252Bhuman%252Bglioblastoma%252Bcell%252Bline%252Bvia%252BssDNA%252Baptamer%26aulast%3DBayra%25C3%25A7%26aufirst%3DAbdullah%2BTahir%26date%3D2018%26date%3D2018%26volume%3D43%26issue%3D1%26spage%3D97%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carla Lucia  Esposito</span>, <span class="hlFld-ContribAuthor ">Silvia  Nuzzo</span>, <span class="hlFld-ContribAuthor ">Silvia  Catuogno</span>, <span class="hlFld-ContribAuthor ">Simona  Romano</span>, <span class="hlFld-ContribAuthor ">Filomena  de Nigris</span>, <span class="hlFld-ContribAuthor ">Vittorio  de Franciscis</span>. </span><span class="cited-content_cbyCitation_article-title">STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Therapy - Nucleic Acids</span><span> <strong>2018,</strong> <em>10 </em>, 398-411. <a href="https://doi.org/10.1016/j.omtn.2017.12.021" title="DOI URL">https://doi.org/10.1016/j.omtn.2017.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.omtn.2017.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.omtn.2017.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Therapy%2520-%2520Nucleic%2520Acids%26atitle%3DSTAT3%252BGene%252BSilencing%252Bby%252BAptamer-siRNA%252BChimera%252Bas%252BSelective%252BTherapeutic%252Bfor%252BGlioblastoma%26aulast%3DEsposito%26aufirst%3DCarla%2BLucia%26date%3D2018%26volume%3D10%26spage%3D398%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Pietrobono</span>, <span class="hlFld-ContribAuthor ">Roberta  Santini</span>, <span class="hlFld-ContribAuthor ">Sinforosa  Gagliardi</span>, <span class="hlFld-ContribAuthor ">Francesca  Dapporto</span>, <span class="hlFld-ContribAuthor ">David  Colecchia</span>, <span class="hlFld-ContribAuthor ">Mario  Chiariello</span>, <span class="hlFld-ContribAuthor ">Cosima  Leone</span>, <span class="hlFld-ContribAuthor ">Massimo  Valoti</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Manetti</span>, <span class="hlFld-ContribAuthor ">Elena  Petricci</span>, <span class="hlFld-ContribAuthor ">Maurizio  Taddei</span>, <span class="hlFld-ContribAuthor ">Barbara  Stecca</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted inhibition of Hedgehog-GLI signaling by novel acylguanidine derivatives inhibits melanoma cell growth by inducing replication stress and mitotic catastrophe. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2018,</strong> <em>9 </em>
                                    (2)
                                     <a href="https://doi.org/10.1038/s41419-017-0142-0" title="DOI URL">https://doi.org/10.1038/s41419-017-0142-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41419-017-0142-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41419-017-0142-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DTargeted%252Binhibition%252Bof%252BHedgehog-GLI%252Bsignaling%252Bby%252Bnovel%252Bacylguanidine%252Bderivatives%252Binhibits%252Bmelanoma%252Bcell%252Bgrowth%252Bby%252Binducing%252Breplication%252Bstress%252Band%252Bmitotic%252Bcatastrophe%26aulast%3DPietrobono%26aufirst%3DSilvia%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabetta  Campodoni</span>, <span class="hlFld-ContribAuthor ">Tatiana  Patricio</span>, <span class="hlFld-ContribAuthor ">Monica  Montesi</span>, <span class="hlFld-ContribAuthor ">Anna  Tampieri</span>, <span class="hlFld-ContribAuthor ">Monica  Sandri</span>, <span class="hlFld-ContribAuthor ">Simone  Sprio</span>. </span><span class="cited-content_cbyCitation_article-title">Biomineralization process generating hybrid nano- and micro-carriers. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 19-42. <a href="https://doi.org/10.1016/B978-0-08-102198-9.00003-X" title="DOI URL">https://doi.org/10.1016/B978-0-08-102198-9.00003-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102198-9.00003-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102198-9.00003-X%26sid%3Dliteratum%253Aachs%26atitle%3DBiomineralization%252Bprocess%252Bgenerating%252Bhybrid%252Bnano-%252Band%252Bmicro-carriers%26aulast%3DCampodoni%26aufirst%3DElisabetta%26date%3D2018%26spage%3D19%26epage%3D42%26pub%3DElsevier%26atitle%3DCore-Shell%252BNanostructures%252Bfor%252BDrug%252BDelivery%252Band%252BTheranostics%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.  Monaco</span>, <span class="hlFld-ContribAuthor ">M.  Maturi</span>, <span class="hlFld-ContribAuthor ">E.  Matteucci</span>, <span class="hlFld-ContribAuthor ">E.  Locatelli</span>, <span class="hlFld-ContribAuthor ">A.  Baschieri</span>, <span class="hlFld-ContribAuthor ">P.  Zani</span>, <span class="hlFld-ContribAuthor ">P.  Armanetti</span>, <span class="hlFld-ContribAuthor ">L.  Menichetti</span>, <span class="hlFld-ContribAuthor ">L.  Sambri</span>, <span class="hlFld-ContribAuthor ">M.  Comes Franchini</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphorescent iridium-containing nanomicelles: synthesis, characterization and preliminary applications in nanomedical imaging. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (59)
                                     , 34162-34167. <a href="https://doi.org/10.1039/C8RA05368E" title="DOI URL">https://doi.org/10.1039/C8RA05368E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA05368E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA05368E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DPhosphorescent%252Biridium-containing%252Bnanomicelles%25253A%252Bsynthesis%25252C%252Bcharacterization%252Band%252Bpreliminary%252Bapplications%252Bin%252Bnanomedical%252Bimaging%26aulast%3DMonaco%26aufirst%3DI.%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D59%26spage%3D34162%26epage%3D34167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pascal  Röthlisberger</span>, <span class="hlFld-ContribAuthor ">Cécile  Gasse</span>, <span class="hlFld-ContribAuthor ">Marcel  Hollenstein</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleic Acid Aptamers: Emerging Applications in Medical Imaging, Nanotechnology, Neurosciences, and Drug Delivery. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (11)
                                     , 2430. <a href="https://doi.org/10.3390/ijms18112430" title="DOI URL">https://doi.org/10.3390/ijms18112430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18112430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18112430%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNucleic%252BAcid%252BAptamers%25253A%252BEmerging%252BApplications%252Bin%252BMedical%252BImaging%25252C%252BNanotechnology%25252C%252BNeurosciences%25252C%252Band%252BDrug%252BDelivery%26aulast%3DR%25C3%25B6thlisberger%26aufirst%3DPascal%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D11%26spage%3D2430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo-Tsang  Huang</span>, <span class="hlFld-ContribAuthor ">Wei-Yun  Lai</span>, <span class="hlFld-ContribAuthor ">Yi-Chung  Chang</span>, <span class="hlFld-ContribAuthor ">Jen-Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Shauh-Der  Yeh</span>, <span class="hlFld-ContribAuthor ">Emily Pei-Ying  Lin</span>, <span class="hlFld-ContribAuthor ">Pan-Chyr  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect. </span><span class="cited-content_cbyCitation_journal-name">Molecular Therapy - Nucleic Acids</span><span> <strong>2017,</strong> <em>8 </em>, 520-528. <a href="https://doi.org/10.1016/j.omtn.2017.08.006" title="DOI URL">https://doi.org/10.1016/j.omtn.2017.08.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.omtn.2017.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.omtn.2017.08.006%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Therapy%2520-%2520Nucleic%2520Acids%26atitle%3DA%252BCTLA-4%252BAntagonizing%252BDNA%252BAptamer%252Bwith%252BAntitumor%252BEffect%26aulast%3DHuang%26aufirst%3DBo-Tsang%26date%3D2017%26volume%3D8%26spage%3D520%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Cécile  Mercier</span>, <span class="hlFld-ContribAuthor ">Monique  Dontenwill</span>, <span class="hlFld-ContribAuthor ">Laurence  Choulier</span>. </span><span class="cited-content_cbyCitation_article-title">Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2017,</strong> <em>9 </em>
                                    (6)
                                     , 69. <a href="https://doi.org/10.3390/cancers9060069" title="DOI URL">https://doi.org/10.3390/cancers9060069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers9060069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers9060069%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DSelection%252Bof%252BNucleic%252BAcid%252BAptamers%252BTargeting%252BTumor%252BCell-Surface%252BProtein%252BBiomarkers%26aulast%3DMercier%26aufirst%3DMarie-C%25C3%25A9cile%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D6%26spage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Copolymer (PLGA-<i>b</i>-PEG-COOH)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DCC/NHS, CH<sub>2</sub>Cl<sub>2</sub>, room temperature, 12 h; (ii) NH<sub>2</sub>-PEG-COOH, DIPEA, room temperature, 12 h.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representation of the Water-in-Oil-in-Water Procedure for the Obtainment of the Final Nanovectors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. U87MG cells were incubated for different periods (from 30 to 60 min) with <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="3f7d707b766f667f6f716f4c127856514b0b116b">[email protected]</a> or <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="c5878a818c959c85958b95b6e8968697">[email protected]</a> or left untreated. After washing and fixation, U87MG cells were labeled with WGA-647 to visualize cell membrane (red) and with DAPI to stain nuclei (blue). <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="edafa2a9a4bdb4adbda3bd9e">[email protected]</a> are displayed in green. White squares indicate the areas shown in insets. White bars correspond to 25 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/medium/jm-2017-005279_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Ex vivo fluorescence imaging of entire brains explanted from mice bearing U87MG orthotopic xenografts 2 h after injection of PBS, <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="ce8c818a879e978e9e809ebde389a7a0bafae09a">[email protected]</a>, or <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="55171a111c050c15051b0526780616077b">[email protected]</a> Magnified views of the tumor areas (white square) are indicated in the insets. White arrows indicate fluorescent signals from Gint4.T-PNPs. (B) Aptamer-PNPs fluorescence in the tumor, at 2 and 4 h post injection, was quantified on six separate slices for each experimental group and expressed as mean fluorescence intensity (MFI) ± SD of 10 microscopy fields randomly taken from each slice. (C) Western blot of p4EBP1 and total 4EBP1 in intracranial U87MG xenografts after completion of the 5-day treatment with saline, <b>1</b>@PNPs-SCR, or <b>1</b>@PNPs-Gint4.T. (left) Four representative tumors per group are shown. α-tubulin was used as internal control. (right) Quantitation of p4EBP1/4EBP1. Each data point represents the sample from an individual mouse (<i>n</i> = 8). One-way ANOVA followed by Tukey’s multiple comparison test (C) or student’s <i>t</i>-test (B). **<i>P</i> < 0.01; *<i>P</i> < 0.05; ns, no significance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-10/acs.jmedchem.7b00527/20170519/images/large/jm-2017-005279_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00527&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Louis, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reifenberger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Deimling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figarella-Branger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavenee, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohgaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiestler, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleihues, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellison, D. W.</span><span> </span><span class="NLM_article-title">The 2016 World Health Organization classification of tumors of the central nervous system: a summary</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span><span class="refDoi"> DOI: 10.1007/s00401-016-1545-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1007%2Fs00401-016-1545-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=27157931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A280%3ADC%252BC28bnsVektA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2016&pages=803-820&issue=6&author=D.+N.+Louisauthor=A.+Perryauthor=G.+Reifenbergerauthor=A.+Von+Deimlingauthor=D.+Figarella-Brangerauthor=W.+K.+Caveneeauthor=H.+Ohgakiauthor=O.+D.+Wiestlerauthor=P.+Kleihuesauthor=D.+W.+Ellison&title=The+2016+World+Health+Organization+classification+of+tumors+of+the+central+nervous+system%3A+a+summary&doi=10.1007%2Fs00401-016-1545-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary</span></div><div class="casAuthors">Louis David N; Perry Arie; Reifenberger Guido; Reifenberger Guido; von Deimling Andreas; von Deimling Andreas; Figarella-Branger Dominique; Cavenee Webster K; Ohgaki Hiroko; Wiestler Otmar D; Kleihues Paul; Ellison David W</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">803-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The 2016 World Health Organization Classification of Tumors of the Central Nervous System is both a conceptual and practical advance over its 2007 predecessor.  For the first time, the WHO classification of CNS tumors uses molecular parameters in addition to histology to define many tumor entities, thus formulating a concept for how CNS tumor diagnoses should be structured in the molecular era.  As such, the 2016 CNS WHO presents major restructuring of the diffuse gliomas, medulloblastomas and other embryonal tumors, and incorporates new entities that are defined by both histology and molecular features, including glioblastoma, IDH-wildtype and glioblastoma, IDH-mutant; diffuse midline glioma, H3 K27M-mutant; RELA fusion-positive ependymoma; medulloblastoma, WNT-activated and medulloblastoma, SHH-activated; and embryonal tumour with multilayered rosettes, C19MC-altered.  The 2016 edition has added newly recognized neoplasms, and has deleted some entities, variants and patterns that no longer have diagnostic and/or biological relevance.  Other notable changes include the addition of brain invasion as a criterion for atypical meningioma and the introduction of a soft tissue-type grading system for the now combined entity of solitary fibrous tumor / hemangiopericytoma-a departure from the manner by which other CNS tumors are graded.  Overall, it is hoped that the 2016 CNS WHO will facilitate clinical, experimental and epidemiological studies that will lead to improvements in the lives of patients with brain tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7YzqOXqWReQqdek-gHSrIfW6udTcc2ebFbSRaQcBxU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bnsVektA%253D%253D&md5=f9ac51999bf1b171477b20ea0085c9e8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00401-016-1545-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-016-1545-1%26sid%3Dliteratum%253Aachs%26aulast%3DLouis%26aufirst%3DD.%2BN.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DReifenberger%26aufirst%3DG.%26aulast%3DVon%2BDeimling%26aufirst%3DA.%26aulast%3DFigarella-Branger%26aufirst%3DD.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DOhgaki%26aufirst%3DH.%26aulast%3DWiestler%26aufirst%3DO.%2BD.%26aulast%3DKleihues%26aufirst%3DP.%26aulast%3DEllison%26aufirst%3DD.%2BW.%26atitle%3DThe%25202016%2520World%2520Health%2520Organization%2520classification%2520of%2520tumors%2520of%2520the%2520central%2520nervous%2520system%253A%2520a%2520summary%26jtitle%3DActa%2520Neuropathol.%26date%3D2016%26volume%3D131%26issue%3D6%26spage%3D803%26epage%3D820%26doi%3D10.1007%2Fs00401-016-1545-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naishadham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer statistic</span> <span class="citation_source-journal">Ca-Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.3322/caac.20138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.3322%2Fcaac.20138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=22237781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A280%3ADC%252BC387jvVaitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=10-29&author=R.+Siegelauthor=D.+Naishadhamauthor=A.+Jemal&title=Cancer+statistic&doi=10.3322%2Fcaac.20138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2012</span></div><div class="casAuthors">Siegel Rebecca; Naishadham Deepa; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">10-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from the National Center for Health Statistics.  A total of 1,638,910 new cancer cases and 577,190 deaths from cancer are projected to occur in the United States in 2012.  During the most recent 5 years for which there are data (2004-2008), overall cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.6% per year in women.  Over the past 10 years of available data (1999-2008), cancer death rates have declined by more than 1% per year in men and women of every racial/ethnic group with the exception of American Indians/Alaska Natives, among whom rates have remained stable.  The most rapid declines in death rates occurred among African American and Hispanic men (2.4% and 2.3% per year, respectively).  Death rates continue to decline for all 4 major cancer sites (lung, colorectum, breast, and prostate), with lung cancer accounting for almost 40% of the total decline in men and breast cancer accounting for 34% of the total decline in women.  The reduction in overall cancer death rates since 1990 in men and 1991 in women translates to the avoidance of about 1,024,400 deaths from cancer.  Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population, with an emphasis on those groups in the lowest socioeconomic bracket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzMtZQZY6EXFMGsG_HTXYFfW6udTcc2eYHECemEidQ-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387jvVaitg%253D%253D&md5=4d68e55759bf217f9a46c22be1af7f86</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3322%2Fcaac.20138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.20138%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DNaishadham%26aufirst%3DD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistic%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2012%26volume%3D62%26spage%3D10%26epage%3D29%26doi%3D10.3322%2Fcaac.20138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Deeken, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löscher, W.</span><span> </span><span class="NLM_article-title">The blood-brain barrier and cancer: transporters, treatment, and trojan horses</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-2854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F1078-0432.CCR-06-2854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=17363519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1663&author=J.+F.+Deekenauthor=W.+L%C3%B6scher&title=The+blood-brain+barrier+and+cancer%3A+transporters%2C+treatment%2C+and+trojan+horses&doi=10.1158%2F1078-0432.CCR-06-2854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses</span></div><div class="casAuthors">Deeken, John F.; Loescher, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1663-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite scientific advances in understanding the causes and treatment of human malignancy, a persistent challenge facing basic and clin. investigators is how to adequately treat primary and metastatic brain tumors.  The blood-brain barrier is a physiol. obstruction to the delivery of systemic chemotherapy to the brain parenchyma and central nervous system (CNS).  A no. of physiol. properties make the endothelium in the CNS distinct from the vasculature found in the periphery.  Recent evidence has shown that a crit. aspect of this barrier is composed of xenobiotic transporters which extrude substrates from the brain into the cerebrospinal fluid and systemic circulation.  These transporters also extrude drugs and toxins if they gain entry into the cytoplasm of brain endothelial cells before they enter the brain.  This review highlights the properties of the blood-brain barrier, including the location, function, and relative importance of the drug transporters that maintain this barrier.  Primary and metastatic brain malignancy can compromise this barrier, allowing some access of chemotherapy treatment to reach the tumor.  The responsiveness of brain tumors to systemic treatment found in past clin. research is discussed, as are possible explanations as to why CNS tumors are nonetheless able to evade therapy.  Finally, strategies to overcome this barrier and better deliver chemotherapy into CNS tumors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxa44seefNF7Vg90H21EOLACvtfcHk0lh4k1L5E_t2cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D&md5=dc7ea92d49779b99871f98a5e2b59858</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2854%26sid%3Dliteratum%253Aachs%26aulast%3DDeeken%26aufirst%3DJ.%2BF.%26aulast%3DL%25C3%25B6scher%26aufirst%3DW.%26atitle%3DThe%2520blood-brain%2520barrier%2520and%2520cancer%253A%2520transporters%252C%2520treatment%252C%2520and%2520trojan%2520horses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1663%26doi%3D10.1158%2F1078-0432.CCR-06-2854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wang, A. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farokhzad, O. C.</span><span> </span><span class="NLM_article-title">Nanoparticle delivery of cancer drugs</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">198</span><span class="refDoi"> DOI: 10.1146/annurev-med-040210-162544</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1146%2Fannurev-med-040210-162544" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=21888516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC38Xisleksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2012&pages=185-198&author=A.+Z.+Wangauthor=R.+Langerauthor=O.+C.+Farokhzad&title=Nanoparticle+delivery+of+cancer+drugs&doi=10.1146%2Fannurev-med-040210-162544"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Nanoparticle delivery of cancer drugs</span></div><div class="casAuthors">Wang, Andrew Z.; Langer, Robert; Farokhzad, Omid C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185-198</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Nanomedicine, the application of nanotechnol. to medicine, enabled the development of nanoparticle therapeutic carriers.  These drug carriers are passively targeted to tumors through the enhanced permeability and retention effect, so they are ideally suited for the delivery of chemotherapeutics in cancer treatment.  Indeed, advances in nanomedicine have rapidly translated into clin. practice.  To date, there are 5 clin. approved nanoparticle chemotherapeutics for cancer and many more under clin. investigation.  In this review, the authors discuss the various nanoparticle drug delivery platforms and the important concepts involved in nanoparticle drug delivery.  The authors also review the clin. data on the approved nanoparticle therapeutics as well as the nanotherapeutics under clin. investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC_JZzo8Pq47Vg90H21EOLACvtfcHk0lh4k1L5E_t2cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xisleksb4%253D&md5=e85e3486cc45faea405d2f5437570bfe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1146%2Fannurev-med-040210-162544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-med-040210-162544%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DA.%2BZ.%26aulast%3DLanger%26aufirst%3DR.%26aulast%3DFarokhzad%26aufirst%3DO.%2BC.%26atitle%3DNanoparticle%2520delivery%2520of%2520cancer%2520drugs%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2012%26volume%3D63%26spage%3D185%26epage%3D198%26doi%3D10.1146%2Fannurev-med-040210-162544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sanna, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nurra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pala, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marceddu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathania, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sechi, M.</span><span> </span><span class="NLM_article-title">Targeted nanoparticles for the delivery of novel bioactive molecules to pancreatic cancer cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">5209</span><span class="NLM_x">–</span> <span class="NLM_lpage">5220</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01571</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01571" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5209-5220&issue=11&author=V.+Sannaauthor=S.+Nurraauthor=N.+Palaauthor=S.+Marcedduauthor=D.+Pathaniaauthor=N.+Neamatiauthor=M.+Sechi&title=Targeted+nanoparticles+for+the+delivery+of+novel+bioactive+molecules+to+pancreatic+cancer+cells&doi=10.1021%2Facs.jmedchem.5b01571"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01571%26sid%3Dliteratum%253Aachs%26aulast%3DSanna%26aufirst%3DV.%26aulast%3DNurra%26aufirst%3DS.%26aulast%3DPala%26aufirst%3DN.%26aulast%3DMarceddu%26aufirst%3DS.%26aulast%3DPathania%26aufirst%3DD.%26aulast%3DNeamati%26aufirst%3DN.%26aulast%3DSechi%26aufirst%3DM.%26atitle%3DTargeted%2520nanoparticles%2520for%2520the%2520delivery%2520of%2520novel%2520bioactive%2520molecules%2520to%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D11%26spage%3D5209%26epage%3D5220%26doi%3D10.1021%2Facs.jmedchem.5b01571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Locatelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes Franchini, M.</span><span> </span><span class="NLM_article-title">Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system</span> <span class="citation_source-journal">J. Nanopart. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1316</span><span class="NLM_x">–</span> <span class="NLM_lpage">1333</span><span class="refDoi"> DOI: 10.1007/s11051-012-1316-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1007%2Fs11051-012-1316-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovFygs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=1316-1333&author=E.+Locatelliauthor=M.+Comes+Franchini&title=Biodegradable+PLGA-b-PEG+polymeric+nanoparticles%3A+synthesis%2C+properties%2C+and+nanomedical+applications+as+drug+delivery+system&doi=10.1007%2Fs11051-012-1316-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties and nanomedical applications as drug delivery system</span></div><div class="casAuthors">Locatelli, Erica; Franchini, Mauro Comes</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nanoparticle Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1316/1-1316/17, 17 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNARFA</span>;
        ISSN:<span class="NLM_cas:issn">1388-0764</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  During the past decades many synthetic polymers have been studied for nanomedicine applications and in particular as drug delivery systems.  For this purpose, polymers must be non-toxic, biodegradable and biocompatible.  Polylactic-co-glycolic acid (PLGA) is one of the most studied polymers due to its complete biodegradability and ability to self-assemble into nano-metric micelles that are able to entrap small mols. like drugs and to release them into body in a time-dependent manner.  Despite fine qualities, using PLGA polymeric nanoparticles for in vivo applications still remains an open challenge due to many factors such as poor stability in water, big diam. (150-200 nm) and the removal of these nanocarriers from the blood stream by the liver and spleen thus reducing the concn. of drugs drastically in tumor tissue.  Polyethylene glycol (PEG) is the most used polymers for drug delivery applications and the first PEGylated product is already on the market for over 20 years.  This is due to its stealth behavior that inhibits the fast recognition by the immune system (opsonization) and generally leads to a reduced blood clearance of nanocarriers increasing blood circulation time.  Furthermore, PEG is hydrophilic and able to stabilize nanoparticles by steric and not ionic effects esp. in water.  PLGA-PEG block copolymer is an emergent system because it can be easily synthesized and it possesses all good qualities of PLGA and also PEG capability so in the last decade it arose as one of the most promising systems for nanoparticles formation, drug loading and in vivo drug delivery applications.  This review will discuss briefly on PLGA-b-PEG synthesis and physicochem. properties, together with its improved qualities with respect to the single PLGA and PEG polymers.  Moreover, we will focus on but in particular will treat nanoparticles formation and uses as new drug delivery system for nanomedical applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23tZMBQIXLLVg90H21EOLACvtfcHk0lgq4LpJ8ltS5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovFygs7g%253D&md5=f73bba881d632cdfecff111981f2470d</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs11051-012-1316-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11051-012-1316-4%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DE.%26aulast%3DComes%2BFranchini%26aufirst%3DM.%26atitle%3DBiodegradable%2520PLGA-b-PEG%2520polymeric%2520nanoparticles%253A%2520synthesis%252C%2520properties%252C%2520and%2520nanomedical%2520applications%2520as%2520drug%2520delivery%2520system%26jtitle%3DJ.%2520Nanopart.%2520Res.%26date%3D2012%26volume%3D14%26spage%3D1316%26epage%3D1333%26doi%3D10.1007%2Fs11051-012-1316-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Locatelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gil, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Israel, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naddaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reese, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Vallejo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llop, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lellouche, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes Franchini, M.</span><span> </span><span class="NLM_article-title">Biocompatible nanocomposite for PET/MRI hybrid imaging</span> <span class="citation_source-journal">Int. J. Nanomed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">6021</span><span class="NLM_x">–</span> <span class="NLM_lpage">6033</span><span class="refDoi"> DOI: 10.2147/IJN.S38107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.2147%2FIJN.S38107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=23271907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslerurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=6021-6033&author=E.+Locatelliauthor=L.+Gilauthor=L.+Israelauthor=L.+Passoniauthor=M.+Naddakaauthor=A.+Pucciauthor=T.+Reeseauthor=V.+Gomez-Vallejoauthor=P.+Milaniauthor=M.+Matteoliauthor=J.+Llopauthor=J.+P.+Lelloucheauthor=M.+Comes+Franchini&title=Biocompatible+nanocomposite+for+PET%2FMRI+hybrid+imaging&doi=10.2147%2FIJN.S38107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Biocompatible nanocomposite for PET/MRI hybrid imaging</span></div><div class="casAuthors">Locatelli, Erica; Gil, Larraitz; Israel, Liron Limor; Passoni, Lorena; Naddaka, Maria; Pucci, Andrea; Reese, Torsten; Gomez-Vallejo, Vanessa; Milani, Paolo; Matteoli, Michela; Llop, Jordi; Lellouche, Jean Paul; Franchini, Mauro Comes</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Nanomedicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6021-6033</span>CODEN:
                <span class="NLM_cas:coden">IJNNHQ</span>;
        ISSN:<span class="NLM_cas:issn">1178-2013</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A novel nanocarrier system was designed and developed with key components uniquely structured at the nanoscale for early cancer diagnosis and treatment.  In order to perform magnetic resonance imaging, hydrophilic superparamagnetic maghemite nanoparticles (NPs) were synthesized and coated with a lipophilic org. ligand.  Next, they were entrapped into polymeric NPs made of biodegradable poly(lactic-co-glycolic acid) linked to polyethylene glycol.  In addn., resulting NPs have been conjugated on their surface with a 2,2'-(7-(4-((2-aminoethyl)amino)-1-carboxy-4-oxobutyl)-1,4,7-triazonane-1,4-diyl)diacetic acid ligand for subsequent 68Ga incorporation.  A cell-based cytotoxicity assay has been employed to verify the in vitro cell viability of human pancreatic cancer cells exposed to this nanosystem.  Finally, in vivo positron emission tomog.-computerized tomog. biodistribution studies in healthy animals were performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprWfhA_gP3nbVg90H21EOLACvtfcHk0lgq4LpJ8ltS5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslerurk%253D&md5=84a31df1c8091c008977e88ab9505b22</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2147%2FIJN.S38107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FIJN.S38107%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DE.%26aulast%3DGil%26aufirst%3DL.%26aulast%3DIsrael%26aufirst%3DL.%26aulast%3DPassoni%26aufirst%3DL.%26aulast%3DNaddaka%26aufirst%3DM.%26aulast%3DPucci%26aufirst%3DA.%26aulast%3DReese%26aufirst%3DT.%26aulast%3DGomez-Vallejo%26aufirst%3DV.%26aulast%3DMilani%26aufirst%3DP.%26aulast%3DMatteoli%26aufirst%3DM.%26aulast%3DLlop%26aufirst%3DJ.%26aulast%3DLellouche%26aufirst%3DJ.%2BP.%26aulast%3DComes%2BFranchini%26aufirst%3DM.%26atitle%3DBiocompatible%2520nanocomposite%2520for%2520PET%252FMRI%2520hybrid%2520imaging%26jtitle%3DInt.%2520J.%2520Nanomed.%26date%3D2012%26volume%3D7%26spage%3D6021%26epage%3D6033%26doi%3D10.2147%2FIJN.S38107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Maeda, H.</span><span> </span><span class="NLM_article-title">Tumor-selective delivery of macromolecular drugs via the epr effect: background and future prospects</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">797</span><span class="NLM_x">–</span> <span class="NLM_lpage">802</span><span class="refDoi"> DOI: 10.1021/bc100070g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc100070g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVKrtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=797-802&author=H.+Maeda&title=Tumor-selective+delivery+of+macromolecular+drugs+via+the+epr+effect%3A+background+and+future+prospects&doi=10.1021%2Fbc100070g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects</span></div><div class="casAuthors">Maeda, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">797-802</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper briefly documents the history of the discovery of the EPR (enhanced permeability and retention) effect and elucidates an analogy between bacterial infection involving proteases that trigger kinin generation and cancer.  The EPR effect of macromols. in cancer tissues is defined, and the distinction between the EPR effect (with ref. to clearance of macromols. from the interstitial space of tumor tissues) and the simple passive targeting of drugs to tumors is described.  Addnl. points of discussion include the uniqueness of tumor vessels, the influence of kinin and other vascular mediators such as nitric oxide (NO) and prostaglandins, and the heterogeneity of the EPR effect.  Two different strategies to augment the EPR effect that were discovered are elevating blood pressure artificially via slow infusion of angiotensin II and applying nitroglycerin or other NO donors.  Use of the nitro-agent increased not only the blood flow of the tumor, but also the delivery of drug to the tumor and the drug's therapeutic effect.  This finding shows an intriguing analogy to hypoxic cardiac infarct tissue, in that both are improved by NO.  These two methods were applied to treatment of rodents and human cancers, in combination with other anticancer agents, with successful results achieved in rodents as well as humans.  These data suggest very appealing prospects for utilization of the EPR effect in future development of cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1C6eqnxCV3LVg90H21EOLACvtfcHk0livCe-cRZKlxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVKrtLw%253D&md5=04609cee8cb26620b364c252d93c5335</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fbc100070g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc100070g%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DH.%26atitle%3DTumor-selective%2520delivery%2520of%2520macromolecular%2520drugs%2520via%2520the%2520epr%2520effect%253A%2520background%2520and%2520future%2520prospects%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D797%26epage%3D802%26doi%3D10.1021%2Fbc100070g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kreuter, J.</span><span> </span><span class="NLM_article-title">Nanoparticles as drug delivery systems</span> <span class="citation_source-journal">ENN</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=161-180&author=J.+Kreuter&title=Nanoparticles+as+drug+delivery+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKreuter%26aufirst%3DJ.%26atitle%3DNanoparticles%2520as%2520drug%2520delivery%2520systems%26jtitle%3DENN%26date%3D2004%26volume%3D7%26spage%3D161%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lao, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phua, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, K. W.</span><span> </span><span class="NLM_article-title">Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation</span> <span class="citation_source-journal">ACS Nano</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">2235</span><span class="NLM_x">–</span> <span class="NLM_lpage">2254</span><span class="refDoi"> DOI: 10.1021/nn507494p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/nn507494p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=2235-2254&issue=3&author=Y.+H.+Laoauthor=K.+K.+Phuaauthor=K.+W.+Leong&title=Aptamer+nanomedicine+for+cancer+therapeutics%3A+barriers+and+potential+for+translation&doi=10.1021%2Fnn507494p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation</span></div><div class="casAuthors">Lao, Yeh-Hsing; Phua, Kyle K. L.; Leong, Kam W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Nano</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">2235-2254</span>CODEN:
                <span class="NLM_cas:coden">ANCAC3</span>;
        ISSN:<span class="NLM_cas:issn">1936-0851</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Aptamer nanomedicine, including therapeutic aptamers and aptamer nanocomplexes, is beginning to fulfill its potential in both clin. trials and preclin. studies.  Esp. in oncol., aptamer nanomedicine may perform better than conventional or antibody-based chemotherapeutics due to specificity compared to the former and stability compared to the latter.  Many proof-of-concept studies on applying aptamers to drug delivery, gene therapy, and cancer imaging have shown promising efficacy and impressive safety in vivo toward translation.  Yet, there remains ample room for improvement and crit. barriers to be addressed.  In this review, we will first introduce the recent progress in clin. trials of aptamer nanomedicine, followed by a discussion of the barriers at the design and in vivo application stages.  We will then highlight recent advances and engineering strategies proposed to tackle these barriers.  Aptamer cancer nanomedicine has the potential to address one of the most important healthcare issues of the society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqze6LjH1t1uLVg90H21EOLACvtfcHk0livCe-cRZKlxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjs1GhtL0%253D&md5=b3c82fc91d325a559bf13b81fd0d5691</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fnn507494p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnn507494p%26sid%3Dliteratum%253Aachs%26aulast%3DLao%26aufirst%3DY.%2BH.%26aulast%3DPhua%26aufirst%3DK.%2BK.%26aulast%3DLeong%26aufirst%3DK.%2BW.%26atitle%3DAptamer%2520nanomedicine%2520for%2520cancer%2520therapeutics%253A%2520barriers%2520and%2520potential%2520for%2520translation%26jtitle%3DACS%2520Nano%26date%3D2015%26volume%3D9%26issue%3D3%26spage%3D2235%26epage%3D2254%26doi%3D10.1021%2Fnn507494p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Camorani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchia, L.</span><span> </span><span class="NLM_article-title">Oligonucleotide aptamers for glioma targeting: an update</span> <span class="citation_source-journal">Cent. Nerv. Syst. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">126</span><span class="NLM_x">–</span> <span class="NLM_lpage">137</span><span class="refDoi"> DOI: 10.2174/1871524915666150430122525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.2174%2F1871524915666150430122525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=25924917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsVWgsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=126-137&issue=2&author=S.+Camoraniauthor=L.+Cerchia&title=Oligonucleotide+aptamers+for+glioma+targeting%3A+an+update&doi=10.2174%2F1871524915666150430122525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oligonucleotide Aptamers for Glioma Targeting: An Update</span></div><div class="casAuthors">Camorani, Simona; Cerchia, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Central Nervous System Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-137</span>CODEN:
                <span class="NLM_cas:coden">CNSAC3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5249</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Malignant glioma is the most prevalent and lethal primary brain tumor.  Due to mol. heterogeneity and organ-specific clin. manifestations, it is essential to improve glioma treatment by shifting from conventional cytotoxic chemotherapy to more targeted therapies.  Hence, innovative approaches based on ligands able to specifically detect and measure mutated proteins assocd. to a specific tumor phenotype are needed in order to refine diagnosis and therapy of glioma.  To date, antibody- based approaches have been developed for in vivo applications but, in most cases, they show toxicity, do not reach adequate sensitivity and have a low permeability across the blood-brain-barrier.  Single-stranded nucleic acid aptamers, generated by the SELEX (Systematic Evolution of Ligands by EXponential enrichment) process, have been shown as a valuable alternative to protein antibodies because may couple the advantages of their chem. nature to the high specific binding of antibodies to their proper targets.  The simplicity of aptamers selection and derivatization with other mols. (nanocarriers, tracers for imaging, drugs) combined to low immunogenicity and toxicity, render them a versatile tool for identification of new biomarkers, in vitro diagnosis, in vivo imaging and targeted therapy.  Aim of this review article is to discuss contemporary applications of aptamers as innovative tools for glioma diagnosis and therapy.  We will describe promising new approaches for the identification of aptamers targeting proteins with a crucial role in glioma, including SELEX protocols against living glioma cells and brain tumor-initiating cells.  Addnl., we will review recently proposed aptamer-based strategies for site-targeted controlled delivery of therapeutics and imaging agents to the brain.  Summarizing, we hope that this article will provide an updated overview of perspectives and challenges for aptamer-based glioma treatment in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsADJeGS27p7Vg90H21EOLACvtfcHk0lgqbxeakATZ1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsVWgsL8%253D&md5=73963ce4ef91812f646dd921093c1b1f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F1871524915666150430122525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1871524915666150430122525%26sid%3Dliteratum%253Aachs%26aulast%3DCamorani%26aufirst%3DS.%26aulast%3DCerchia%26aufirst%3DL.%26atitle%3DOligonucleotide%2520aptamers%2520for%2520glioma%2520targeting%253A%2520an%2520update%26jtitle%3DCent.%2520Nerv.%2520Syst.%2520Agents%2520Med.%2520Chem.%26date%3D2015%26volume%3D15%26issue%3D2%26spage%3D126%26epage%3D137%26doi%3D10.2174%2F1871524915666150430122525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">20</span><span class="NLM_x">) </span> <span class="NLM_fpage">5115</span><span class="NLM_x">–</span> <span class="NLM_lpage">5123</span><span class="refDoi"> DOI: 10.1016/j.biomaterials.2012.03.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1016%2Fj.biomaterials.2012.03.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=22484043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1ajtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=5115-5123&issue=20&author=H.+Gaoauthor=J.+Qianauthor=S.+Caoauthor=Z.+Yangauthor=Z.+Pangauthor=S.+Panauthor=L.+Fanauthor=Z.+Xiauthor=X.+Jiangauthor=Q.+Zhang&title=Precise+glioma+targeting+of+and+penetration+by+aptamer+and+peptide+dual-functioned+nanoparticles&doi=10.1016%2Fj.biomaterials.2012.03.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles</span></div><div class="casAuthors">Gao, Huile; Qian, Jun; Cao, Shijie; Yang, Zhi; Pang, Zhiqing; Pan, Shuaiqi; Fan, Li; Xi, Zhangjie; Jiang, Xinguo; Zhang, Qizhi</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5115-5123</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The treatment of a brain glioma is still one of the most difficult challenges in oncol.  To effectively treat brain glioma and reduce the side effects, drugs must be transported across the blood brain barrier (BBB) and then targeted to the brain cancer cells because most anti-tumor drugs are highly toxic to the normal brain tissue.  A cascade delivery strategy was developed to perform these two aims and to achieve enhanced and precisely targeted delivery.  Herein, we utilize a phage-displayed TGN peptide and an AS1411 aptamer, which are specific targeting ligands of the BBB and cancer cells, resp. and we conjugate them with nanoparticles to establish the brain glioma cascade delivery system (AsTNP).  In vitro cell uptake and three-dimensional tumor spheroid penetration studies demonstrated that the system could not only target endothelial and tumor cells but also penetrate the endothelial monolayers and tumor cells to reach the core of the tumor spheroids, which was extremely important but mostly ignored in glioma therapy.  In vivo imaging further demonstrated that the AsTNP provided the highest tumor distribution and tumor/normal brain ratio.  The distribution was also reconfirmed by fluorescent images of the brain slides.  As a result, the docetaxel-loaded AsTNP presents the best anti-glioma effect with improved glioma bearing survival.  In conclusion, the AsTNP could precisely target to the brain glioma, which was a valuable target for glioma imaging and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdM4ckZPwFebVg90H21EOLACvtfcHk0lgqbxeakATZ1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1ajtLg%253D&md5=1e3a4d9b178e45637ca0ca2943d01f1e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2012.03.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2012.03.058%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DPang%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DXi%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DPrecise%2520glioma%2520targeting%2520of%2520and%2520penetration%2520by%2520aptamer%2520and%2520peptide%2520dual-functioned%2520nanoparticles%26jtitle%3DBiomaterials%26date%3D2012%26volume%3D33%26issue%3D20%26spage%3D5115%26epage%3D5123%26doi%3D10.1016%2Fj.biomaterials.2012.03.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Whole-cell SELEX aptamer-functionalised poly (ethyleneglycol)-poly (ε-caprolactone) nanoparticles for enhanced targeted glioblastoma therapy</span> <span class="citation_source-journal">Biomaterials</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">6264</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span><span class="refDoi"> DOI: 10.1016/j.biomaterials.2012.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1016%2Fj.biomaterials.2012.05.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=6264-6272&issue=26&author=H.+Gaoauthor=J.+Qianauthor=Z.+Yangauthor=Z.+Pangauthor=Z.+Xiauthor=S.+Caoauthor=Y.+Wangauthor=S.+Panauthor=S.+Zhangauthor=W.+Wangauthor=X.+Jiangauthor=X.+Jiangauthor=Q.+Zhang&title=Whole-cell+SELEX+aptamer-functionalised+poly+%28ethyleneglycol%29-poly+%28%CE%B5-caprolactone%29+nanoparticles+for+enhanced+targeted+glioblastoma+therapy&doi=10.1016%2Fj.biomaterials.2012.05.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2012.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2012.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DPang%26aufirst%3DZ.%26aulast%3DXi%26aufirst%3DZ.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DWhole-cell%2520SELEX%2520aptamer-functionalised%2520poly%2520%2528ethyleneglycol%2529-poly%2520%2528%25CE%25B5-caprolactone%2529%2520nanoparticles%2520for%2520enhanced%2520targeted%2520glioblastoma%2520therapy%26jtitle%3DBiomaterials%26date%3D2012%26volume%3D33%26issue%3D26%26spage%3D6264%26epage%3D6272%26doi%3D10.1016%2Fj.biomaterials.2012.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Kim, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guryanova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitomi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lathia, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serwanski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weil, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjelmeland, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, J. N.</span><span> </span><span class="NLM_article-title">Platelet-derived growth factor receptors differentially form intertumoral and intratumoral heterogeneity</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1247</span><span class="NLM_x">–</span> <span class="NLM_lpage">1262</span><span class="refDoi"> DOI: 10.1101/gad.193565.112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1101%2Fgad.193565.112" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=1247-1262&issue=11&author=Y.+Kimauthor=E.+Kimauthor=Q.+Wuauthor=O.+Guryanovaauthor=M.+Hitomiauthor=J.+D.+Lathiaauthor=D.+Serwanskiauthor=A.+E.+Sloanauthor=R.+J.+Weilauthor=J.+Leeauthor=A.+Nishiyamaauthor=S.+Baoauthor=A.+B.+Hjelmelandauthor=J.+N.+Rich&title=Platelet-derived+growth+factor+receptors+differentially+form+intertumoral+and+intratumoral+heterogeneity&doi=10.1101%2Fgad.193565.112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1101%2Fgad.193565.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.193565.112%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DGuryanova%26aufirst%3DO.%26aulast%3DHitomi%26aufirst%3DM.%26aulast%3DLathia%26aufirst%3DJ.%2BD.%26aulast%3DSerwanski%26aufirst%3DD.%26aulast%3DSloan%26aufirst%3DA.%2BE.%26aulast%3DWeil%26aufirst%3DR.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DBao%26aufirst%3DS.%26aulast%3DHjelmeland%26aufirst%3DA.%2BB.%26aulast%3DRich%26aufirst%3DJ.%2BN.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520receptors%2520differentially%2520form%2520intertumoral%2520and%2520intratumoral%2520heterogeneity%26jtitle%3DGenes%2520Dev.%26date%3D2012%26volume%3D26%26issue%3D11%26spage%3D1247%26epage%3D1262%26doi%3D10.1101%2Fgad.193565.112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Akhavan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pourzia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourian, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nathanson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nael, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamanoi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblum, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavenee, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bensinger, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">De-repression of PDGFRβ transcription promotes acquired resistance to EGFR tyrosine kinase inhibitors in glioblastoma patients</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">547</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-12-0502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F2159-8290.CD-12-0502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=534-547&author=D.+Akhavanauthor=A.+L.+Pourziaauthor=A.+A.+Nourianauthor=K.+J.+Williamsauthor=D.+Nathansonauthor=I.+Babicauthor=G.+R.+Villaauthor=K.+Tanakaauthor=A.+Naelauthor=H.+Yangauthor=J.+Dangauthor=H.+V.+Vintersauthor=W.+H.+Yongauthor=M.+Flaggauthor=F.+Tamanoiauthor=T.+Sasayamaauthor=C.+D.+Jamesauthor=H.+I.+Kornblumauthor=T.+F.+Cloughesyauthor=W.+K.+Caveneeauthor=S.+J.+Bensingerauthor=P.+S.+Mischel&title=De-repression+of+PDGFR%CE%B2+transcription+promotes+acquired+resistance+to+EGFR+tyrosine+kinase+inhibitors+in+glioblastoma+patients&doi=10.1158%2F2159-8290.CD-12-0502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-12-0502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-12-0502%26sid%3Dliteratum%253Aachs%26aulast%3DAkhavan%26aufirst%3DD.%26aulast%3DPourzia%26aufirst%3DA.%2BL.%26aulast%3DNourian%26aufirst%3DA.%2BA.%26aulast%3DWilliams%26aufirst%3DK.%2BJ.%26aulast%3DNathanson%26aufirst%3DD.%26aulast%3DBabic%26aufirst%3DI.%26aulast%3DVilla%26aufirst%3DG.%2BR.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DNael%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDang%26aufirst%3DJ.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DYong%26aufirst%3DW.%2BH.%26aulast%3DFlagg%26aufirst%3DM.%26aulast%3DTamanoi%26aufirst%3DF.%26aulast%3DSasayama%26aufirst%3DT.%26aulast%3DJames%26aufirst%3DC.%2BD.%26aulast%3DKornblum%26aufirst%3DH.%2BI.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DCavenee%26aufirst%3DW.%2BK.%26aulast%3DBensinger%26aufirst%3DS.%2BJ.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DDe-repression%2520of%2520PDGFR%25CE%25B2%2520transcription%2520promotes%2520acquired%2520resistance%2520to%2520EGFR%2520tyrosine%2520kinase%2520inhibitors%2520in%2520glioblastoma%2520patients%26jtitle%3DCancer%2520Discovery%26date%3D2013%26volume%3D3%26spage%3D534%26epage%3D547%26doi%3D10.1158%2F2159-8290.CD-12-0502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gil del Alcazar, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardebeck, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomimatsu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachoo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burma, S.</span><span> </span><span class="NLM_article-title">Inhibition of DNA double-strand break repair by the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for radiosensitization of glioblastoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1248</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-1607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F1078-0432.CCR-13-1607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=24366691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXks1Ohurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=1235-1248&issue=5&author=C.+R.+Gil+del+Alcazarauthor=M.+C.+Hardebeckauthor=B.+Mukherjeeauthor=N.+Tomimatsuauthor=X.+Gaoauthor=J.+Yanauthor=X.+J.+Xieauthor=R.+Bachooauthor=L.+Liauthor=A.+A.+Habibauthor=S.+Burma&title=Inhibition+of+DNA+double-strand+break+repair+by+the+dual+PI3K%2FmTOR+inhibitor+NVP-BEZ235+as+a+strategy+for+radiosensitization+of+glioblastoma&doi=10.1158%2F1078-0432.CCR-13-1607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of DNA Double-Strand Break Repair by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 as a Strategy for Radiosensitization of Glioblastoma</span></div><div class="casAuthors">Gil del Alcazar, Carlos Rodrigo; Hardebeck, Molly Catherine; Mukherjee, Bipasha; Tomimatsu, Nozomi; Gao, Xiaohuan; Yan, Jingsheng; Xie, Xian-Jin; Bachoo, Robert; Li, Li; Habib, Amyn A.; Burma, Sandeep</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1235-1248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Inhibitors of the DNA damage response (DDR) have great potential for radiosensitization of numerous cancers, including glioblastomas, which are extremely radio- and chemoresistant brain tumors.  Currently, there are no DNA double-strand break (DSB) repair inhibitors that have been successful in treating glioblastoma.  Our lab. previously demonstrated that the dual phosphoinositide 3-kinase/mTOR inhibitor NVP-BEZ235 can potently inhibit the two central DDR kinases, DNA-dependent protein kinase catalytic subunit (DNA-PKcs) and ataxia-telangiectasia mutated (ATM), in vitro.  Here, we tested whether NVP-BEZ235 could also inhibit ATM and DNA-PKcs in tumors in vivo and assessed its potential as a radio- and chemosensitizer in preclin. mouse glioblastoma models.  Exptl. Design: The radiosensitizing effect of NVP-BEZ235 was tested by following tumor growth in s.c. and orthotopic glioblastoma models.  Tumors were generated using the radioresistant U87-vIII glioma cell line and GBM9 neurospheres in nude mice.  These tumors were then treated with ionizing radiation and/or NVP-BEZ235 and analyzed for DNA-PKcs and ATM activation, DSB repair inhibition, and attenuation of growth.  Results: NVP-BEZ235 potently inhibited both DNA-PKcs and ATM kinases and attenuated the repair of ionizing radiation-induced DNA damage in tumors.  This resulted in striking tumor radiosensitization, which extended the survival of brain tumor-bearing mice.  Notably, tumors displayed a higher DSB-load when compared with normal brain tissue.  NVP-BEZ235 also sensitized a subset of s.c. tumors to temozolomide, a drug routinely used concurrently with ionizing radiation for the treatment of glioblastoma.  Conclusions: These results demonstrate that it may be possible to significantly improve glioblastoma therapy by combining ionizing radiation with potent and bioavailable DNA repair inhibitors such as NVP-BEZ235.  Clin Cancer Res; 20(5); 1235-48. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU7klfy2L_M7Vg90H21EOLACvtfcHk0liel2-9vc_6bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXks1Ohurg%253D&md5=22c4c555e6d11d3ea1b426ce7bb261c7</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1607%26sid%3Dliteratum%253Aachs%26aulast%3DGil%2Bdel%2BAlcazar%26aufirst%3DC.%2BR.%26aulast%3DHardebeck%26aufirst%3DM.%2BC.%26aulast%3DMukherjee%26aufirst%3DB.%26aulast%3DTomimatsu%26aufirst%3DN.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DBachoo%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DHabib%26aufirst%3DA.%2BA.%26aulast%3DBurma%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520DNA%2520double-strand%2520break%2520repair%2520by%2520the%2520dual%2520PI3K%252FmTOR%2520inhibitor%2520NVP-BEZ235%2520as%2520a%2520strategy%2520for%2520radiosensitization%2520of%2520glioblastoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D20%26issue%3D5%26spage%3D1235%26epage%3D1248%26doi%3D10.1158%2F1078-0432.CCR-13-1607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Camorani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rienzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catuogno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iaboni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condorelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Franciscis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchia, L.</span><span> </span><span class="NLM_article-title">Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ Aptamer</span> <span class="citation_source-journal">Mol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">841</span><span class="refDoi"> DOI: 10.1038/mt.2013.300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1038%2Fmt.2013.300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=24566984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs12ht74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=828-841&author=S.+Camoraniauthor=C.+Espositoauthor=A.+Rienzoauthor=S.+Catuognoauthor=M.+Iaboniauthor=G.+Condorelliauthor=V.+De+Franciscisauthor=L.+Cerchia&title=Inhibition+of+receptor+signaling+and+of+glioblastoma-derived+tumor+growth+by+a+novel+PDGFR%CE%B2+Aptamer&doi=10.1038%2Fmt.2013.300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer</span></div><div class="casAuthors">Camorani, Simona; Esposito, Carla L.; Rienzo, Anna; Catuogno, Silvia; Iaboni, Margherita; Condorelli, Gerolama; de Franciscis, Vittorio; Cerchia, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">828-841</span>CODEN:
                <span class="NLM_cas:coden">MTOHCK</span>;
        ISSN:<span class="NLM_cas:issn">1525-0016</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelet-derived growth factor receptor β (PDGFRβ) is a cell-surface tyrosine kinase receptor implicated in several cellular processes including proliferation, migration, and angiogenesis.  It represents a compelling therapeutic target in many human tumors, including glioma.  A no. of tyrosine kinase inhibitors under development as antitumor agents have been found to inhibit PDGFRβ.  However, they are not selective as they present multiple tyrosine kinase targets.  Here, we report a novel PDGFRβ-specific antagonist represented by a nuclease-resistant RNA-aptamer, named Gint4.  T.  This aptamer is able to specifically bind to the human PDGFRβ ectodomain (Kd: 9.6 nmol/l) causing a strong inhibition of ligand-dependent receptor activation and of downstream signaling in cell lines and primary cultures of human glioblastoma cells.  Moreover, Gint4.  T aptamer drastically inhibits cell migration and proliferation, induces differentiation, and blocks tumor growth in vivo.  In addn., Gint4.  T aptamer prevents PDGFRβ heterodimerization with and resultant transactivation of epidermal growth factor receptor.  As a result, the combination of Gint4.  T and an epidermal growth factor receptor-targeted aptamer is better at slowing tumor growth than either single aptamer alone.  These findings reveal Gint4.  T as a PDGFRβ-drug candidate with translational potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos-a6AeMu6cbVg90H21EOLACvtfcHk0lgR4L5Ry3EwMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs12ht74%253D&md5=81b64a3fbb3079a1b56f27b522936dd1</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fmt.2013.300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmt.2013.300%26sid%3Dliteratum%253Aachs%26aulast%3DCamorani%26aufirst%3DS.%26aulast%3DEsposito%26aufirst%3DC.%26aulast%3DRienzo%26aufirst%3DA.%26aulast%3DCatuogno%26aufirst%3DS.%26aulast%3DIaboni%26aufirst%3DM.%26aulast%3DCondorelli%26aufirst%3DG.%26aulast%3DDe%2BFranciscis%26aufirst%3DV.%26aulast%3DCerchia%26aufirst%3DL.%26atitle%3DInhibition%2520of%2520receptor%2520signaling%2520and%2520of%2520glioblastoma-derived%2520tumor%2520growth%2520by%2520a%2520novel%2520PDGFR%25CE%25B2%2520Aptamer%26jtitle%3DMol.%2520Ther.%26date%3D2014%26volume%3D22%26spage%3D828%26epage%3D841%26doi%3D10.1038%2Fmt.2013.300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gentili, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ori, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes Franchini, M.</span><span> </span><span class="NLM_article-title">Double phase transfer of gold nanorods for surface functionalization and entrapment into PEG-Based nanocarriers</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">5874</span><span class="NLM_x">–</span> <span class="NLM_lpage">5876</span><span class="refDoi"> DOI: 10.1039/b911582j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1039%2Fb911582j" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=5874-5876&author=D.+Gentiliauthor=G.+Oriauthor=M.+Comes+Franchini&title=Double+phase+transfer+of+gold+nanorods+for+surface+functionalization+and+entrapment+into+PEG-Based+nanocarriers&doi=10.1039%2Fb911582j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1039%2Fb911582j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb911582j%26sid%3Dliteratum%253Aachs%26aulast%3DGentili%26aufirst%3DD.%26aulast%3DOri%26aufirst%3DG.%26aulast%3DComes%2BFranchini%26aufirst%3DM.%26atitle%3DDouble%2520phase%2520transfer%2520of%2520gold%2520nanorods%2520for%2520surface%2520functionalization%2520and%2520entrapment%2520into%2520PEG-Based%2520nanocarriers%26jtitle%3DChem.%2520Commun.%26date%3D2009%26volume%3D39%26spage%3D5874%26epage%3D5876%26doi%3D10.1039%2Fb911582j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Schuch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deiters, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Köhler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuchmann, H. P.</span><span> </span><span class="NLM_article-title">Production of W/O/W (water-in-oil-in-water) multiple emulsions: droplet breakup and release of water</span> <span class="citation_source-journal">J. Colloid Interface Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span><span class="refDoi"> DOI: 10.1016/j.jcis.2013.03.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1016%2Fj.jcis.2013.03.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=23643254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntVaksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2013&pages=157-164&author=A.+Schuchauthor=P.+Deitersauthor=J.+Henneauthor=K.+K%C3%B6hlerauthor=H.+P.+Schuchmann&title=Production+of+W%2FO%2FW+%28water-in-oil-in-water%29+multiple+emulsions%3A+droplet+breakup+and+release+of+water&doi=10.1016%2Fj.jcis.2013.03.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Production of W/O/W (water-in-oil-in-water) multiple emulsions. Droplet breakup and release of water</span></div><div class="casAuthors">Schuch, Anna; Deiters, Philipp; Henne, Julius; Kohler, Karsten; Schuchmann, Heike P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Colloid and Interface Science</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-164</span>CODEN:
                <span class="NLM_cas:coden">JCISA5</span>;
        ISSN:<span class="NLM_cas:issn">0021-9797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We investigate breakup of W/O/W double emulsion droplets at high viscosity ratios and coalescence of inner water droplets dependent on the dispersed phase content (DPC) of the inner emulsion.The rheol. analyses of the inner emulsions confirm the behavior expected from literature - increasing viscosity with increasing DPC and elastic behavior for high DPC.  The resulting droplet sizes seem to be influenced only by the viscosity ratio calcd. using the viscosity of the inner emulsion.  An influence of the elastic properties of the inner emulsions could not be obsd.  Moreover, breakup of double emulsion droplets seems to follow the same rules as breakup of Newtonian droplets.  In the second part of the paper we focus on the release of water from double emulsions by coalescence.  A direct correlation between resulting double emulsion droplet sizes and encapsulation efficiency was found for each system.  The initial inner dispersed phase content has a big influence on the release rate.  This can partly be explained by the influence of the dispersed phase content on collision rate.  For high internal phase concns. inner droplets coalesce with each other.  The so formed bigger inner droplets seem to increase the overall release rate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWxMDw8Knqj7Vg90H21EOLACvtfcHk0lgR4L5Ry3EwMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntVaksLc%253D&md5=dd21d9746fb5b23446d9c5a07c57c136</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jcis.2013.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcis.2013.03.066%26sid%3Dliteratum%253Aachs%26aulast%3DSchuch%26aufirst%3DA.%26aulast%3DDeiters%26aufirst%3DP.%26aulast%3DHenne%26aufirst%3DJ.%26aulast%3DK%25C3%25B6hler%26aufirst%3DK.%26aulast%3DSchuchmann%26aufirst%3DH.%2BP.%26atitle%3DProduction%2520of%2520W%252FO%252FW%2520%2528water-in-oil-in-water%2529%2520multiple%2520emulsions%253A%2520droplet%2520breakup%2520and%2520release%2520of%2520water%26jtitle%3DJ.%2520Colloid%2520Interface%2520Sci.%26date%3D2013%26volume%3D402%26spage%3D157%26epage%3D164%26doi%3D10.1016%2Fj.jcis.2013.03.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Makadia, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span> </span><span class="NLM_article-title">Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier</span> <span class="citation_source-journal">Polymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1397</span><span class="refDoi"> DOI: 10.3390/polym3031377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.3390%2Fpolym3031377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=22577513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOis7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=1377-1397&issue=3&author=H.+K.+Makadiaauthor=S.+J.+Siegel&title=Poly+lactic-co-glycolic+acid+%28PLGA%29+as+biodegradable+controlled+drug+delivery+carrier&doi=10.3390%2Fpolym3031377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier</span></div><div class="casAuthors">Makadia, Hirenkumar K.; Siegel, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Polymers (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1377-1397</span>CODEN:
                <span class="NLM_cas:coden">POLYCK</span>;
        ISSN:<span class="NLM_cas:issn">2073-4360</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  In past two decades poly lactic-co-glycolic acid (PLGA) has been among the most attractive polymeric candidates used to fabricate devices for drug delivery and tissue engineering applications.  PLGA is biocompatible and biodegradable, exhibits a wide range of erosion times, has tunable mech. properties and most importantly, is a FDA approved polymer.  In particular, PLGA has been extensively studied for the development of devices for controlled delivery of small mol. drugs, proteins and other macromols. in com. use and in research.  This manuscript describes the various fabrication techniques for these devices and the factors affecting their degrdn. and drug release.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqKSnjbA3YlrVg90H21EOLACvtfcHk0lhHkY0WUWl3Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOis7jJ&md5=dcc6e49beb083af56e0cc3213bb99f72</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3390%2Fpolym3031377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fpolym3031377%26sid%3Dliteratum%253Aachs%26aulast%3DMakadia%26aufirst%3DH.%2BK.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26atitle%3DPoly%2520lactic-co-glycolic%2520acid%2520%2528PLGA%2529%2520as%2520biodegradable%2520controlled%2520drug%2520delivery%2520carrier%26jtitle%3DPolymers%26date%3D2011%26volume%3D3%26issue%3D3%26spage%3D1377%26epage%3D1397%26doi%3D10.3390%2Fpolym3031377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Camorani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crescenzi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colecchia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpentieri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amoresano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiariello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchia, L.</span><span> </span><span class="NLM_article-title">Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37570</span><span class="NLM_x">–</span> <span class="NLM_lpage">37587</span><span class="refDoi"> DOI: 10.18632/oncotarget.6066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.18632%2Foncotarget.6066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=26461476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A280%3ADC%252BC28zhs1SjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=37570-37587&author=S.+Camoraniauthor=E.+Crescenziauthor=D.+Colecchiaauthor=A.+Carpentieriauthor=A.+Amoresanoauthor=M.+Fedeleauthor=M.+Chiarielloauthor=L.+Cerchia&title=Aptamer+targeting+EGFRvIII+mutant+hampers+its+constitutive+autophosphorylation+and+affects+migration%2C+invasion+and+proliferation+of+glioblastoma+cells&doi=10.18632%2Foncotarget.6066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells</span></div><div class="casAuthors">Camorani Simona; Crescenzi Elvira; Fedele Monica; Cerchia Laura; Colecchia David; Chiariello Mario; Carpentieri Andrea; Amoresano Angela</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">37570-87</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Glioblastoma Multiforme (GBM) is the most common and aggressive human brain tumor, associated with very poor survival despite surgery, radiotherapy and chemotherapy.The epidermal growth factor receptor (EGFR) and the platelet-derived growth factor receptor β (PDGFRβ) are hallmarks in GBM with driving roles in tumor progression.  In approximately half of the tumors with amplified EGFR, the EGFRvIII truncated extracellular mutant is detected.  EGFRvIII does not bind ligands, is highly oncogenic and its expression confers resistance to EGFR tyrosine kinase inhibitors (TKIs).  It has been demonstrated that EGFRvIII-dependent cancers may escape targeted therapy by developing dependence on PDGFRβ signaling, thus providing a strong rationale for combination therapy aimed at blocking both EGFRvIII and PDGFRβsignaling.We have recently generated two nuclease resistant RNA aptamers, CL4 and Gint4.T, as high affinity ligands and inhibitors of the human wild-type EGFR (EGFRwt) and PDGFRβ, respectively.Herein, by different approaches, we demonstrate that CL4 aptamer binds to the EGFRvIII mutant even though it lacks most of the extracellular domain.  As a consequence of binding, the aptamer inhibits EGFRvIII autophosphorylation and downstream signaling pathways, thus affecting migration, invasion and proliferation of EGFRvIII-expressing GBM cell lines.Further, we show that targeting EGFRvIII by CL4, as well as by EGFR-TKIs, erlotinib and gefitinib, causes upregulation of PDGFRβ.  Importantly, CL4 and gefitinib cooperate with the anti-PDGFRβ Gint4.T aptamer in inhibiting cell proliferation.The proposed aptamer-based strategy could have impact on targeted molecular cancer therapies and may result in progresses against GBMs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzbSs0VCb97WZyxfu64m4ffW6udTcc2ebVnHX8pbVXRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zhs1SjtQ%253D%253D&md5=570c85775ada7655e509c0ef0b8c2d8e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6066%26sid%3Dliteratum%253Aachs%26aulast%3DCamorani%26aufirst%3DS.%26aulast%3DCrescenzi%26aufirst%3DE.%26aulast%3DColecchia%26aufirst%3DD.%26aulast%3DCarpentieri%26aufirst%3DA.%26aulast%3DAmoresano%26aufirst%3DA.%26aulast%3DFedele%26aufirst%3DM.%26aulast%3DChiariello%26aufirst%3DM.%26aulast%3DCerchia%26aufirst%3DL.%26atitle%3DAptamer%2520targeting%2520EGFRvIII%2520mutant%2520hampers%2520its%2520constitutive%2520autophosphorylation%2520and%2520affects%2520migration%252C%2520invasion%2520and%2520proliferation%2520of%2520glioblastoma%2520cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D37570%26epage%3D37587%26doi%3D10.18632%2Foncotarget.6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kong, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamori, T.</span><span> </span><span class="NLM_article-title">Advances in development of phosphatidylinositol 3-kinase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">2839</span><span class="NLM_x">–</span> <span class="NLM_lpage">2854</span><span class="refDoi"> DOI: 10.2174/092986709788803222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.2174%2F092986709788803222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=19689267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvVynt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=2839-2854&issue=22&author=D.+Kongauthor=T.+Yamori&title=Advances+in+development+of+phosphatidylinositol+3-kinase+inhibitors&doi=10.2174%2F092986709788803222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in development of phosphatidylinositol 3-kinase inhibitors</span></div><div class="casAuthors">Kong, Dexin; Yamori, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2839-2854</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphatidylinositol 3-kinases (P13Ks) are a class of lipid kinases that phosphorylate phosphatidylinositol 4,5-bisphosphate (PIP2) at the 3-OH of the inositol ring to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3), which in turn activates Akt and the downstream effectors like mTOR, and therefore play important roles in cell growth, survival, etc.  The phosphatase and tensin homolog deleted in chromosome ten (PTEN), acts as the catalytic antagonist of PI3K by dephosphorylating PIP3 to PIP2.  PI3K has become an important drug target for cancer therapy, since gain-of-function mutations of PIK3CA encoding PI3Kα, as well as loss-of-function mutations of PTEN, have been frequently found in human cancers.  The pharmaceutical development of PI3K inhibitors has made a great leap forward during the last 3 years.  While PI3Kβ, δ and γ isoform-specific PI3K inhibitors (TGX-221, IC87114 and AS-605240) have been developed for therapy of coronary heart disease, asthma, and glomerulonephritis, resp., a promising PI3Kα specific inhibitor is not yet available.  Correspondingly, almost all of the promising PI3K inhibitors under development for cancer therapy, such as NVP-BEZ235, GDC-0941 and ZSTK474, are pan-PI3K isoform inhibitors.  Each of these pan-PI3K inhibitors seems to induce a common G1 phase arrest.  All have shown favorable in vivo anticancer efficacies and low toxicities, and therefore most have entered evaluation in clin. trials.  P-Akt and p-S6 have been reported to be feasible pharmacodynamic biomarkers for monitoring the efficacy of these agents.  In the process of discovery of these and other PI3K inhibitors, detailed structure-activity relation studies were carried out.  This review summarizes key advances in the development of PI3K inhibitors, which is preceded by an introduction of PI3K family and their functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo34auL80q6urVg90H21EOLACvtfcHk0liqtGq40zYQWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvVynt7c%253D&md5=7bcedc62a6b1a0b570143d49ba861fee</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F092986709788803222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986709788803222%26sid%3Dliteratum%253Aachs%26aulast%3DKong%26aufirst%3DD.%26aulast%3DYamori%26aufirst%3DT.%26atitle%3DAdvances%2520in%2520development%2520of%2520phosphatidylinositol%25203-kinase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2009%26volume%3D16%26issue%3D22%26spage%3D2839%26epage%3D2854%26doi%3D10.2174%2F092986709788803222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Gingras, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gygi, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raught, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakiewicz, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoekstra, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenberg, N.</span><span> </span><span class="NLM_article-title">Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1422</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.1101/gad.13.11.1422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1101%2Fgad.13.11.1422" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1999&pages=1422-1437&issue=11&author=A.+C.+Gingrasauthor=S.+P.+Gygiauthor=B.+Raughtauthor=R.+D.+Polakiewiczauthor=R.+T.+Abrahamauthor=M.+F.+Hoekstraauthor=R.+Aebersoldauthor=N.+Sonenberg&title=Regulation+of+4E-BP1+phosphorylation%3A+a+novel+two-step+mechanism&doi=10.1101%2Fgad.13.11.1422"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1101%2Fgad.13.11.1422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.13.11.1422%26sid%3Dliteratum%253Aachs%26aulast%3DGingras%26aufirst%3DA.%2BC.%26aulast%3DGygi%26aufirst%3DS.%2BP.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DPolakiewicz%26aufirst%3DR.%2BD.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DHoekstra%26aufirst%3DM.%2BF.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSonenberg%26aufirst%3DN.%26atitle%3DRegulation%2520of%25204E-BP1%2520phosphorylation%253A%2520a%2520novel%2520two-step%2520mechanism%26jtitle%3DGenes%2520Dev.%26date%3D1999%26volume%3D13%26issue%3D11%26spage%3D1422%26epage%3D1437%26doi%3D10.1101%2Fgad.13.11.1422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Carcaboso, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmeliegy, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4499</span><span class="NLM_x">–</span> <span class="NLM_lpage">4508</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-4264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F0008-5472.CAN-09-4264" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=4499-4508&issue=11&author=A.+M.+Carcabosoauthor=M.+A.+Elmeliegyauthor=J.+Shenauthor=S.+J.+Juelauthor=Z.+M.+Zhangauthor=C.+Calabreseauthor=L.+Traceyauthor=C.+M.+Watersauthor=C.+F.+Stewart&title=Tyrosine+kinase+inhibitor+gefitinib+enhances+topotecan+penetration+of+gliomas&doi=10.1158%2F0008-5472.CAN-09-4264"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-4264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-4264%26sid%3Dliteratum%253Aachs%26aulast%3DCarcaboso%26aufirst%3DA.%2BM.%26aulast%3DElmeliegy%26aufirst%3DM.%2BA.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DJuel%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BM.%26aulast%3DCalabrese%26aufirst%3DC.%26aulast%3DTracey%26aufirst%3DL.%26aulast%3DWaters%26aufirst%3DC.%2BM.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26atitle%3DTyrosine%2520kinase%2520inhibitor%2520gefitinib%2520enhances%2520topotecan%2520penetration%2520of%2520gliomas%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D11%26spage%3D4499%26epage%3D4508%26doi%3D10.1158%2F0008-5472.CAN-09-4264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Agarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchanda, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelbaum, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlfest, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmquist, W. F.</span><span> </span><span class="NLM_article-title">Function of the blood-brain barrier and restriction of drug delivery to invasive glioma cells: findings in an orthotopic rat xenograft model of glioma</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1124/dmd.112.048322</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1124%2Fdmd.112.048322" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=33-39&author=S.+Agarwalauthor=P.+Manchandaauthor=M.+A.+Vogelbaumauthor=J.+R.+Ohlfestauthor=W.+F.+Elmquist&title=Function+of+the+blood-brain+barrier+and+restriction+of+drug+delivery+to+invasive+glioma+cells%3A+findings+in+an+orthotopic+rat+xenograft+model+of+glioma&doi=10.1124%2Fdmd.112.048322"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.112.048322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.112.048322%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DS.%26aulast%3DManchanda%26aufirst%3DP.%26aulast%3DVogelbaum%26aufirst%3DM.%2BA.%26aulast%3DOhlfest%26aufirst%3DJ.%2BR.%26aulast%3DElmquist%26aufirst%3DW.%2BF.%26atitle%3DFunction%2520of%2520the%2520blood-brain%2520barrier%2520and%2520restriction%2520of%2520drug%2520delivery%2520to%2520invasive%2520glioma%2520cells%253A%2520findings%2520in%2520an%2520orthotopic%2520rat%2520xenograft%2520model%2520of%2520glioma%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D33%26epage%3D39%26doi%3D10.1124%2Fdmd.112.048322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alicke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barck, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carano, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edgar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharbanda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeppen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plise, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokorny, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reslan, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkaria, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gould, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, H. S.</span><span> </span><span class="NLM_article-title">Targeting the PI3K pathway in the brain-efficacy of a PI3K inhibitor optimized to cross, the blood-brain barrier</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6239</span><span class="NLM_x">–</span> <span class="NLM_lpage">6248</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-0720</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1158%2F1078-0432.CCR-12-0720" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=22992516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs12jur3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=6239-6248&author=L.+Salphatiauthor=T.+P.+Heffronauthor=B.+Alickeauthor=M.+Nishimuraauthor=K.+Barckauthor=R.+A.+Caranoauthor=J.+Cheongauthor=K.+A.+Edgarauthor=J.+Greveauthor=S.+Kharbandaauthor=H.+Koeppenauthor=S.+Lauauthor=L.+B.+Leeauthor=J.+Pangauthor=E.+G.+Pliseauthor=J.+L.+Pokornyauthor=H.+B.+Reslanauthor=J.+N.+Sarkariaauthor=J.+J.+Wallinauthor=X.+Zhangauthor=S.+E.+Gouldauthor=A.+G.+Oliveroauthor=H.+S.+Phillips&title=Targeting+the+PI3K+pathway+in+the+brain-efficacy+of+a+PI3K+inhibitor+optimized+to+cross%2C+the+blood-brain+barrier&doi=10.1158%2F1078-0432.CCR-12-0720"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PI3K Pathway in the Brain-Efficacy of a PI3K Inhibitor Optimized to Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Salphati, Laurent; Heffron, Timothy P.; Alicke, Bruno; Nishimura, Merry; Barck, Kai; Carano, Richard A.; Cheong, Jonathan; Edgar, Kyle A.; Greve, Joan; Kharbanda, Samir; Koeppen, Hartmut; Lau, Shari; Lee, Leslie B.; Pang, Jodie; Plise, Emile G.; Pokorny, Jenny L.; Reslan, Hani Bou; Sarkaria, Jann N.; Wallin, Jeffrey J.; Zhang, Xiaolin; Gould, Stephen E.; Olivero, Alan G.; Phillips, Heidi S.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6239-6248</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Glioblastoma (GBM), the most common primary brain tumor in adults, presents a high frequency of alteration in the PI3K pathway.  Our objectives were to identify a dual PI3K/mTOR inhibitor optimized to cross the blood-brain barrier (BBB) and characterize its brain penetration, pathway modulation in the brain and efficacy in orthotopic xenograft models of GBM.  Exptl. Design: Physicochem. properties of PI3K inhibitors were optimized using in silico tools, leading to the identification of GNE-317.  This compd. was tested in cells overexpressing P-glycoprotein (P-gp) or breast cancer resistance protein (BCRP).  Following administration to mice, GNE-317 plasma and brain concns. were detd., and phosphorylated biomarkers (pAkt, p4EBP1, and pS6) were measured to assess PI3K pathway suppression in the brain.  GNE-317 efficacy was evaluated in the U87, GS2, and GBM10 orthotopic models of GBM.  Results: GNE-317 was identified as having physicochem. properties predictive of low efflux by P-gp and BCRP.  Studies in transfected MDCK cells showed that GNE-317 was not a substrate of either transporter.  GNE-317 markedly inhibited the PI3K pathway in mouse brain, causing 40% to 90% suppression of the pAkt and pS6 signals up to 6-h postdose.  GNE-317 was efficacious in the U87, GS2, and GBM10 orthotopic models, achieving tumor growth inhibition of 90% and 50%, and survival benefit, resp.  Conclusions: These results indicated that specific optimization of PI3K inhibitors to cross the BBB led to potent suppression of the PI3K pathway in healthy brain.  The efficacy of GNE-317 in 3 intracranial models of GBM suggested that this compd. could be effective in the treatment of GBM.  Clin Cancer Res; 18(22); 6239-48. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw61JdQWneebVg90H21EOLACvtfcHk0lh9sRSxSBYRjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs12jur3J&md5=04450de4d9e3106d7f4d8fb831f9e9ac</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-0720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-0720%26sid%3Dliteratum%253Aachs%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DAlicke%26aufirst%3DB.%26aulast%3DNishimura%26aufirst%3DM.%26aulast%3DBarck%26aufirst%3DK.%26aulast%3DCarano%26aufirst%3DR.%2BA.%26aulast%3DCheong%26aufirst%3DJ.%26aulast%3DEdgar%26aufirst%3DK.%2BA.%26aulast%3DGreve%26aufirst%3DJ.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DKoeppen%26aufirst%3DH.%26aulast%3DLau%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPlise%26aufirst%3DE.%2BG.%26aulast%3DPokorny%26aufirst%3DJ.%2BL.%26aulast%3DReslan%26aufirst%3DH.%2BB.%26aulast%3DSarkaria%26aufirst%3DJ.%2BN.%26aulast%3DWallin%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPhillips%26aufirst%3DH.%2BS.%26atitle%3DTargeting%2520the%2520PI3K%2520pathway%2520in%2520the%2520brain-efficacy%2520of%2520a%2520PI3K%2520inhibitor%2520optimized%2520to%2520cross%252C%2520the%2520blood-brain%2520barrier%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26spage%3D6239%26epage%3D6248%26doi%3D10.1158%2F1078-0432.CCR-12-0720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Plate, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breier, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Risau, W.</span><span> </span><span class="NLM_article-title">Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">534</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1992&pages=529-534&issue=4&author=K.+H.+Plateauthor=G.+Breierauthor=C.+L.+Farrellauthor=W.+Risau&title=Platelet-derived+growth+factor+receptor-beta+is+induced+during+tumor+development+and+upregulated+during+tumor+progression+in+endothelial+cells+in+human+gliomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlate%26aufirst%3DK.%2BH.%26aulast%3DBreier%26aufirst%3DG.%26aulast%3DFarrell%26aufirst%3DC.%2BL.%26aulast%3DRisau%26aufirst%3DW.%26atitle%3DPlatelet-derived%2520growth%2520factor%2520receptor-beta%2520is%2520induced%2520during%2520tumor%2520development%2520and%2520upregulated%2520during%2520tumor%2520progression%2520in%2520endothelial%2520cells%2520in%2520human%2520gliomas%26jtitle%3DLab.%2520Invest.%26date%3D1992%26volume%3D67%26issue%3D4%26spage%3D529%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Esposito, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuzzo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rienzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alder, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricci-Vitiani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catuogno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Franciscis, V.</span><span> </span><span class="NLM_article-title">A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells</span> <span class="citation_source-journal">J. Controlled Release</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">238</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/j.jconrel.2016.07.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.1016%2Fj.jconrel.2016.07.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=27448441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ersLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=238&publication_year=2016&pages=43-57&author=C.+L.+Espositoauthor=S.+Nuzzoauthor=S.+A.+Kumarauthor=A.+Rienzoauthor=C.+L.+Lawrenceauthor=R.+Palliniauthor=L.+Shawauthor=J.+E.+Alderauthor=L.+Ricci-Vitianiauthor=S.+Catuognoauthor=V.+de+Franciscis&title=A+combined+microRNA-based+targeted+therapeutic+approach+to+eradicate+glioblastoma+stem-like+cells&doi=10.1016%2Fj.jconrel.2016.07.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells</span></div><div class="casAuthors">Esposito, Carla L.; Nuzzo, Silvia; Kumar, Swati A.; Rienzo, Anna; Lawrence, Clare L.; Pallini, Roberto; Shaw, Lisa; Alder, Jane E.; Ricci-Vitiani, Lucia; Catuogno, Silvia; de Franciscis, Vittorio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">238</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">43-57</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A minor population of glioblastoma stem-like cells (GSCs) has been implicated in the relapse and resistance of glioblastoma to therapeutic treatments.  Based on knowledge of the involvement of multiple microRNAs in GSC propagation, we designed a combinational approach to target the GSC population with multiple miRNA-based therapeutics.  As carriers for the targeted delivery we took advantage of two aptamers that bind to, and inhibit, the receptor tyrosine kinases, Axl and PDGFRβ.  We showed that the aptamer conjugates are transported through an in vitro blood-brain barrier (BBB) model.  Furthermore, combining miR-137 and antimiR-10b synergizes with the receptor inhibitory function of aptamer carriers and prevents GSC expansion.  Results highlighted the potential of combining multifunctional RNA-based therapeutics for selective targeting of GSCs and offer a proof of principle strategy to potentially fulfill the still unmet need for effective and safe treatment of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoplPwWarxGb7Vg90H21EOLACvtfcHk0lh9sRSxSBYRjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ersLbP&md5=6dedad082afe6256c959391029644947</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2016.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2016.07.032%26sid%3Dliteratum%253Aachs%26aulast%3DEsposito%26aufirst%3DC.%2BL.%26aulast%3DNuzzo%26aufirst%3DS.%26aulast%3DKumar%26aufirst%3DS.%2BA.%26aulast%3DRienzo%26aufirst%3DA.%26aulast%3DLawrence%26aufirst%3DC.%2BL.%26aulast%3DPallini%26aufirst%3DR.%26aulast%3DShaw%26aufirst%3DL.%26aulast%3DAlder%26aufirst%3DJ.%2BE.%26aulast%3DRicci-Vitiani%26aufirst%3DL.%26aulast%3DCatuogno%26aufirst%3DS.%26aulast%3Dde%2BFranciscis%26aufirst%3DV.%26atitle%3DA%2520combined%2520microRNA-based%2520targeted%2520therapeutic%2520approach%2520to%2520eradicate%2520glioblastoma%2520stem-like%2520cells%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2016%26volume%3D238%26spage%3D43%26epage%3D57%26doi%3D10.1016%2Fj.jconrel.2016.07.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Martin, R. C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Locatelli, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaco, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comes Franchini, M.</span><span> </span><span class="NLM_article-title">Gold nanorods and curcumin-loaded nanomicelles for efficient <i>in vivo</i> photothermal therapy of Barrett’s esophagus</span> <span class="citation_source-journal">Nanomedicine (London, U. K.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1723</span><span class="NLM_x">–</span> <span class="NLM_lpage">1733</span><span class="refDoi"> DOI: 10.2217/nnm.15.25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=10.2217%2Fnnm.15.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=25706349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVSru7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1723-1733&author=R.+C.+G.+Martinauthor=E.+Locatelliauthor=Y.+Liauthor=W.+Zhangauthor=S.+Liauthor=I.+Monacoauthor=M.+Comes+Franchini&title=Gold+nanorods+and+curcumin-loaded+nanomicelles+for+efficient+in+vivo+photothermal+therapy+of+Barrett%E2%80%99s+esophagus&doi=10.2217%2Fnnm.15.25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Gold nanorods and curcumin-loaded nanomicelles for efficient in vivo photothermal therapy of Barrett's esophagus</span></div><div class="casAuthors">Martin, Robert C. G.; Locatelli, Erica; Li, Yan; Zhang, Weizhong; Li, Suping; Monaco, Ilaria; Franchini, Mauro Comes</div><div class="citationInfo"><span class="NLM_cas:title">Nanomedicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1723-1733</span>CODEN:
                <span class="NLM_cas:coden">NLUKAC</span>;
        ISSN:<span class="NLM_cas:issn">1743-5889</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">Aim: Provide an enhanced local drug delivery, nanoparticle(s) to minimize systemic effects and achieve enhanced permeability and drug retention into abnormal cells and stroma.  Materials & methods: Here a simultaneous loading of lipophilic gold nanorods (GNRs) and curcumin into polymeric nanomicelles made of biocompatible PLGA-b-PEG copolymer through a double re-emulsification process has been developed.  Results: Initial results in vitro on Barrett's esophagus and esophageal adenocarcinoma cell lines demonstrated a significant redn. in cell viability with curcumin and GNRs exposure (p < 0.05).  In vivo Barrett's-assocd. animal model confirmed these results with successful in vivo demonstrated eradication of all high-grade dysplastic premalignant cancer cells.  Conclusion: The synthesis of this novel nanosystem contg. GNRs and curcumin is safe and effective in treating and eradicating premalignant esophageal adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE94vSxHlsPbVg90H21EOLACvtfcHk0ljntZ1MmAGLHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVSru7fE&md5=9740aef90c83f8ed712b6e4f5fe4ed28</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2217%2Fnnm.15.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Fnnm.15.25%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DR.%2BC.%2BG.%26aulast%3DLocatelli%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DMonaco%26aufirst%3DI.%26aulast%3DComes%2BFranchini%26aufirst%3DM.%26atitle%3DGold%2520nanorods%2520and%2520curcumin-loaded%2520nanomicelles%2520for%2520efficient%2520in%2520vivo%2520photothermal%2520therapy%2520of%2520Barrett%25E2%2580%2599s%2520esophagus%26jtitle%3DNanomedicine%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2015%26volume%3D10%26spage%3D1723%26epage%3D1733%26doi%3D10.2217%2Fnnm.15.25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i15"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00527">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_15633"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00527">10.1021/acs.jmedchem.7b00527</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedure, quantitative analysis, in vitro and in vivo additional experiments (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_001.pdf">jm7b00527_si_001.pdf (1.62 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00527/suppl_file/jm7b00527_si_002.csv">jm7b00527_si_002.csv (0.26 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00527&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-10%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00527%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00527" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ad7a0bb9f2428","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
